Graves disease, strict definition

E4_GRAVES_STRICT

No definition available.

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps	FinnGen
Phenotype data	519870
1. Apply sex-specific rule None	519870
2. Check conditions GRAVES_COND and not AMIODARONE	9738
3. Check pre-conditions, main-only, mode, registry filters None 0 out of 7 registries used, show all original rules.	0
4. Check minimum number of events None	0
5. Include endpoints E4_THYTOXGOITDIF GRAVES_OPHT	4613
6. Filter based on genotype QC (FinnGen only)	4417

Control definitions (FinnGen only)

Controls for this endpoint are individuals that are not cases.

Extra metadata

First used in FinnGen datafreeze: DF7

NAME	E4_GRAVES_STRICT
CONTROL_EXCLUDE
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE	E4_THYTOXGOITDIF\|GRAVES_OPHT
PRE_CONDITIONS
CONDITIONS	GRAVES_COND&!AMIODARONE
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10
HD_ICD_9
HD_ICD_8
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10
COD_ICD_9
COD_ICD_8
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Graves disease, strict definition based on the number of shared cases.

Similar with more cases:

Similar with less cases:

None

Case counts by codes

↥

FinnGen case counts by registry codes:

No data for upset plot.

No data for upset table.

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	23064	18836	4057
Only index persons	22484	18513	3971
Unadjusted period prevalence (%)
Whole population	0.46	0.54	0.11
Only index persons	0.59	0.68	0.15
Median age at first event (years)
Whole population	49.31	49.21	50.36
Only index persons	49.26	49.12	49.95

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	4417	3732	685
Unadjusted period prevalence (%)	1.17	1.32	0.31
Median age at first event (years)	50.45	49.67	54.71

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
4613: Matched controls
46130

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

H03BB01

ATC

carbimazole; oral

3983.8

307.7

4514

522

XX7CT

NOMESCO Finland

Radioiodine therapy of thydoid tissue

30.7

307.7

435

156

H03AA01

ATC

levothyroxine sodium; systemic

12.5

307.7

3348

8071

E05.9

ICD-10 Finland

Thyrotoxicosis, unspecified

116.7

307.7

2271

380

BAA60

NOMESCO Finland

Total thyroidectomy

47.5

307.7

1438

436

E89.00

ICD-10 Finland

Postirradiation hypothyroidism

59.9

307.7

596

114

BA1AE

NOMESCO Finland

Thyroiid ultrasound examination

14.6

307.7

436

327

C07AA05

ATC

propranolol; systemic

5.1

307.7

2191

6978

104

Kela drug reimbursment

Thyroid insufficiency

9.5

307.7

1275

1775

E05.0

ICD-10 Finland

Thyrotoxicosis with diffuse goitre

20269.2

307.7

4554

175

E05

ICD-10 Finland

Thyrotoxicosis [hyperthyroidism]

103.3

307.7

940

114

T85

ICPC

Hyperthyroidism/thyrotoxicosis

47.3

307.7

342

H06.2*E05.9

ICD-10 Finland

Dysthyroid exophthalmos

319.4

307.7

610

E05.2

ICD-10 Finland

Thyrotoxicosis with toxic multinodular goitre

31.6

307.7

473

166

E89.01

ICD-10 Finland

Postsurgical hypothyroidism

37.1

307.7

971

329

E03.2

ICD-10 Finland

Hypothyroidism due to medicaments and other exogenous substances

35.7

289.7

182

E05.89

ICD-10 Finland

Other thyrotoxicosis

59.8

259.9

145

C07AB07

ATC

bisoprolol; oral

2.8

253.9

2479

13506

T86

ICPC

Hypothyroidism/myxoedema

4.9

229.8

554

1254

EP1AE

NOMESCO Finland

Neck ultrasound examination

4.5

215.6

574

1405

E05.80

ICD-10 Finland

Subacute thyrotoxicosis

14.0

204.6

190

141

CA1BG

NOMESCO Finland

Eye and orbita MRI examination with high intensity magnet

26.9

198.3

136

E03.89

ICD-10 Finland

Other specified hypothyroidism

4.9

197.4

468

1041

E05.1

ICD-10 Finland

Thyrotoxicosis with toxic single thyroid nodule

46.7

194.4

114

O99.2

ICD-10 Finland

Endocrine, nutritional and metabolic diseases complicating pregnancy, childbirth and the puerperium

7.2

182.1

280

412

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

2.4

171.7

1926

10647

E89.2

ICD-10 Finland

Postprocedural hypoparathyroidism

19.5

167.9

131

H062, E050,

ICD-10 Finland

345.5

167.3

168

H06.2

ICD-10 Finland

Dysthyroid exophthalmos

288.2

163.8

166

E03.9

ICD-10 Finland

Hypothyroidism, unspecified

2.8

162.9

1026

4302

H03BA02

ATC

propylthiouracil; oral

73.0

159.1

S01XA20

ATC

artificial tears and other indifferent preparations; ophthalmic

2.1

126.4

2300

14906

H05.2

ICD-10 Finland

Exophthalmic conditions

33.1

117.0

CA1CG

NOMESCO Finland

Eye and orbita extensive MRI examination with high intensity magnet

11.5

116.9

122

109

E03

ICD-10 Finland

Other hypothyroidism

3.0

108.0

515

1831

E89.09

ICD-10 Finland

Postprocedural hypothyroidism, other or several procedures

20.1

102.8

CA1AD

NOMESCO Finland

Orbita CT

26.3

101.4

A11CC03

ATC

alfacalcidol; systemic

5.4

83.9

170

327

BA3AT

NOMESCO Finland

Cytology of thyroid with ultrasound quidance

5.4

76.3

154

295

BBA70

NOMESCO Finland

Implantation or transplantation of parathyroid gland

20.2

73.1

J38.0

ICD-10 Finland

Paralysis of vocal cords and larynx

5.4

73.0

145

274

E83.51

ICD-10 Finland

Hypocalcemia

8.7

66.3

E05.5

ICD-10 Finland

Thyroid crisis or storm

140.1

65.1

106

Kela drug reimbursment

Hypoparathyroidism

11.1

62.4

E06.3

ICD-10 Finland

Autoimmune thyroiditis

6.9

62.2

141

Z03.80

ICD-10 Finland

Observation for other suspected diseases and conditions

3.0

54.3

251

869

R00.0

ICD-10 Finland

Tachycardia, unspecified

2.7

48.1

273

1055

H50.2

ICD-10 Finland

Vertical strabismus

6.5

43.8

110

C73.91

ICD-10 Finland

Papillary carcinoma of the thyroid gland (thyroid gland)

4.3

43.2

114

273

E06.2

ICD-10 Finland

Chronic thyroiditis with transient thyrotoxicosis

70.5

37.0

WX402

NOMESCO Finland

General anaesthesia

1.6

36.1

1078

7407

ZXA10

NOMESCO Finland

Bilateral

1.7

35.3

759

4796

R00.2

ICD-10 Finland

Palpitations

1.9

35.1

467

2557

H53.2

ICD-10 Finland

Diplopia

2.8

34.6

174

631

CAC30

NOMESCO Finland

Decompression of orbit to sinuses

171.2

32.7

XCK00

NOMESCO Finland

Perimetry

2.3

32.4

265

1210

Z01.0

ICD-10 Finland

Examination of eyes and vision

1.6

31.5

768

5002

E03.80

ICD-10 Finland

Hypothyroidism caused by autoimmune thyroiditis

2.8

30.2

157

579

H04.10

ICD-10 Finland

Dry eye syndrome

1.7

29.8

617

3847

XCW99

NOMESCO Finland

Other investigative procedure of eye

1.9

29.2

427

2406

A11CC02

ATC

dihydrotachysterol; oral

10.4

28.0

8260/3-C73.9

ICD-O-3

Papillary adenocarcinoma, NOS, of thyroid gland

3.7

27.9

250

WX408

NOMESCO Finland

General anesthesy, balanced

1.5

27.4

1072

7745

E05.4

ICD-10 Finland

Thyrotoxicosis factitia

23.9

26.9

C07AB02

ATC

metoprolol; systemic

1.6

26.1

661

4328

ZXE10

NOMESCO Finland

More than one and less than three hours

1.4

25.7

1448

11195

E06.9

ICD-10 Finland

Thyroiditis, unspecified

6.4

24.8

E07.9

ICD-10 Finland

Disorder of thyroid, unspecified

6.3

24.0

CEC00

NOMESCO Finland

Recession of extraocular muscle

7.0

23.7

CAC44

NOMESCO Finland

Combined decompression of orbit

87.2

23.7

CAC20

NOMESCO Finland

Lateral decompression of orbit

241.2

23.7

H50.6

ICD-10 Finland

Mechanical strabismus

33.5

23.3

E04.0

ICD-10 Finland

Nontoxic diffuse goitre

4.0

23.0

160

R94.6

ICD-10 Finland

Abnormal results of thyroid function studies

4.8

22.7

104

CBK00

NOMESCO Finland

Myotomy or resection of tarsal muscle or levator muscle of eyelid for correction of retraction

231.1

22.6

2420A

ICD-9 Finland

Thyrotoxicosis with or without goitre, Toxic diffuse goitre

20.8

22.5

H02AB06

ATC

prednisolone; systemic

1.4

21.6

1998

16641

WX404

NOMESCO Finland

Intravenous generell anesthesy

1.5

20.8

883

6438

K04

ICPC

Palpitations/awareness of heart

1.9

19.7

255

1379

I48

ICD-10 Finland

Atrial fibrillation and flutter

1.6

19.7

495

3224

H50.8

ICD-10 Finland

Other specified strabismus

15.3

19.7

E10.9

ICD-10 Finland

Type 1 diabetes mellitus, Without complications

2.1

19.5

182

877

E04.9

ICD-10 Finland

Nontoxic goitre, unspecified

2.5

19.0

122

501

XCD10

NOMESCO Finland

Electrophysiological examination of eye

2.7

18.0

372

WF099

NOMESCO Finland

Other radiotherapy

5.3

17.9

2AB04, ,

NOMESCO Finland

7.3

17.8

E89.0

ICD-10 Finland

Postprocedural hypothyroidism

19.3

16.8

ZX120

NOMESCO Finland

Intravenous

1.7

16.8

356

2223

K90.0

ICD-10 Finland

Coeliac disease

2.2

16.3

140

653

E50.0

ICD-10 Finland

Vitamin A deficiency with conjunctival xerosis

+∞

15.6

BA1AE, ,

SPAT

2.6

15.5

341

K80

ICPC

Cardiac arrhythmia NOS

1.6

15.4

347

2198

N02BE01

ATC

paracetamol; systemic, rectal

1.4

15.1

4000

37810

E05.81

ICD-10 Finland

Overproduction of thyroid-stimulating hormone

45.1

15.0

H02.5

ICD-10 Finland

Other disorders affecting eyelid function

10.8

14.9

E04.2

ICD-10 Finland

Nontoxic multinodular goitre

1.9

14.9

173

904

H02AB07

ATC

prednisone; oral

1.5

14.8

518

3620

G73.0*E05.9

ICD-10 Finland

Myasthenic syndromes in thyrotoxicosis [hyperthyroidism]

+∞

14.6

GD1AA

NOMESCO Finland

Thorax X-ray examination

1.3

14.5

1704

14415

E10.3

ICD-10 Finland

Type 1 diabetes mellitus, With ophthalmic complications

2.2

14.4

125

587

BAA50

NOMESCO Finland

Lobectomy and resection of contralateral lobe of thyroid gland

12.7

13.9

CA1BD

NOMESCO Finland

Extensive orbita CT

20.1

13.8

CA1BM

NOMESCO Finland

Eye and orbita MRI examination with 3 Tesla magnet

75.4

13.6

E05.3

ICD-10 Finland

Thyrotoxicosis from ectopic thyroid tissue

75.4

13.6

H50.0

ICD-10 Finland

Convergent concomitant strabismus

3.6

13.5

119

H04AA01

ATC

glucagon; nasal, parenteral

2.3

13.2

103

463

T89

ICPC

Diabetes insulin dependent

1.9

12.9

161

862

CEC60

NOMESCO Finland

Transposition of extraocular muscle with adjustable suture

14.7

11.8

E06.1

ICD-10 Finland

Subacute thyroiditis

3.2

11.6

142

CEC90

NOMESCO Finland

Total transposition of extraocular muscle or muscles

65.1

11.6

CK2S4

NOMESCO Finland

Plain photography of ocular fundus

1.7

11.4

220

1340

E10.7

ICD-10 Finland

Type 1 diabetes mellitus, With multiple complications

2.3

11.4

388

ZXD10

NOMESCO Finland

Scheduled procedure

1.3

11.3

1452

12323

TPH04

NOMESCO Finland

Cathetrisation of vein

1.3

11.2

791

6214

E20.8

ICD-10 Finland

Other hypoparathyroidism

25.1

11.1

E89.1

ICD-10 Finland

Postprocedural hypoinsulinaemia

20.1

11.1

A04

ICPC

Weakness/tiredness general

1.4

11.0

641

4893

WX110

NOMESCO Finland

Infiltration anesthesia

1.3

10.9

3200

29687

CS424

NOMESCO Finland

Visual field testing with Goldmann perimetry

3.2

10.7

129

R53

ICD-10 Finland

Malaise and fatigue

1.3

10.6

1072

8830

E07.89

ICD-10 Finland

Other specified disorders of thyroid

9.2

10.5

N07BA03

ATC

varenicline; oral

1.7

10.5

201

1224

O992, E050,

ICD-10 Finland

+∞

10.4

R06.0

ICD-10 Finland

Dyspnoea

1.3

10.4

989

8081

XCK10

NOMESCO Finland

Photography of fundus of eye

1.5

10.3

281

1863

BAA25

NOMESCO Finland

Bilateral partial excision of thyroid gland

8.8

10.3

A02BC02

ATC

pantoprazole; systemic

1.2

10.2

2863

26322

207

Kela drug reimbursment

Chronic arrhythmias

1.5

10.1

361

2533

CK2X4

NOMESCO Finland

Optical coherence tomography (OCT) of ocular fundus

1.5

10.0

304

2061

R63.4

ICD-10 Finland

Abnormal weight loss

1.8

10.0

136

751

Z71.2

ICD-10 Finland

Person consulting for explanation of investigation findings

1.2

9.9

1283

10872

UDQ12

NOMESCO Finland

Flexible laryngoscopy

1.6

9.5

215

1367

290

Kela drug reimbursment

Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation

1.4

9.4

374

2675

TFP20

NOMESCO Finland

Cardiodefibrillation

1.7

9.3

166

992

R25.1

ICD-10 Finland

Tremor, unspecified

1.9

9.3

106

553

8341/3-C73.9

ICD-O-3

Papillary microcarcinoma of thyroid gland

9.5

9.2

SPAT1249

SPAT

Treatment-related counselling outside office

1.2

9.0

1572

13714

CS494

NOMESCO Finland

Other visual field testing

2.0

9.0

448

CBK99

NOMESCO Finland

Other operation for retraction of eyelid

36.8

9.0

A10AB05

ATC

insulin aspart; parenteral

1.5

9.0

239

1576

Z03.9

ICD-10 Finland

Observation for suspected disease or condition, unspecified

1.3

9.0

692

5492

A60

ICPC

General and Unspecified, Result test/procedure

1.7

9.0

159

950

A10AB01

ATC

insulin (human); parenteral

1.8

8.9

122

676

CKC12

NOMESCO Finland

Photocoagulation of retina

1.8

8.9

133

758

CEW99

NOMESCO Finland

Other operation on extraocular muscle

12.5

8.9

H3601, E103,

ICD-10 Finland

3.0

8.8

123

I48.0

ICD-10 Finland

Paroxysmal atrial fibrillation

1.5

8.7

233

1538

SPAT1097

SPAT

Recording of ECG

1.4

8.7

432

3211

M14.5*E05.9

ICD-10 Finland

Arthropathy in thyrotoxicosis [hyperthyroidism]

50.1

8.7

351

Kela drug reimbursment

Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation

1.4

8.6

337

2403

XCH00

NOMESCO Finland

Eye pressure measurement

1.7

8.5

152

911

A10AE05

ATC

insulin detemir; parenteral

1.7

8.4

166

1020

E10

ICD-10 Finland

Type 1 diabetes mellitus

2.1

8.4

379

R49.08

ICD-10 Finland

Other specified dysphonia

1.9

8.1

495

E03.4

ICD-10 Finland

Atrophy of thyroid (acquired)

17.2

8.1

H36.09*E10.3

ICD-10 Finland

Insulin-dependent diabetes mellitus - Diabetic retinopathy

2.7

7.9

148

I49.9

ICD-10 Finland

Cardiac arrhythmia, unspecified

1.3

7.9

502

3879

E03.0

ICD-10 Finland

Congenital hypothyroidism with diffuse goitre

3.1

7.8

105

A10AE04

ATC

insulin glargine; parenteral

1.5

7.8

275

1927

A12AA04

ATC

calcium carbonate; oral

2.5

7.7

185

ZY020

NOMESCO Finland

Telephone, letter or other consultation without direct patient contact

1.5

7.6

217

1455

ZXE00

NOMESCO Finland

One hour or less

1.2

7.4

1520

13406

N05CF01

ATC

zopiclone; oral

1.2

7.4

1150

9877

EBA05

NOMESCO Finland

Complicated extraction of tooth

1.2

7.4

873

7290

CA1CM

NOMESCO Finland

Eye and orbita extensive MRI examination with 3 Tesla magnet

6.0

7.4

K29.4

ICD-10 Finland

Chronic atrophic gastritis

2.1

7.2

286

XW1AT

NOMESCO Finland

Biopsy from other organ close to skin with ultrasound quidance

3.0

7.2

105

A99

ICPC

Disease/condition unspecnature/site

1.4

7.2

381

2864

A91

ICPC

Abnormal result investigation NOS

1.5

7.2

187

1231

F29

ICPC

Eye symptom/complaint other

1.3

7.1

418

3191

XCW12

NOMESCO Finland

Assessment of colour vision

10.0

7.0

A10AB04

ATC

insulin lispro; parenteral

1.7

6.9

112

654

E10.1

ICD-10 Finland

Type 1 diabetes mellitus, With ketoacidosis

2.4

6.9

183

K02.1

ICD-10 Finland

Caries of dentine

1.2

6.9

2594

24056

ZYC06

NOMESCO Finland

Real-time text-based remote transaction

4.0

6.9

Z35.8

ICD-10 Finland

Supervision of other high-risk pregnancies

1.3

6.8

408

3127

Z3231

NOMESCO Finland

Registered nurse

1.2

6.8

946

8035

FM1EE

NOMESCO Finland

Extensive structural and functional ultrasound examination of heart

1.3

6.7

686

5627

C07AA07

ATC

sotalol; systemic

1.9

6.7

412

A10AA01, ,

ATC

1.8

6.7

491

SGA02

NOMESCO Finland

Opening and preparing the root canals

1.3

6.7

478

3752

E21.3

ICD-10 Finland

Hyperparathyroidism, unspecified

2.3

6.6

193

E27.1

ICD-10 Finland

Primary adrenocortical insufficiency

4.2

6.5

A10AA02, ,

ATC

1.8

6.5

554

A98

ICPC

Health maint/preventive medicine

1.6

6.5

4483

44089

E06.0

ICD-10 Finland

Acute thyroiditis

5.7

6.4

BWD00

NOMESCO Finland

Reoperation for deep haemorrhage in endocrine surgery

14.3

6.4

EB1AA

NOMESCO Finland

Intraoral radiographic dental examination

1.2

6.4

2365

21846

WX704

NOMESCO Finland

Intubation

1.4

6.3

288

2114

H50.52

ICD-10 Finland

Exophoria

2.2

6.3

236

CS444

NOMESCO Finland

Visual field testing with Octopus automated perimetry

1.7

6.3

105

620

O90.5

ICD-10 Finland

Postpartum thyroiditis

11.0

6.3

E8901, E050,

ICD-10 Finland

+∞

6.2

CE2W4

NOMESCO Finland

Eye movement mapping

5.3

6.1

A10AE06

ATC

insulin degludec; parenteral

1.7

6.1

114

694

R21

ICPC

Throat symptom/complaint

1.2

6.1

969

8325

WX290

NOMESCO Finland

Other blockage of nerve

1.2

6.1

2112

19383

TimeCodeWAS

↥

TODO / Current known limitations:

Only showing the top 300 codes, because showing all (sometimes 20k) makes the page too slow.
Legend / how to read the glyphs.
Show details (e.g. Fisher or Chi-square test, LR+, etc.) when clicking on a row.
Explanation on the underlying data / how the TimeCodeWAS is done (e.g. matched cases / controls, eligibility).
Download CSV.
No filters and sorters.
Limited amount of endpoints (~400) having TimeCodeWAS data.
Cross-links to Risteys lab test pages for lab test codes.

OMOP concept

ln(OR)

%cases with code / %controls with code

2×2 table

carbimazole; oral
H03BB01 [21602765]

4.1e+00

7.1e+00

8.4e+00

1.0e+50

8.5e+00

8.6e+00

6.2e+00

cases:10.88%

controls:0.21%

cases:52.59%

controls:0.09%

cases:48.13%

controls:0.02%

cases:18.45%

controls:0.00%

cases:49.15%

controls:0.02%

cases:80.91%

controls:0.08%

cases:52.32%

controls:0.21%

500

4096

45839

2417

2179

45896

2212

2384

45926

848

3748

45936

2259

2337

45899

3687

870

45234

2123

1935

39816

Thyrotropin receptor Ab [Units/volume] in Serum
5385-0 [3017044]

2.5e+00

4.9e+00

8.0e+00

1.0e+50

4.8e+00

5.2e+00

4.4e+00

cases:4.22%

controls:0.36%

cases:18.52%

controls:0.16%

cases:29.35%

controls:0.02%

cases:0.54%

controls:0.00%

cases:2.81%

controls:0.02%

cases:25.65%

controls:0.19%

cases:34.60%

controls:0.63%

194

166

4402

45770

851

3745

45861

1349

3247

45929

4571

45936

129

4467

45896

1169

3388

45185

1404

252

2654

39649

Thyrotoxicosis, unspecified
E05.9 [45586131]

3.6e+00

6.2e+00

—

6.0e+00

5.9e+00

4.6e+00

cases:4.81%

controls:0.14%

cases:21.43%

controls:0.05%

—

cases:4.87%

controls:0.01%

cases:14.51%

controls:0.05%

cases:15.62%

controls:0.19%

221

4375

45870

985

3611

45911

—

224

4372

45901

661

3896

45249

634

3424

39827

Endocrinology
46 [38004485]

5.0e-01

1.8e+00

2.5e+00

8.5e+00

4.1e+00

4.5e+00

3.4e+00

cases:6.44%

controls:4.00%

cases:13.73%

controls:2.57%

cases:6.20%

controls:0.55%

cases:62.40%

controls:0.03%

cases:25.17%

controls:0.58%

cases:70.70%

controls:2.60%

cases:60.79%

controls:5.01%

296

1836

4300

44100

631

1181

3965

44755

285

251

4311

45685

2868

1728

45921

1157

266

3439

45641

3222

1177

1335

44093

2467

2001

1591

37900

Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma
14928-6 [3026989]

1.5e+00

3.5e+00

6.1e+00

1.0e+50

5.3e+00

4.7e+00

3.6e+00

cases:5.42%

controls:1.23%

cases:16.80%

controls:0.61%

cases:35.12%

controls:0.12%

cases:1.15%

controls:0.00%

cases:15.88%

controls:0.10%

cases:40.40%

controls:0.64%

cases:40.61%

controls:1.80%

249

564

4347

45372

772

279

3824

45657

1614

2982

45883

4543

45936

730

3866

45862

1841

290

2716

44980

1648

717

2410

39184

Thyrotoxicosis with diffuse goitre
E05.0 [45600628]

1.3e+00

3.7e+00

1.0e+50

—

1.0e+01

7.9e+00

cases:0.39%

controls:0.10%

cases:1.65%

controls:0.04%

cases:1.11%

controls:0.00%

cases:92.45%

controls:0.00%

—

cases:85.41%

controls:0.03%

cases:69.89%

controls:0.08%

4578

45889

4520

45916

4545

45936

4249

347

45936

—

3892

665

45258

2836

1222

39868

Thyrotoxicosis with toxic multinodular goitre
E05.2 [45600629]

2.3e+00

4.3e+00

—

1.0e+50

4.8e+00

4.0e+00

cases:0.96%

controls:0.10%

cases:3.55%

controls:0.05%

—

cases:0.85%

controls:0.00%

cases:1.33%

controls:0.01%

cases:5.22%

controls:0.04%

cases:4.24%

controls:0.08%

4552

45890

163

4433

45913

—

4557

45936

4535

45902

238

4319

45250

172

3886

39869

propranolol; oral, parenteral
C07AA05 [21601670]

6.4e-01

2.4e+00

3.5e+00

5.7e+00

2.9e+00

1.7e+00

1.2e+00

cases:8.83%

controls:4.88%

cases:20.84%

controls:2.29%

cases:12.45%

controls:0.43%

cases:3.57%

controls:0.01%

cases:7.70%

controls:0.45%

cases:12.73%

controls:2.48%

cases:17.87%

controls:5.92%

406

2243

4190

43693

958

1052

3638

44884

572

199

4024

45737

164

4432

45930

354

208

4242

45699

580

1121

3977

44149

725

2364

3333

37537

Thyroperoxidase Ab [Units/volume] in Serum or Plasma
8099-4 [3027238]

9.7e-01

2.9e+00

5.6e+00

—

3.3e+00

1.4e+00

1.5e+00

cases:3.89%

controls:1.52%

cases:8.51%

controls:0.50%

cases:13.86%

controls:0.06%

—

cases:1.17%

controls:0.04%

cases:2.28%

controls:0.56%

cases:8.82%

controls:2.21%

179

697

4417

45239

391

229

4205

45707

637

3959

45909

—

4542

45887

104

255

4453

45015

358

880

3700

39021

Thyroxine (T4) free [Moles/volume] in Serum or Plasma
14920-3 [3008486]

1.3e-01

1.6e+00

4.0e+00

3.5e+00

2.9e+00

2.1e+00

1.4e+00

cases:22.93%

controls:20.67%

cases:39.75%

controls:12.27%

cases:47.02%

controls:1.58%

cases:1.89%

controls:0.06%

cases:22.76%

controls:1.60%

cases:54.47%

controls:12.79%

cases:66.26%

controls:32.98%

1054

9494

3542

36442

1827

5637

2769

40299

2161

724

2435

45212

4509

45910

1046

734

3550

45173

2482

5788

2075

39482

2689

13161

1369

26740

Thyrotoxicosis [hyperthyroidism]
E05 [45533007]

3.8e+00

6.4e+00

1.0e+50

—

5.1e+00

cases:1.28%

controls:0.03%

cases:8.29%

controls:0.02%

cases:5.16%

controls:0.00%

cases:0.13%

controls:0.00%

—

cases:5.86%

controls:0.04%

4537

45922

381

4215

45929

237

4359

45936

4590

45936

—

238

3820

39886

Internal Medicine
11 [38004456]

1.4e-01

1.0e+00

1.7e+00

6.7e+00

2.1e+00

1.9e+00

1.1e+00

cases:20.97%

controls:18.70%

cases:17.75%

controls:7.21%

cases:6.68%

controls:1.24%

cases:27.72%

controls:0.05%

cases:8.99%

controls:1.22%

cases:32.30%

controls:6.90%

cases:35.81%

controls:16.11%

964

8592

3632

37344

816

3313

3780

42623

307

568

4289

45368

1274

3322

45914

413

560

4183

45347

1472

3125

3085

42145

1453

6428

2605

33473

Thyrotropin [Units/volume] in Serum or Plasma
3016-3 [3009201]

8.6e-02

1.3e+00

3.7e+00

3.3e+00

2.6e+00

1.8e+00

1.0e+00

cases:27.83%

controls:26.13%

cases:41.14%

controls:16.61%

cases:47.11%

controls:2.16%

cases:1.89%

controls:0.07%

cases:22.74%

controls:2.17%

cases:54.84%

controls:17.40%

cases:67.20%

controls:41.79%

1279

12005

3317

33931

1891

7629

2705

38307

2165

991

2431

44945

4509

45902

1045

997

3551

44910

2499

7879

2058

37391

2727

16674

1331

23227

Subacute thyrotoxicosis
E05.80 [2000501412]

2.6e+00

4.5e+00

—

3.5e+00

2.8e+00

cases:0.74%

controls:0.06%

cases:1.59%

controls:0.02%

—

cases:0.75%

controls:0.02%

cases:1.23%

controls:0.07%

4562

45910

4523

45928

—

4523

45260

4008

39872

Thyroid ultrasound examination
BA1AE [2001300735]

1.7e+00

3.4e+00

1.0e+50

—

4.5e+00

3.4e+00

cases:0.54%

controls:0.10%

cases:0.94%

controls:0.03%

cases:0.22%

controls:0.00%

—

cases:2.33%

controls:0.03%

cases:3.50%

controls:0.12%

4571

45892

4553

45921

4586

45936

—

106

4451

45258

142

3916

39853

Neck ultrasound examination
EP1AE [2001302284]

5.8e-02

1.8e+00

3.0e+00

—

2.9e+00

2.8e+00

2.4e+00

cases:0.65%

controls:0.62%

cases:1.11%

controls:0.18%

cases:0.35%

controls:0.02%

—

cases:0.28%

controls:0.02%

cases:2.94%

controls:0.18%

cases:4.98%

controls:0.49%

283

4566

45653

4545

45852

4580

45928

—

4583

45900

134

4423

45187

202

194

3856

39707

Thyroid insufficiency
104 [2001600104]

4.8e-02

8.9e-01

—

3.8e+00

4.6e+00

4.2e+00

cases:0.41%

controls:0.39%

cases:0.22%

controls:0.09%

—

cases:0.48%

controls:0.01%

cases:7.72%

controls:0.08%

cases:14.79%

controls:0.27%

181

4577

45755

4586

45895

—

4574

45902

352

4205

45232

600

106

3458

39795

Total thyroidectomy
BAA60 [2001300753]

—

1.5e+00

1.0e+50

—

5.5e+00

5.3e+00

—

cases:0.20%

controls:0.04%

cases:0.22%

controls:0.00%

cases:0.85%

controls:0.00%

—

cases:10.14%

controls:0.05%

cases:15.60%

controls:0.09%

—

4587

45916

4586

45936

4557

45936

—

462

4095

45249

633

3425

39865

Pharmacy visit
OMOP4822462 [581458]

3.3e-01

1.2e+00

1.3e+00

2.7e+00

1.3e+00

2.4e+00

1.9e+00

cases:96.54%

controls:95.27%

cases:94.76%

controls:84.98%

cases:74.48%

controls:43.77%

cases:24.61%

controls:2.24%

cases:74.93%

controls:44.07%

cases:98.55%

controls:85.51%

cases:99.48%

controls:96.57%

4437

43765

159

2171

4355

39035

241

6901

3423

20108

1173

25828

1131

1027

3465

44909

3444

20232

1152

25675

4491

38711

6559

4037

38534

1367

Cytology report of Tissue fine needle aspirate Cyto stain
33718-8 [3043109]

3.2e-01

1.5e+00

3.2e+00

—

2.9e+00

2.2e+00

1.3e+00

cases:0.57%

controls:0.41%

cases:0.59%

controls:0.14%

cases:0.33%

controls:0.01%

—

cases:0.24%

controls:0.01%

cases:0.92%

controls:0.10%

cases:1.55%

controls:0.43%

189

4570

45747

4569

45873

4581

45930

—

4585

45901

4515

45225

172

3995

39729

Endocrine, nutritional and metabolic diseases complicating pregnancy, childbirth and the puerperium
O99.2 [45534321]

1.0e+00

1.4e+00

1.9e+00

—

3.3e+00

2.8e+00

2.5e+00

cases:0.57%

controls:0.20%

cases:0.41%

controls:0.10%

cases:0.13%

controls:0.02%

—

cases:0.30%

controls:0.01%

cases:1.40%

controls:0.09%

cases:3.40%

controls:0.28%

4570

45843

4577

45889

4590

45927

—

4582

45902

4493

45231

138

112

3920

39789

Outpatient Visit
OP [9202]

1.0e-01

3.9e-01

6.0e-01

5.8e+00

1.4e+00

1.7e+00

1.2e+00

cases:74.98%

controls:73.05%

cases:58.57%

controls:48.87%

cases:17.86%

controls:10.71%

cases:64.19%

controls:0.55%

cases:32.42%

controls:10.61%

cases:84.05%

controls:48.96%

cases:93.42%

controls:80.98%

3446

33555

1150

12381

2692

22450

1904

23486

821

4918

3775

41018

2950

252

1646

45684

1490

4871

3106

41036

3830

22164

727

23106

3791

32313

267

7588

Autoimmune thyroiditis
E06.3 [45557105]

1.8e+00

3.1e+00

1.0e+50

3.6e+00

2.4e+00

cases:0.30%

controls:0.05%

cases:0.39%

controls:0.02%

cases:0.13%

controls:0.00%

cases:0.37%

controls:0.00%

cases:0.17%

controls:0.00%

cases:0.48%

controls:0.01%

cases:0.74%

controls:0.07%

4582

45913

4578

45928

4590

45936

4579

45936

4588

45907

4535

45264

4028

39875

Postsurgical hypothyroidism
E89.01 [2000501554]

—

2.4e+00

3.9e+00

4.3e+00

—

cases:0.17%

controls:0.02%

cases:4.81%

controls:0.10%

cases:13.73%

controls:0.21%

—

4588

45900

219

4338

45223

557

3501

39819

Postprocedural hypothyroidism
E89.0 [45552421]

—

1.2e+00

—

5.0e+00

5.3e+00

—

cases:0.15%

controls:0.05%

—

cases:6.47%

controls:0.05%

cases:12.57%

controls:0.07%

—

4589

45914

—

295

4262

45249

510

3548

39872

pH of Serum or Plasma
2753-2 [3018418]

1.3e-01

7.4e-01

2.3e+00

3.1e+00

1.7e+00

1.4e+00

1.1e+00

cases:5.20%

controls:4.59%

cases:5.27%

controls:2.59%

cases:4.33%

controls:0.45%

cases:0.37%

controls:0.02%

cases:2.13%

controls:0.39%

cases:10.45%

controls:2.78%

cases:19.62%

controls:7.85%

239

2107

4357

43829

242

1189

4354

44747

199

208

4397

45728

4579

45928

177

4498

45730

476

1258

4081

44012

796

3132

3262

36769

Atrial fibrillation and flutter
I48 [45596206]

9.8e-02

1.1e+00

1.8e+00

4.6e+00

1.3e+00

9.3e-01

5.4e-01

cases:3.07%

controls:2.79%

cases:4.72%

controls:1.61%

cases:1.83%

controls:0.32%

cases:1.44%

controls:0.02%

cases:1.20%

controls:0.34%

cases:3.77%

controls:1.52%

cases:5.37%

controls:3.21%

141

1282

4455

44654

217

739

4379

45197

146

4512

45790

4530

45929

158

4541

45749

172

687

4385

44583

218

1280

3840

38621

Calcium.ionized [Moles/volume] in Serum or Plasma
1995-0 [3021347]

3.3e-02

7.1e-01

2.3e+00

3.1e+00

1.6e+00

1.3e+00

1.0e+00

cases:7.53%

controls:7.30%

cases:7.94%

controls:4.06%

cases:6.20%

controls:0.65%

cases:0.57%

controls:0.03%

cases:2.89%

controls:0.59%

cases:13.98%

controls:4.28%

cases:26.56%

controls:11.65%

346

3355

4250

42581

365

1867

4231

44069

285

300

4311

45636

4570

45924

133

270

4463

45637

637

1937

3920

43333

1078

4649

2980

35252

Neutrophils [#/volume] in Blood by Automated count
751-8 [3013650]

-7.2e-03

6.7e-01

2.6e+00

2.4e+00

1.9e+00

1.6e+00

8.6e-01

cases:11.92%

controls:12.00%

cases:14.86%

controls:8.20%

cases:21.37%

controls:1.95%

cases:1.13%

controls:0.11%

cases:11.62%

controls:1.94%

cases:29.54%

controls:7.90%

cases:34.38%

controls:18.14%

548

5512

4048

40424

683

3767

3913

42169

982

898

3614

45038

4544

45886

534

890

4062

45017

1346

3578

3211

41692

1395

7239

2663

32662

Nontoxic multinodular goitre
E04.2 [45576425]

7.0e-01

1.5e+00

2.4e+00

—

2.6e+00

1.8e+00

7.2e-01

cases:0.78%

controls:0.39%

cases:0.72%

controls:0.16%

cases:0.22%

controls:0.02%

—

cases:0.35%

controls:0.03%

cases:0.86%

controls:0.14%

cases:0.86%

controls:0.42%

179

4560

45757

4563

45862

4586

45927

—

4580

45895

4518

45205

168

4023

39733

Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
19072-8 [3016431]

3.4e-02

6.8e-01

2.3e+00

2.9e+00

1.6e+00

1.2e+00

1.0e+00

cases:8.55%

controls:8.29%

cases:9.01%

controls:4.76%

cases:7.01%

controls:0.76%

cases:0.61%

controls:0.03%

cases:3.37%

controls:0.71%

cases:15.58%

controls:5.03%

cases:29.99%

controls:13.67%

393

3806

4203

42130

414

2186

4182

43750

322

347

4274

45589

4568

45920

155

328

4441

45579

710

2278

3847

42992

1217

5453

2841

34448

Postirradiation hypothyroidism
E89.00 [2000501553]

—

-1.0e+50

4.6e+00

5.0e+00

—

cases:0.00%

controls:0.01%

cases:2.83%

controls:0.03%

cases:8.95%

controls:0.07%

—

4596

45902

129

4428

45257

363

3695

39875

Nontoxic goitre, unspecified
E04.9 [45537948]

1.1e+00

2.2e+00

—

2.5e+00

2.1e+00

1.2e+00

cases:0.50%

controls:0.16%

cases:0.63%

controls:0.07%

—

cases:0.13%

controls:0.01%

cases:0.57%

controls:0.07%

cases:0.67%

controls:0.21%

4573

45861

4567

45905

—

4590

45902

4531

45239

4031

39819

Observation for other suspected diseases and conditions
Z03.80 [2000503756]

3.9e-01

1.9e+00

3.2e+00

—

2.1e+00

1.8e+00

cases:0.46%

controls:0.31%

cases:0.78%

controls:0.12%

cases:0.41%

controls:0.02%

—

cases:0.75%

controls:0.09%

cases:1.60%

controls:0.26%

142

4575

45794

4560

45883

4577

45928

—

4523

45228

104

3993

39797

Short blood count panel - Blood
55429-5 [40758558]

-5.6e-02

5.2e-01

2.3e+00

2.1e+00

1.7e+00

1.5e+00

8.2e-01

cases:5.27%

controls:5.55%

cases:5.55%

controls:3.36%

cases:7.59%

controls:0.80%

cases:0.37%

controls:0.04%

cases:3.94%

controls:0.75%

cases:11.96%

controls:3.07%

cases:14.76%

controls:7.12%

242

2551

4354

43385

255

1544

4341

44392

349

369

4247

45567

4579

45916

181

343

4415

45564

545

1389

4012

43881

599

2839

3459

37062

Nontoxic diffuse goitre
E04.0 [45537946]

1.4e+00

2.8e+00

—

2.4e+00

2.3e+00

cases:0.26%

controls:0.07%

cases:0.24%

controls:0.02%

—

cases:0.24%

controls:0.02%

cases:0.44%

controls:0.04%

4584

45906

4585

45929

—

4546

45260

4040

39884

bisoprolol; oral
C07AB07 [21601689]

1.8e-01

1.2e+00

1.7e+00

3.1e+00

1.1e+00

8.9e-01

7.3e-01

cases:13.69%

controls:11.64%

cases:26.44%

controls:10.03%

cases:14.30%

controls:2.97%

cases:2.02%

controls:0.10%

cases:8.77%

controls:3.09%

cases:21.92%

controls:10.38%

cases:25.90%

controls:14.38%

629

5349

3967

40587

1215

4609

3381

41327

657

1364

3939

44572

4503

45892

403

1418

4193

44489

999

4698

3558

40572

1051

5737

3007

34164

General Surgery
2 [38004447]

7.8e-02

2.6e-01

4.7e-01

4.7e+00

1.5e+00

1.3e+00

8.9e-01

cases:15.80%

controls:14.79%

cases:5.87%

controls:4.58%

cases:0.96%

controls:0.60%

cases:2.89%

controls:0.03%

cases:2.52%

controls:0.59%

cases:13.03%

controls:4.06%

cases:23.63%

controls:11.23%

726

6793

3870

39143

270

2106

4326

43830

276

4552

45660

133

4463

45924

116

269

4480

45638

594

1839

3963

43431

959

4479

3099

35422

Office Visit
OMOP4822458 [581477]

-1.2e-01

1.6e-01

9.1e-01

4.2e+00

1.7e+00

1.2e+00

5.6e-01

cases:8.25%

controls:9.21%

cases:3.15%

controls:2.71%

cases:0.98%

controls:0.40%

cases:1.17%

controls:0.02%

cases:2.05%

controls:0.39%

cases:7.09%

controls:2.31%

cases:9.78%

controls:5.81%

379

4233

4217

41703

145

1245

4451

44691

183

4551

45753

4542

45928

180

4502

45727

323

1045

4234

44225

397

2319

3661

37582

Cytology of thyroid with ultrasound quidance
BA3AT [2001300769]

5.8e-01

2.9e+00

—

3.4e+00

2.2e+00

cases:0.17%

controls:0.10%

cases:0.54%

controls:0.03%

—

cases:0.88%

controls:0.03%

cases:0.99%

controls:0.11%

4588

45891

4571

45922

—

4517

45256

4018

39857

Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
6768-6 [3035995]

-1.1e-02

5.3e-01

2.4e+00

2.2e+00

1.6e+00

1.0e+00

6.3e-01

cases:17.15%

controls:17.31%

cases:17.67%

controls:11.22%

cases:19.95%

controls:2.12%

cases:0.74%

controls:0.08%

cases:9.20%

controls:2.06%

cases:26.86%

controls:11.43%

cases:40.29%

controls:26.40%

788

7951

3808

37985

812

5156

3784

40780

917

973

3679

44963

4562

45898

423

946

4173

44961

1224

5176

3333

40094

1635

10535

2423

29366

12 lead EKG panel
34534-8 [3044889]

8.4e-02

9.0e-01

2.8e+00

3.0e+00

6.9e-01

4.8e-01

cases:15.88%

controls:14.79%

cases:17.78%

controls:8.09%

cases:14.49%

controls:0.97%

cases:0.57%

controls:0.03%

cases:1.76%

controls:0.89%

cases:12.09%

controls:7.84%

cases:32.13%

controls:22.64%

730

6795

3866

39141

817

3714

3779

42222

666

446

3930

45490

4570

45923

410

4515

45497

551

3548

4006

41722

1304

9032

2754

30869

Supplier / Service Provider
OMOP5117446 [33004]

-8.8e-01

-9.2e-01

4.6e-01

1.1e+00

3.6e+00

3.2e+00

2.8e+00

cases:12.97%

controls:26.52%

cases:4.37%

controls:10.31%

cases:1.65%

controls:1.05%

cases:0.11%

controls:0.04%

cases:2.11%

controls:0.06%

cases:9.81%

controls:0.45%

cases:16.98%

controls:1.18%

596

12181

4000

33755

201

4735

4395

41201

484

4520

45452

4591

45919

4499

45879

447

205

4110

45065

689

470

3369

39431

Eye and orbita extensive MRI examination with high intensity magnet
CA1CG [2001300869]

—

1.0e+50

4.6e+00

3.5e+00

—

cases:0.11%

controls:0.00%

cases:1.08%

controls:0.01%

cases:1.18%

controls:0.04%

—

4591

45907

4508

45265

4010

39886

Parathyrin.intact [Moles/volume] in Serum or Plasma
14866-8 [3010566]

2.8e-01

3.7e-01

2.4e+00

—

2.2e+00

1.7e+00

1.8e+00

cases:0.33%

controls:0.25%

cases:0.22%

controls:0.15%

cases:0.26%

controls:0.02%

—

cases:0.17%

controls:0.02%

cases:0.90%

controls:0.17%

cases:2.61%

controls:0.44%

113

4581

45823

4586

45867

4584

45925

—

4588

45898

4516

45192

106

175

3952

39726

Telephone, letter or other consultation without direct patient contact
ZY020 [2001311600]

9.5e-02

6.2e-01

1.6e+00

1.0e+50

2.7e+00

2.2e+00

1.3e+00

cases:0.87%

controls:0.79%

cases:0.44%

controls:0.24%

cases:0.20%

controls:0.04%

cases:0.26%

controls:0.00%

cases:0.44%

controls:0.03%

cases:1.80%

controls:0.20%

cases:1.92%

controls:0.51%

364

4556

45572

108

4576

45828

4587

45918

4584

45936

4576

45893

4475

45181

204

3980

39697

Thyroxine (T4) free [Moles/volume] in Serum or Plasma by Dialysis
70217-5 [42868691]

—

2.3e+00

—

2.6e+00

2.9e+00

—

cases:0.22%

controls:0.02%

—

cases:0.33%

controls:0.02%

cases:1.43%

controls:0.08%

—

4586

45926

—

4542

45259

4000

39869

Chronic arrhythmias
207 [2001600205]

-8.4e-02

1.8e+00

2.8e+00

—

2.3e+00

9.0e-01

6.1e-02

cases:0.78%

controls:0.85%

cases:1.37%

controls:0.23%

cases:0.46%

controls:0.03%

—

cases:0.28%

controls:0.03%

cases:0.61%

controls:0.25%

cases:1.16%

controls:1.09%

391

4560

45545

106

4533

45830

4575

45923

—

4583

45894

113

4529

45157

435

4011

39466

Postprocedural hypoparathyroidism
E89.2 [45586178]

-1.0e+50

—

3.8e+00

4.0e+00

cases:0.00%

controls:0.04%

cases:0.00%

controls:0.03%

—

cases:1.03%

controls:0.02%

cases:2.24%

controls:0.04%

4596

45917

4596

45922

—

4510

45259

3967

39884

"edoxaban
B01AF03 [1123891]

7.2e-01

1.3e+00

1.9e+00

—

2.0e+00

1.3e+00

1.2e+00

cases:0.15%

controls:0.07%

cases:0.33%

controls:0.08%

cases:0.24%

controls:0.04%

—

cases:0.26%

controls:0.03%

cases:0.42%

controls:0.12%

cases:0.57%

controls:0.17%

4589

45902

4581

45897

4585

45919

—

4584

45891

4538

45217

4035

39832

Leukocytes [#/volume] in Blood
26464-8 [3010813]

2.1e-02

5.5e-01

2.4e+00

2.1e+00

1.5e+00

8.1e-01

3.2e-01

cases:38.64%

controls:38.14%

cases:44.54%

controls:31.72%

cases:44.76%

controls:6.79%

cases:2.70%

controls:0.33%

cases:23.22%

controls:6.46%

cases:53.08%

controls:33.54%

cases:66.44%

controls:58.99%

1776

17520

2820

28416

2047

14571

2549

31365

2057

3121

2539

42815

124

153

4472

45783

1067

2966

3529

42941

2419

15182

2138

30088

2696

23536

1362

16365

Erythrocytes [#/volume] in Blood
26453-1 [3026361]

2.1e-02

5.4e-01

2.4e+00

2.1e+00

1.5e+00

8.1e-01

3.1e-01

cases:38.58%

controls:38.09%

cases:44.34%

controls:31.69%

cases:44.71%

controls:6.77%

cases:2.70%

controls:0.33%

cases:23.17%

controls:6.45%

cases:53.02%

controls:33.47%

cases:66.29%

controls:58.95%

1773

17495

2823

28441

2038

14556

2558

31380

2055

3110

2541

42826

124

153

4472

45783

1065

2961

3531

42946

2416

15151

2141

30119

2690

23523

1368

16378

Platelets [#/volume] in Blood
26515-7 [3007461]

1.9e-02

5.4e-01

2.4e+00

2.1e+00

1.5e+00

8.1e-01

3.2e-01

cases:38.42%

controls:37.97%

cases:44.19%

controls:31.60%

cases:44.65%

controls:6.75%

cases:2.68%

controls:0.33%

cases:23.15%

controls:6.44%

cases:52.95%

controls:33.33%

cases:66.29%

controls:58.82%

1766

17442

2830

28494

2031

14518

2565

31418

2052

3099

2544

42837

123

153

4473

45783

1064

2958

3532

42949

2413

15090

2144

30180

2690

23469

1368

16432

MCH [Entitic mass]
28539-5 [3035941]

2.3e-02

5.4e-01

2.4e+00

2.1e+00

1.5e+00

8.1e-01

3.2e-01

cases:38.58%

controls:38.02%

cases:44.28%

controls:31.63%

cases:44.69%

controls:6.76%

cases:2.68%

controls:0.33%

cases:23.17%

controls:6.44%

cases:53.00%

controls:33.42%

cases:66.31%

controls:58.92%

1773

17467

2823

28469

2035

14530

2561

31406

2054

3104

2542

42832

123

153

4473

45783

1065

2957

3531

42950

2415

15130

2142

30140

2691

23510

1367

16391

MCV [Entitic mean volume] in Red Blood Cells
30428-7 [3024731]

2.0e-02

5.4e-01

2.4e+00

2.1e+00

1.5e+00

8.1e-01

3.2e-01

cases:38.56%

controls:38.09%

cases:44.34%

controls:31.67%

cases:44.69%

controls:6.77%

cases:2.68%

controls:0.33%

cases:23.17%

controls:6.45%

cases:53.00%

controls:33.44%

cases:66.34%

controls:58.91%

1772

17496

2824

28440

2038

14549

2558

31387

2054

3109

2542

42827

123

153

4473

45783

1065

2961

3531

42946

2415

15139

2142

30131

2692

23505

1366

16396

Hematocrit [Volume Fraction] of Blood by calculation
20570-8 [3009542]

2.0e-02

5.4e-01

2.4e+00

2.1e+00

1.5e+00

8.1e-01

3.2e-01

cases:38.58%

controls:38.11%

cases:44.36%

controls:31.68%

cases:44.69%

controls:6.78%

cases:2.68%

controls:0.34%

cases:23.19%

controls:6.46%

cases:53.00%

controls:33.46%

cases:66.34%

controls:58.93%

1773

17504

2823

28432

2039

14551

2557

31385

2054

3116

2542

42820

123

154

4473

45782

1066

2967

3530

42940

2415

15146

2142

30124

2692

23515

1366

16386

Hemoglobin [Mass/volume] in Blood
718-7 [3000963]

2.1e-02

5.4e-01

2.4e+00

2.1e+00

1.5e+00

8.1e-01

3.1e-01

cases:38.66%

controls:38.17%

cases:44.45%

controls:31.76%

cases:44.73%

controls:6.80%

cases:2.68%

controls:0.33%

cases:23.19%

controls:6.47%

cases:53.02%

controls:33.51%

cases:66.34%

controls:59.05%

1777

17534

2819

28402

2043

14589

2553

31347

2056

3125

2540

42811

123

153

4473

45783

1066

2968

3530

42939

2416

15168

2141

30102

2692

23561

1366

16340

Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
1742-6 [3006923]

2.3e-02

5.2e-01

2.4e+00

1.9e+00

1.5e+00

8.1e-01

4.0e-01

cases:31.29%

controls:30.79%

cases:34.03%

controls:23.40%

cases:34.33%

controls:4.32%

cases:1.15%

controls:0.17%

cases:15.95%

controls:4.03%

cases:43.12%

controls:25.14%

cases:60.33%

controls:50.52%

1438

14143

3158

31793

1564

10748

3032

35188

1578

1986

3018

43950

4543

45859

733

1849

3863

44058

1965

11381

2592

33889

2448

20156

1610

19745

Ophthalmology
18 [38004463]

-2.6e-02

2.4e-01

8.1e-01

3.6e+00

1.1e+00

1.0e+00

7.0e-01

cases:12.42%

controls:12.71%

cases:7.14%

controls:5.71%

cases:2.09%

controls:0.94%

cases:1.28%

controls:0.03%

cases:3.11%

controls:1.01%

cases:15.49%

controls:6.04%

cases:27.18%

controls:15.61%

571

5839

4025

40097

328

2625

4268

43311

433

4500

45503

4537

45920

143

464

4453

45443

706

2735

3851

42535

1103

6229

2955

33672

levothyroxine sodium; oral, parenteral
H03AA01 [21602754]

-8.9e-02

5.9e-02

-4.1e-01

3.0e+00

6.7e-01

1.7e+00

2.5e+00

cases:9.55%

controls:10.35%

cases:10.86%

controls:10.29%

cases:2.07%

controls:3.08%

cases:1.76%

controls:0.09%

cases:5.87%

controls:3.09%

cases:40.47%

controls:10.74%

cases:63.55%

controls:12.44%

439

4755

4157

41181

499

4729

4097

41207

1415

4501

44521

4515

45896

270

1420

4326

44487

1844

4864

2713

40406

2579

4962

1479

34939

Thyroglobulin Ab [Units/volume] in Serum or Plasma
8098-6 [3025547]

-5.3e-01

1.3e+00

2.8e+00

—

1.6e+00

1.9e+00

cases:0.15%

controls:0.26%

cases:0.52%

controls:0.14%

cases:0.46%

controls:0.03%

—

cases:0.75%

controls:0.16%

cases:1.92%

controls:0.30%

119

4589

45817

4572

45871

4575

45923

—

4523

45199

121

3980

39780

Radioiodine therapy of thyroid tissue
XX7CT [2001311149]

—

2.5e+00

—

1.0e+50

—

4.9e+00

—

cases:0.24%

controls:0.02%

—

cases:0.39%

controls:0.00%

cases:0.20%

controls:0.00%

—

cases:5.03%

controls:0.04%

—

4585

45927

—

4578

45936

4587

45907

—

204

3854

39886

Outpatient Hospital
22 [8756]

4.6e-02

3.3e-01

6.1e-01

3.9e+00

9.8e-01

1.0e+00

6.1e-01

cases:25.85%

controls:24.97%

cases:9.64%

controls:7.14%

cases:1.46%

controls:0.80%

cases:1.91%

controls:0.04%

cases:2.11%

controls:0.81%

cases:14.48%

controls:5.82%

cases:24.30%

controls:14.90%

1188

11471

3408

34465

443

3282

4153

42654

368

4529

45568

4508

45918

370

4499

45537

660

2633

3897

42637

986

5946

3072

33955

Parathyrin.intact [Mass/volume] in Serum or Plasma
2731-8 [3000067]

1.0e-01

4.9e-01

1.9e+00

—

2.1e+00

1.8e+00

1.6e+00

cases:1.24%

controls:1.12%

cases:1.15%

controls:0.71%

cases:0.76%

controls:0.12%

—

cases:0.78%

controls:0.09%

cases:4.34%

controls:0.74%

cases:8.55%

controls:1.86%

515

4539

45421

325

4543

45611

4561

45883

—

4560

45864

198

335

4359

44935

347

741

3711

39160

Emergency Room Visit
ER [9203]

1.9e-01

6.6e-01

1.3e+00

3.9e+00

7.9e-01

3.5e-01

2.6e-01

cases:39.36%

controls:34.84%

cases:20.37%

controls:11.63%

cases:4.96%

controls:1.45%

cases:3.26%

controls:0.07%

cases:3.05%

controls:1.40%

cases:14.15%

controls:10.45%

cases:32.26%

controls:26.95%

1809

16003

2787

29933

936

5342

3660

40594

228

666

4368

45270

150

4446

45904

140

643

4456

45264

645

4730

3912

40540

1309

10752

2749

29149

Erythrocyte [DistWidth] in Red Blood Cells
30385-9 [3002385]

-4.2e-02

4.1e-01

2.2e+00

2.0e+00

1.4e+00

7.9e-01

3.6e-01

cases:22.82%

controls:23.58%

cases:26.33%

controls:19.24%

cases:29.66%

controls:4.26%

cases:1.65%

controls:0.22%

cases:14.58%

controls:4.09%

cases:36.03%

controls:20.35%

cases:48.45%

controls:39.57%

1049

10831

3547

35105

1210

8838

3386

37098

1363

1955

3233

43981

100

4520

45836

670

1877

3926

44030

1642

9212

2915

36058

1966

15790

2092

24111

CBC panel - Blood by Automated count
58410-2 [40761511]

3.2e-02

5.3e-01

2.2e+00

2.0e+00

1.3e+00

6.8e-01

3.9e-01

cases:32.83%

controls:32.13%

cases:32.83%

controls:22.32%

cases:27.26%

controls:3.95%

cases:1.35%

controls:0.19%

cases:12.90%

controls:3.70%

cases:36.65%

controls:22.63%

cases:56.88%

controls:47.27%

1509

14759

3087

31177

1509

10255

3087

35681

1253

1813

3343

44123

4534

45851

593

1698

4003

44209

1670

10243

2887

35027

2308

18860

1750

21041

Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation
290 [2001600222]

-4.1e-01

1.5e+00

2.4e+00

—

2.2e+00

9.4e-01

2.1e-01

cases:0.61%

controls:0.91%

cases:1.20%

controls:0.27%

cases:0.33%

controls:0.03%

—

cases:0.26%

controls:0.03%

cases:0.81%

controls:0.32%

cases:1.60%

controls:1.30%

420

4568

45516

123

4541

45813

4581

45923

—

4584

45894

144

4520

45126

519

3993

39382

Inpatient Hospital
21 [8717]

1.1e-02

4.3e-01

6.4e-01

4.1e+00

7.6e-01

7.1e-01

4.4e-01

cases:31.85%

controls:31.61%

cases:14.36%

controls:9.80%

cases:2.33%

controls:1.24%

cases:3.26%

controls:0.06%

cases:2.55%

controls:1.21%

cases:15.87%

controls:8.51%

cases:29.30%

controls:21.05%

1464

14521

3132

31415

660

4504

3936

41432

107

569

4489

45367

150

4446

45910

117

555

4479

45352

723

3852

3834

41418

1189

8399

2869

31502

Troponin T.cardiac [Mass/volume] in Serum or Plasma
6598-7 [3019800]

9.0e-02

9.0e-01

1.8e+00

3.5e+00

8.1e-01

1.8e-01

1.6e-01

cases:6.14%

controls:5.64%

cases:6.53%

controls:2.77%

cases:2.15%

controls:0.35%

cases:0.44%

controls:0.01%

cases:0.67%

controls:0.30%

cases:3.53%

controls:2.97%

cases:11.36%

controls:9.89%

282

2589

4314

43347

300

1271

4296

44665

162

4497

45774

4576

45930

138

4565

45769

161

1343

4396

43927

461

3945

3597

35956

EKG study
11524-6 [3013512]

-9.2e-02

6.4e-01

1.8e+00

3.1e+00

8.9e-01

3.6e-01

2.9e-01

cases:4.77%

controls:5.20%

cases:5.48%

controls:2.97%

cases:2.24%

controls:0.39%

cases:0.28%

controls:0.01%

cases:0.78%

controls:0.32%

cases:4.41%

controls:3.11%

cases:11.53%

controls:8.85%

219

2388

4377

43548

252

1365

4344

44571

103

179

4493

45757

4583

45930

149

4560

45758

201

1408

4356

43862

468

3533

3590

36368

pH of Specimen
17433-4 [3019225]

-1.0e-01

5.9e-01

2.6e+00

—

1.8e+00

1.0e+00

cases:1.50%

controls:1.66%

cases:1.61%

controls:0.89%

cases:1.57%

controls:0.12%

—

cases:0.72%

controls:0.12%

cases:2.39%

controls:0.88%

cases:5.52%

controls:2.07%

762

4527

45174

411

4522

45525

4524

45880

—

4563

45854

109

400

4448

44870

224

825

3834

39076

Cardiodefibrillation
TFP20 [2001303224]

2.2e-01

1.4e+00

3.1e+00

—

1.7e+00

6.9e-01

cases:0.63%

controls:0.51%

cases:0.72%

controls:0.17%

cases:0.24%

controls:0.01%

—

cases:0.92%

controls:0.17%

cases:0.89%

controls:0.45%

232

4567

45704

4563

45857

4585

45931

—

4515

45193

179

4022

39722

Essential (primary) hypertension
I10 [45591453]

1.6e-02

2.8e-01

4.7e-01

4.4e+00

9.4e-01

3.3e-01

2.2e-01

cases:12.42%

controls:12.25%

cases:8.20%

controls:6.30%

cases:1.65%

controls:1.04%

cases:4.18%

controls:0.05%

cases:2.70%

controls:1.07%

cases:9.30%

controls:6.84%

cases:21.04%

controls:17.63%

571

5626

4025

40310

377

2894

4219

43042

477

4520

45459

192

4404

45911

124

493

4472

45414

424

3096

4133

42174

854

7034

3204

32867

Glucose [Moles/volume] in Serum or Plasma
14749-6 [3013826]

2.3e-02

5.5e-01

1.5e+00

2.9e+00

8.0e-01

4.9e-01

3.1e-01

cases:10.47%

controls:10.26%

cases:8.92%

controls:5.35%

cases:2.98%

controls:0.66%

cases:0.57%

controls:0.03%

cases:1.57%

controls:0.71%

cases:8.73%

controls:5.54%

cases:21.73%

controls:16.92%

481

4711

4115

41225

410

2456

4186

43480

137

303

4459

45633

4570

45922

326

4524

45581

398

2507

4159

42763

882

6750

3176

33151

Otolaryngology
4 [38004449]

8.6e-02

2.4e-01

6.8e-01

3.2e+00

1.2e+00

9.6e-01

5.9e-01

cases:10.77%

controls:9.97%

cases:4.50%

controls:3.59%

cases:1.02%

controls:0.52%

cases:0.65%

controls:0.03%

cases:1.52%

controls:0.49%

cases:8.62%

controls:3.49%

cases:17.23%

controls:10.38%

495

4580

4101

41356

207

1649

4389

44287

240

4549

45696

4566

45924

223

4526

45684

393

1582

4164

43688

699

4140

3359

35761

Normoblasts [#/volume] in Blood
715-3 [3021589]

3.4e-04

4.5e-01

2.0e+00

1.6e+00

1.2e+00

8.1e-01

5.3e-01

cases:7.85%

controls:7.85%

cases:9.81%

controls:6.47%

cases:9.83%

controls:1.43%

cases:0.39%

controls:0.08%

cases:4.29%

controls:1.37%

cases:14.11%

controls:6.80%

cases:22.89%

controls:14.94%

361

3607

4235

42329

451

2972

4145

42964

452

658

4144

45278

4578

45900

197

628

4399

45279

643

3078

3914

42192

929

5960

3129

33941

Other thyrotoxicosis
E05.89 [2000501414]

2.4e+00

—

4.2e+00

cases:0.20%

controls:0.02%

—

cases:0.96%

controls:0.02%

4587

45928

—

4019

39895

Palpitations/awareness of heart
K04 [2002000547]

4.9e-01

2.1e+00

3.6e+00

—

7.2e-01

8.9e-01

cases:0.72%

controls:0.44%

cases:1.31%

controls:0.16%

cases:0.61%

controls:0.02%

—

cases:0.29%

controls:0.14%

cases:1.45%

controls:0.60%

203

4563

45733

4536

45861

4568

45928

—

4544

45207

241

3999

39660

Hyperthyroidism/thyrotoxicosis
T85 [2002001127]

2.0e+00

—

1.0e+50

—

4.5e+00

cases:0.28%

controls:0.04%

—

cases:1.20%

controls:0.00%

—

cases:3.33%

controls:0.04%

4583

45919

—

4541

45936

—

135

3923

39885

Palpitations
R00.2 [45558446]

1.1e-01

1.8e+00

3.0e+00

—

7.1e-01

9.3e-01

cases:0.94%

controls:0.84%

cases:1.68%

controls:0.29%

cases:0.50%

controls:0.02%

—

cases:0.64%

controls:0.31%

cases:3.20%

controls:1.29%

387

4553

45549

131

4519

45805

4573

45925

—

142

4528

45128

130

513

3928

39388

Medical doctor
Z2221 [2001311556]

2.1e-01

5.8e-01

1.1e+00

3.0e+00

4.1e-01

7.5e-01

8.0e-01

cases:7.20%

controls:5.94%

cases:2.76%

controls:1.57%

cases:0.65%

controls:0.22%

cases:0.26%

controls:0.01%

cases:0.35%

controls:0.23%

cases:2.70%

controls:1.29%

cases:6.23%

controls:2.91%

331

2727

4265

43209

127

720

4469

45216

100

4566

45836

4584

45930

106

4580

45801

123

583

4434

44687

253

1162

3805

38739

Disorder of thyroid, unspecified
E07.9 [45533008]

1.8e+00

3.1e+00

1.0e+50

—

1.6e+00

cases:0.15%

controls:0.03%

cases:0.28%

controls:0.01%

cases:0.17%

controls:0.00%

—

cases:0.22%

controls:0.05%

4589

45924

4583

45930

4588

45936

—

4049

39883

Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation
351 [2001600312]

-3.2e-01

1.8e+00

2.6e+00

—

2.0e+00

5.6e-01

9.7e-03

cases:0.57%

controls:0.78%

cases:1.52%

controls:0.25%

cases:0.39%

controls:0.03%

—

cases:0.20%

controls:0.03%

cases:0.44%

controls:0.25%

cases:1.13%

controls:1.12%

358

4570

45578

117

4526

45819

4578

45922

—

4587

45895

114

4537

45156

448

4012

39453

Diplopia
H53.2 [45576792]

-1.2e-02

2.0e+00

—

2.4e+00

2.0e+00

cases:0.20%

controls:0.20%

cases:0.39%

controls:0.05%

—

cases:0.92%

controls:0.08%

cases:1.60%

controls:0.23%

4587

45845

4578

45911

—

4515

45232

3993

39811

Pediatric Endocrinology
OMOP4822030 [45756809]

-2.2e-01

—

1.0e+50

2.7e+00

1.9e+00

1.8e+00

cases:0.11%

controls:0.13%

—

cases:0.11%

controls:0.00%

cases:0.20%

controls:0.01%

cases:0.37%

controls:0.06%

cases:0.42%

controls:0.07%

4591

45874

—

4591

45936

4587

45901

4540

45244

4041

39872

Dysthyroid exophthalmos
H06.2*E05.9 [2000502261]

—

1.0e+50

—

6.3e+00

—

cases:2.26%

controls:0.00%

cases:1.91%

controls:0.00%

—

cases:10.20%

controls:0.02%

—

104

4492

45936

4508

45907

—

414

3644

39893

prednisolone; oral, parenteral
H02AB06 [21602734]

1.5e-01

3.2e-01

6.3e-01

3.1e+00

1.0e+00

6.3e-01

5.8e-01

cases:12.23%

controls:10.67%

cases:6.14%

controls:4.55%

cases:1.28%

controls:0.69%

cases:0.50%

controls:0.02%

cases:1.94%

controls:0.72%

cases:7.97%

controls:4.39%

cases:18.31%

controls:11.16%

562

4900

4034

41036

282

2090

4314

43846

315

4537

45621

4573

45926

329

4507

45578

363

1988

4194

43282

743

4452

3315

35449

MCHC [Entitic Mass/volume] in Red Blood Cells
28540-3 [3003338]

-3.4e-02

3.8e-01

2.0e+00

2.1e+00

1.3e+00

5.2e-01

4.3e-02

cases:28.05%

controls:28.74%

cases:29.61%

controls:22.35%

cases:27.26%

controls:4.61%

cases:1.74%

controls:0.22%

cases:14.43%

controls:4.42%

cases:33.79%

controls:23.36%

cases:45.61%

controls:44.55%

1289

13203

3307

32733

1361

10266

3235

35670

1253

2117

3343

43819

103

4516

45833

663

2031

3933

43876

1540

10577

3017

34693

1851

17775

2207

22126

prednisolone
A07EA01 [21600653]

1.6e-01

3.1e-01

6.3e-01

3.1e+00

1.0e+00

6.3e-01

5.7e-01

cases:12.29%

controls:10.71%

cases:6.14%

controls:4.57%

cases:1.28%

controls:0.69%

cases:0.50%

controls:0.02%

cases:1.94%

controls:0.72%

cases:7.97%

controls:4.41%

cases:18.33%

controls:11.24%

565

4919

4031

41017

282

2097

4314

43839

316

4537

45620

4573

45926

330

4507

45577

363

1997

4194

43273

744

4486

3314

35415

Papillary adenocarcinoma, NOS, of thyroid gland
8260/3-C73.9 [44503609]

—

1.6e+00

—

1.0e+50

3.6e+00

2.7e+00

—

cases:0.11%

controls:0.02%

—

cases:0.15%

controls:0.00%

cases:0.55%

controls:0.02%

cases:0.81%

controls:0.06%

—

4591

45926

—

4589

45907

4532

45263

4025

39879

Laboratory Visit
OMOP4822461 [32036]

1.9e-02

3.7e-01

1.9e+00

2.0e+00

1.2e+00

5.5e-01

2.0e-01

cases:44.50%

controls:44.02%

cases:50.59%

controls:41.51%

cases:50.09%

controls:12.56%

cases:4.59%

controls:0.65%

cases:31.09%

controls:12.01%

cases:57.67%

controls:44.05%

cases:69.59%

controls:65.13%

2045

20219

2551

25717

2325

19070

2271

26866

2302

5768

2294

40168

211

297

4385

45639

1429

5513

3167

40394

2628

19942

1929

25328

2824

25989

1234

13912

Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma
13875-0 [3036185]

—

2.6e+00

—

3.6e+00

3.0e-01

—

cases:0.17%

controls:0.01%

—

cases:0.55%

controls:0.02%

cases:0.17%

controls:0.13%

—

4588

45930

—

4532

45263

4051

39850

Emergency Medicine
93 [38004510]

7.7e-02

5.8e-01

1.2e+00

3.2e+00

8.3e-01

2.1e-01

2.0e-01

cases:13.36%

controls:12.50%

cases:11.38%

controls:6.73%

cases:2.98%

controls:0.95%

cases:1.09%

controls:0.05%

cases:2.11%

controls:0.93%

cases:9.11%

controls:7.48%

cases:26.66%

controls:23.01%

614

5740

3982

40196

523

3090

4073

42846

137

435

4459

45501

4546

45915

428

4499

45479

415

3386

4142

41884

1082

9181

2976

30720

Erythrocyte sedimentation rate [Velocity] in Red Blood Cells by Westergren method
4537-7 [3013707]

3.1e-02

7.8e-01

2.5e+00

1.9e+00

5.9e-01

1.0e-01

3.6e-01

cases:18.34%

controls:17.88%

cases:19.13%

controls:9.76%

cases:14.16%

controls:1.35%

cases:0.17%

controls:0.03%

cases:2.31%

controls:1.29%

cases:10.71%

controls:9.76%

cases:33.19%

controls:25.82%

843

8212

3753

37724

879

4483

3717

41453

651

620

3945

45316

4588

45924

106

591

4490

45316

488

4419

4069

40851

1347

10303

2711

29598

Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma
13874-3 [3035062]

—

2.4e+00

—

3.6e+00

2.8e-01

—

cases:0.17%

controls:0.02%

—

cases:0.55%

controls:0.02%

cases:0.17%

controls:0.13%

—

4588

45929

—

4532

45263

4051

39849

Sodium [Moles/volume] in Serum or Plasma
2951-2 [3019550]

7.3e-03

5.4e-01

1.9e+00

2.2e+00

6.3e-01

2.7e-01

4.0e-01

cases:29.16%

controls:29.01%

cases:32.42%

controls:21.87%

cases:21.17%

controls:3.90%

cases:1.83%

controls:0.20%

cases:6.74%

controls:3.72%

cases:28.31%

controls:23.08%

cases:55.99%

controls:46.10%

1340

13324

3256

32612

1490

10047

3106

35889

973

1790

3623

44146

4512

45846

310

1706

4286

44201

1290

10448

3267

34822

2272

18396

1786

21505

Potassium [Moles/volume] in Serum or Plasma
2823-3 [3023103]

6.8e-03

5.5e-01

1.9e+00

2.2e+00

6.4e-01

2.7e-01

4.0e-01

cases:29.35%

controls:29.21%

cases:33.05%

controls:22.16%

cases:21.26%

controls:3.98%

cases:1.83%

controls:0.20%

cases:6.94%

controls:3.78%

cases:28.64%

controls:23.37%

cases:56.31%

controls:46.40%

1349

13418

3247

32518

1519

10179

3077

35757

977

1830

3619

44106

4512

45843

319

1736

4277

44171

1305

10580

3252

34690

2285

18513

1773

21388

dihydrotachysterol; oral
A11CC02 [21600817]

—

2.8e+00

3.0e+00

—

cases:0.22%

controls:0.01%

cases:0.47%

controls:0.02%

—

4547

45264

4039

39892

Paralysis of vocal cords and larynx
J38.0 [45543265]

—

3.1e+00

2.8e+00

—

cases:1.27%

controls:0.06%

cases:1.87%

controls:0.12%

—

4499

45243

3982

39853

Coeliac disease
K90.0 [45586745]

7.6e-01

9.8e-01

1.9e+00

1.0e+50

1.7e+00

1.3e+00

9.0e-01

cases:0.81%

controls:0.38%

cases:0.44%

controls:0.16%

cases:0.17%

controls:0.03%

cases:0.24%

controls:0.00%

cases:0.15%

controls:0.03%

cases:0.68%

controls:0.19%

cases:1.26%

controls:0.51%

174

4559

45762

4576

45861

4588

45924

4585

45936

4589

45894

4526

45184

205

4007

39696

alfacalcidol; oral, parenteral
A11CC03 [21600818]

-7.5e-01

-6.2e-01

—

1.7e+00

1.9e+00

2.1e+00

cases:0.11%

controls:0.23%

cases:0.11%

controls:0.20%

—

cases:0.24%

controls:0.04%

cases:1.23%

controls:0.18%

cases:2.22%

controls:0.28%

106

4591

45830

4591

45843

—

4585

45887

4501

45190

110

3968

39791

potassium chloride; oral
A12BA01 [21600877]

-3.3e-01

2.1e-02

2.5e-01

3.0e+00

1.1e+00

1.0e+00

6.5e-01

cases:0.91%

controls:1.26%

cases:0.72%

controls:0.70%

cases:0.24%

controls:0.19%

cases:0.22%

controls:0.01%

cases:0.44%

controls:0.15%

cases:2.15%

controls:0.80%

cases:3.13%

controls:1.66%

581

4554

45355

323

4563

45613

4585

45850

4586

45931

4576

45838

363

4459

44907

127

662

3931

39239

Neutrophils [#/volume] in Blood
26499-4 [3017732]

-1.6e-01

8.6e-01

2.2e+00

—

1.9e+00

6.9e-01

1.7e-01

cases:1.00%

controls:1.17%

cases:1.48%

controls:0.63%

cases:0.98%

controls:0.11%

—

cases:0.74%

controls:0.12%

cases:1.51%

controls:0.77%

cases:3.55%

controls:3.00%

537

4550

45399

291

4528

45645

4551

45886

—

4562

45854

348

4488

44922

144

1199

3914

38702

Other specified counselling
Z71.8 [45581061]

4.8e-03

2.7e-01

1.1e+00

2.8e+00

9.8e-01

3.8e-01

3.1e-01

cases:4.24%

controls:4.22%

cases:2.63%

controls:2.02%

cases:0.91%

controls:0.30%

cases:0.22%

controls:0.01%

cases:0.76%

controls:0.29%

cases:3.34%

controls:2.30%

cases:11.21%

controls:8.46%

195

1940

4401

43996

121

928

4475

45008

140

4554

45796

4586

45930

132

4561

45775

152

1040

4405

44230

455

3374

3603

36527

Vertical strabismus
H50.2 [45533348]

-1.0e+50

—

2.1e+00

3.5e+00

cases:0.00%

controls:0.04%

—

cases:0.18%

controls:0.02%

cases:1.16%

controls:0.04%

4596

45918

—

4549

45260

4011

39887

calcium (different salts in combination); oral
A12AA20 [21600872]

-2.7e-02

-1.9e-04

2.0e-01

2.6e+00

8.0e-01

9.6e-01

1.2e+00

cases:8.18%

controls:8.38%

cases:6.29%

controls:6.29%

cases:1.76%

controls:1.45%

cases:0.78%

controls:0.06%

cases:3.35%

controls:1.54%

cases:15.51%

controls:6.60%

cases:25.75%

controls:9.72%

376

3851

4220

42085

289

2889

4307

43047

667

4515

45269

4560

45910

154

707

4442

45200

707

2987

3850

42283

1045

3880

3013

36021

IgA [Mass/volume] in Serum or Plasma
2458-8 [3007164]

-2.5e-02

7.8e-01

2.3e+00

—

1.4e+00

7.1e-01

4.4e-01

cases:3.72%

controls:3.81%

cases:2.89%

controls:1.35%

cases:1.35%

controls:0.14%

—

cases:0.50%

controls:0.13%

cases:2.85%

controls:1.43%

cases:8.55%

controls:5.70%

171

1751

4425

44185

133

622

4463

45314

4534

45870

—

4573

45849

130

647

4427

44623

347

2276

3711

37625

Eosinophils [#/volume] in Blood
26449-9 [3013115]

-8.9e-02

4.7e-01

1.6e+00

9.0e-01

5.5e-01

3.8e-01

cases:9.66%

controls:10.47%

cases:10.36%

controls:6.75%

cases:6.07%

controls:1.32%

cases:0.33%

controls:0.07%

cases:3.20%

controls:1.33%

cases:11.26%

controls:6.84%

cases:22.45%

controls:16.47%

444

4809

4152

41127

476

3100

4120

42836

279

606

4317

45330

4581

45906

147

610

4449

45297

513

3098

4044

42172

911

6570

3147

33331

Upper gastrointestinal surgery
106 [44777669]

5.8e-02

3.1e-01

5.7e-01

3.1e+00

8.6e-01

7.4e-01

4.1e-01

cases:9.01%

controls:8.54%

cases:4.50%

controls:3.35%

cases:0.85%

controls:0.48%

cases:0.70%

controls:0.03%

cases:1.26%

controls:0.54%

cases:6.36%

controls:3.13%

cases:12.96%

controls:9.00%

414

3925

4182

42011

207

1539

4389

44397

222

4557

45714

4564

45922

247

4538

45660

290

1417

4267

43853

526

3591

3532

36310

Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)/1.73 sq M
62238-1 [40764999]

4.4e-02

4.5e-01

1.8e+00

2.0e+00

5.5e-01

2.7e-01

4.0e-01

cases:21.65%

controls:20.91%

cases:25.37%

controls:17.76%

cases:18.34%

controls:3.55%

cases:1.22%

controls:0.17%

cases:5.66%

controls:3.34%

cases:23.85%

controls:19.33%

cases:48.69%

controls:38.90%

995

9605

3601

36331

1166

8160

3430

37776

843

1632

3753

44304

4540

45857

260

1535

4336

44372

1087

8752

3470

36518

1976

15523

2082

24378

varenicline; oral
N07BA03 [21604819]

4.9e-01

9.7e-01

1.5e+00

—

1.8e+00

1.1e+00

9.6e-01

cases:1.33%

controls:0.81%

cases:0.59%

controls:0.22%

cases:0.13%

controls:0.03%

—

cases:0.24%

controls:0.04%

cases:0.59%

controls:0.20%

cases:1.65%

controls:0.64%

374

4535

45562

103

4569

45833

4590

45923

—

4585

45889

4530

45179

256

3991

39645

Thyroglobulin [Mass/volume] in Serum or Plasma
3013-0 [3036535]

—

2.7e-01

1.9e+00

—

1.4e+00

2.0e+00

—

cases:0.17%

controls:0.13%

cases:0.17%

controls:0.03%

—

cases:0.55%

controls:0.13%

cases:1.55%

controls:0.22%

—

4588

45875

4588

45924

—

4532

45210

3995

39814

Biopsy from other organ close to skin with ultrasound quidance
XW1AT [2001311084]

—

2.6e+00

—

cases:0.15%

controls:0.01%

cases:0.42%

controls:0.03%

—

4550

45265

4041

39889

Type 2 diabetes mellitus, without complications
E11.9 [45561952]

-2.2e-01

-1.3e-01

4.5e-02

4.5e+00

8.0e-01

2.5e-01

8.5e-02

cases:2.92%

controls:3.61%

cases:1.76%

controls:2.01%

cases:0.39%

controls:0.37%

cases:1.11%

controls:0.01%

cases:0.76%

controls:0.34%

cases:2.74%

controls:2.15%

cases:5.52%

controls:5.09%

134

1658

4462

44278

922

4515

45014

172

4578

45764

4545

45930

157

4561

45750

125

974

4432

44296

224

2032

3834

37869

Basophils/Leukocytes in Blood
30180-4 [3022096]

-1.0e-01

4.4e-01

1.5e+00

1.6e+00

8.6e-01

4.8e-01

3.8e-01

cases:8.53%

controls:9.35%

cases:9.14%

controls:6.09%

cases:5.07%

controls:1.16%

cases:0.30%

controls:0.06%

cases:2.70%

controls:1.15%

cases:9.41%

controls:6.03%

cases:19.79%

controls:14.44%

392

4293

4204

41643

420

2798

4176

43138

233

535

4363

45401

4582

45907

124

530

4472

45377

429

2730

4128

42540

803

5760

3255

34141

Eosinophils/Leukocytes in Blood
26450-7 [3006504]

-9.9e-02

4.4e-01

1.5e+00

1.6e+00

8.6e-01

4.8e-01

3.8e-01

cases:8.55%

controls:9.36%

cases:9.14%

controls:6.10%

cases:5.09%

controls:1.17%

cases:0.30%

controls:0.06%

cases:2.70%

controls:1.16%

cases:9.37%

controls:6.03%

cases:19.71%

controls:14.42%

393

4298

4203

41638

420

2802

4176

43134

234

537

4362

45399

4582

45907

124

531

4472

45376

427

2732

4130

42538

800

5753

3258

34148

Lymphocytes/Leukocytes in Blood
26478-8 [3002030]

-1.1e-01

4.6e-01

1.5e+00

1.6e+00

8.6e-01

4.8e-01

3.6e-01

cases:8.90%

controls:9.80%

cases:9.66%

controls:6.31%

cases:5.18%

controls:1.21%

cases:0.30%

controls:0.06%

cases:2.76%

controls:1.19%

cases:9.70%

controls:6.24%

cases:20.26%

controls:15.05%

409

4500

4187

41436

444

2899

4152

43037

238

554

4358

45382

4582

45907

127

546

4469

45361

442

2823

4115

42447

822

6004

3236

33897

Monocytes/Leukocytes in Blood
26485-3 [3019069]

-1.0e-01

4.3e-01

1.5e+00

1.6e+00

8.6e-01

4.8e-01

3.8e-01

cases:8.55%

controls:9.39%

cases:9.07%

controls:6.11%

cases:5.03%

controls:1.17%

cases:0.30%

controls:0.06%

cases:2.70%

controls:1.16%

cases:9.39%

controls:6.04%

cases:19.89%

controls:14.46%

393

4314

4203

41622

417

2808

4179

43128

231

537

4365

45399

4582

45907

124

532

4472

45375

428

2733

4129

42537

807

5770

3251

34131

Creatinine [Moles/volume] in Serum or Plasma
14682-9 [3020564]

1.9e-02

4.6e-01

1.7e+00

2.0e+00

5.0e-01

2.0e-01

3.2e-01

cases:32.88%

controls:32.45%

cases:36.18%

controls:26.27%

cases:23.41%

controls:5.15%

cases:1.76%

controls:0.24%

cases:7.83%

controls:4.89%

cases:32.08%

controls:27.88%

cases:59.86%

controls:51.96%

1511

14908

3085

31028

1663

12069

2933

33867

1076

2367

3520

43569

111

4515

45825

360

2246

4236

43661

1462

12620

3095

32650

2429

20731

1629

19170

Case Management Agency
251B00000X [38004193]

4.6e-02

2.0e-01

5.5e-01

3.4e+00

3.8e-01

3.3e-01

3.6e-01

cases:66.88%

controls:65.87%

cases:63.25%

controls:58.52%

cases:34.51%

controls:23.38%

cases:30.53%

controls:1.47%

cases:31.22%

controls:23.64%

cases:69.26%

controls:61.83%

cases:87.09%

controls:82.51%

3074

30257

1522

15679

2907

26883

1689

19053

1586

10740

3010

35196

1403

673

3193

45263

1435

10851

3161

35056

3156

27991

1401

17279

3534

32921

524

6980

Neutrophils/Leukocytes in Blood
26511-6 [3018010]

-1.0e-01

4.5e-01

1.5e+00

8.7e-01

4.7e-01

3.4e-01

cases:8.68%

controls:9.54%

cases:9.27%

controls:6.10%

cases:5.13%

controls:1.16%

cases:0.30%

controls:0.07%

cases:2.72%

controls:1.16%

cases:9.44%

controls:6.09%

cases:19.64%

controls:14.85%

399

4382

4197

41554

426

2804

4170

43132

236

533

4360

45403

4582

45906

125

533

4471

45374

430

2758

4127

42512

797

5926

3261

33975

Abnormal weight loss
R63.4 [45568144]

6.6e-01

2.5e+00

2.7e+00

—

2.0e-01

cases:0.44%

controls:0.23%

cases:1.02%

controls:0.08%

cases:0.28%

controls:0.02%

—

cases:0.37%

controls:0.30%

104

4576

45832

4549

45897

4583

45927

—

121

4043

39780

25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
68438-1 [40771025]

4.9e-02

4.1e-01

2.0e+00

2.3e+00

1.2e+00

8.4e-01

6.3e-01

cases:7.40%

controls:7.07%

cases:6.09%

controls:4.14%

cases:3.35%

controls:0.46%

cases:0.11%

controls:0.01%

cases:1.59%

controls:0.47%

cases:10.07%

controls:4.61%

cases:24.40%

controls:14.62%

340

3248

4256

42688

280

1904

4316

44032

154

211

4442

45725

4591

45931

214

4523

45693

459

2085

4098

43185

990

5832

3068

34069

Lymphocytes [#/volume] in Blood
26474-7 [3019198]

-1.3e-01

4.6e-01

1.5e+00

8.6e-01

4.5e-01

3.5e-01

cases:9.36%

controls:10.48%

cases:10.18%

controls:6.71%

cases:5.46%

controls:1.28%

cases:0.30%

controls:0.07%

cases:2.98%

controls:1.29%

cases:10.25%

controls:6.80%

cases:21.66%

controls:16.34%

430

4813

4166

41123

468

3082

4128

42854

251

586

4345

45350

4582

45905

137

592

4459

45315

467

3077

4090

42193

879

6521

3179

33380

Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
1920-8 [3013721]

-1.0e-01

4.0e-01

1.2e+00

2.7e+00

8.2e-01

1.9e-01

-1.2e-02

cases:6.24%

controls:6.89%

cases:5.00%

controls:3.41%

cases:1.46%

controls:0.45%

cases:0.20%

controls:0.01%

cases:1.07%

controls:0.47%

cases:4.17%

controls:3.46%

cases:10.30%

controls:10.41%

287

3164

4309

42772

230

1568

4366

44368

208

4529

45728

4587

45930

217

4547

45690

190

1568

4367

43702

418

4155

3640

35746

Other specified cardiac arrhythmias
I49.8 [45576877]

2.8e-01

1.5e+00

2.8e+00

—

7.7e-01

7.9e-01

cases:0.26%

controls:0.20%

cases:0.26%

controls:0.06%

cases:0.17%

controls:0.01%

—

cases:0.18%

controls:0.08%

cases:0.69%

controls:0.32%

4584

45845

4584

45910

4588

45931

—

4549

45233

126

4030

39775

Tissue transglutaminase IgA Ab [Units/volume] in Serum
31017-7 [3019050]

9.2e-02

8.7e-01

2.2e+00

—

9.2e-01

6.5e-01

4.1e-01

cases:5.07%

controls:4.65%

cases:3.68%

controls:1.57%

cases:1.50%

controls:0.17%

—

cases:0.46%

controls:0.18%

cases:3.27%

controls:1.74%

cases:10.47%

controls:7.19%

233

2134

4363

43802

169

721

4427

45215

4527

45860

—

4575

45823

149

787

4408

44483

425

2867

3633

37034

Calcium [Moles/volume] in Serum or Plasma
2000-8 [3015377]

4.8e-02

7.2e-01

2.8e+00

1.8e+00

5.5e-01

6.4e-01

8.9e-01

cases:5.79%

controls:5.53%

cases:5.48%

controls:2.73%

cases:7.48%

controls:0.49%

cases:0.11%

controls:0.02%

cases:0.83%

controls:0.48%

cases:5.05%

controls:2.72%

cases:17.92%

controls:8.22%

266

2540

4330

43396

252

1256

4344

44680

344

223

4252

45713

4591

45928

219

4558

45688

230

1230

4327

44040

727

3280

3331

36621

Abnormal results of thyroid function studies
R94.6 [45563335]

1.5e+00

3.3e+00

1.0e+50

—

-1.0e+50

1.7e+00

cases:0.17%

controls:0.04%

cases:0.30%

controls:0.01%

cases:0.15%

controls:0.00%

—

cases:0.00%

controls:0.02%

cases:0.20%

controls:0.04%

4588

45919

4582

45931

4589

45936

—

4557

45261

4050

39887

Differential panel, method unspecified - Blood
69738-3 [42870588]

-1.1e-01

3.3e-01

1.4e+00

1.7e+00

8.0e-01

4.3e-01

3.9e-01

cases:5.44%

controls:6.05%

cases:5.55%

controls:4.05%

cases:3.15%

controls:0.81%

cases:0.22%

controls:0.04%

cases:1.78%

controls:0.81%

cases:6.32%

controls:4.22%

cases:13.26%

controls:9.42%

250

2777

4346

43159

255

1860

4341

44076

145

372

4451

45564

4586

45918

370

4514

45537

288

1910

4269

43360

538

3758

3520

36143

Free T4 and TSH panel - Serum or Plasma
24348-5 [3001019]

3.9e-01

1.4e+00

2.7e+00

—

8.4e-01

9.5e-02

9.4e-01

cases:1.63%

controls:1.11%

cases:2.02%

controls:0.53%

cases:0.74%

controls:0.05%

—

cases:0.13%

controls:0.06%

cases:0.59%

controls:0.54%

cases:4.53%

controls:1.83%

511

4521

45425

243

4503

45693

4562

45914

—

4590

45881

244

4530

45026

184

729

3874

39172

Monocytes [#/volume] in Blood
26484-6 [3001604]

-1.3e-01

4.6e-01

1.5e+00

1.4e+00

8.4e-01

4.6e-01

3.7e-01

cases:8.75%

controls:9.86%

cases:9.79%

controls:6.42%

cases:5.31%

controls:1.23%

cases:0.26%

controls:0.07%

cases:2.85%

controls:1.25%

cases:10.03%

controls:6.57%

cases:21.39%

controls:15.78%

402

4527

4194

41409

450

2948

4146

42988

244

564

4352

45372

4584

45905

131

576

4465

45331

457

2976

4100

42294

868

6296

3190

33605

Basophils [#/volume] in Blood
26444-0 [3006315]

-1.2e-01

4.7e-01

1.5e+00

1.4e+00

8.3e-01

4.6e-01

3.7e-01

cases:8.83%

controls:9.89%

cases:9.88%

controls:6.43%

cases:5.33%

controls:1.23%

cases:0.26%

controls:0.07%

cases:2.85%

controls:1.26%

cases:10.03%

controls:6.58%

cases:21.37%

controls:15.80%

406

4543

4190

41393

454

2955

4142

42981

245

566

4351

45370

4584

45905

131

578

4465

45329

457

2981

4100

42289

867

6305

3191

33596

C reactive protein [Mass/volume] in Serum or Plasma
1988-5 [3020460]

3.1e-02

5.8e-01

1.3e+00

1.9e+00

6.0e-01

2.7e-01

2.6e-01

cases:29.61%

controls:28.97%

cases:30.00%

controls:19.43%

cases:12.68%

controls:3.68%

cases:1.50%

controls:0.22%

cases:6.18%

controls:3.48%

cases:24.62%

controls:19.93%

cases:50.15%

controls:43.67%

1361

13309

3235

32627

1379

8924

3217

37012

583

1692

4013

44244

101

4527

45835

284

1598

4312

44309

1122

9021

3435

36249

2035

17426

2023

22475

Neuro-ophthalmology Physician
207WX0109X [903241]

—

3.0e+00

2.0e+00

—

cases:0.31%

controls:0.02%

cases:0.59%

controls:0.08%

—

4543

45263

4034

39868

hypromellose
S01KA02 [21605115]

2.0e-01

4.8e-01

1.0e+00

—

1.4e+00

1.2e+00

8.4e-01

cases:3.15%

controls:2.59%

cases:1.59%

controls:0.98%

cases:0.41%

controls:0.15%

—

cases:0.78%

controls:0.20%

cases:3.58%

controls:1.09%

cases:6.06%

controls:2.72%

145

1192

4451

44744

452

4523

45484

4577

45867

—

4560

45817

163

495

4394

44775

246

1084

3812

38817

Bilirubin.total [Moles/volume] in Serum or Plasma
14631-6 [3006140]

6.1e-02

3.4e-01

1.0e+00

2.2e+00

7.6e-01

4.4e-01

1.9e-01

cases:9.60%

controls:9.08%

cases:7.22%

controls:5.23%

cases:2.81%

controls:1.05%

cases:0.46%

controls:0.05%

cases:2.22%

controls:1.05%

cases:8.08%

controls:5.37%

cases:17.15%

controls:14.67%

441

4169

4155

41767

332

2404

4264

43532

129

481

4467

45455

4575

45912

102

480

4494

45427

368

2431

4189

42839

696

5853

3362

34048

Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma
1778-0 [3020013]

5.4e-01

1.8e+00

—

3.1e+00

3.2e-01

cases:0.13%

controls:0.08%

cases:0.17%

controls:0.03%

—

cases:0.48%

controls:0.02%

cases:0.17%

controls:0.13%

4590

45901

4588

45923

—

4535

45260

4051

39851

prednisone; oral
H02AB07 [21602735]

4.0e-01

1.0e+00

9.9e-01

—

1.7e+00

1.0e+00

6.8e-01

cases:2.33%

controls:1.57%

cases:1.33%

controls:0.47%

cases:0.24%

controls:0.09%

—

cases:0.41%

controls:0.08%

cases:1.16%

controls:0.42%

cases:2.19%

controls:1.12%

107

719

4489

45217

218

4535

45718

4585

45895

—

4577

45872

191

4504

45079

448

3969

39453

prednisone
A07EA03 [21600655]

4.0e-01

1.0e+00

9.9e-01

—

1.7e+00

1.0e+00

6.8e-01

cases:2.33%

controls:1.57%

cases:1.33%

controls:0.47%

cases:0.24%

controls:0.09%

—

cases:0.41%

controls:0.08%

cases:1.16%

controls:0.42%

cases:2.19%

controls:1.12%

107

719

4489

45217

218

4535

45718

4585

45895

—

4577

45872

191

4504

45079

448

3969

39453

Blood group antibody screen [Presence] in Serum or Plasma
890-4 [3001079]

1.6e-02

7.4e-02

4.8e-01

2.8e+00

7.7e-01

6.7e-01

5.7e-01

cases:8.59%

controls:8.47%

cases:4.40%

controls:4.09%

cases:0.76%

controls:0.47%

cases:0.22%

controls:0.01%

cases:1.00%

controls:0.47%

cases:6.67%

controls:3.53%

cases:19.57%

controls:12.05%

395

3889

4201

42047

202

1881

4394

44055

218

4561

45718

4586

45930

214

4550

45693

304

1599

4253

43671

794

4810

3264

35091

Eye and orbita MRI examination with high intensity magnet
CA1BG [2001300865]

-1.0e+50

—

1.0e+50

—

4.8e+00

cases:0.00%

controls:0.02%

—

cases:0.20%

controls:0.00%

—

cases:1.72%

controls:0.02%

4596

45928

—

4587

45907

—

3988

39895

Visual field testing with Goldmann perimetry
CS424 [2001301475]

—

2.3e+00

2.4e+00

—

cases:0.15%

controls:0.02%

cases:0.44%

controls:0.04%

—

4550

45263

4040

39885

Emergency Room and Inpatient Visit
ERIP [262]

1.5e-01

5.2e-01

9.4e-01

3.2e+00

5.0e-02

-7.3e-02

6.7e-02

cases:3.72%

controls:3.23%

cases:3.33%

controls:2.01%

cases:0.70%

controls:0.27%

cases:0.39%

controls:0.02%

cases:0.30%

controls:0.29%

cases:2.30%

controls:2.47%

cases:9.86%

controls:9.28%

171

1484

4425

44452

153

925

4443

45011

126

4564

45810

4578

45929

133

4582

45774

105

1120

4452

44150

400

3703

3658

36198

Cardiac arrhythmia NOS
K80 [2002000607]

3.7e-01

1.4e+00

2.7e+00

—

4.3e-01

6.2e-01

cases:0.98%

controls:0.68%

cases:1.17%

controls:0.30%

cases:0.37%

controls:0.03%

—

cases:0.39%

controls:0.26%

cases:1.97%

controls:1.07%

312

4551

45624

136

4542

45800

4579

45924

—

117

4539

45153

427

3978

39474

Extensive structural and functional ultrasound examination of heart
FM1EE [2001303307]

3.9e-03

6.8e-01

1.4e+00

1.0e+50

1.5e+00

7.4e-01

3.3e-01

cases:2.55%

controls:2.54%

cases:2.00%

controls:1.03%

cases:0.50%

controls:0.12%

cases:0.22%

controls:0.00%

cases:0.44%

controls:0.10%

cases:2.13%

controls:1.03%

cases:4.44%

controls:3.24%

117

1165

4479

44771

472

4504

45464

4573

45881

4586

45936

4576

45860

467

4460

44803

180

1293

3878

38608

metoprolol; oral, parenteral
C07AB02 [21601684]

5.5e-02

5.8e-01

9.1e-01

2.5e+00

5.7e-01

2.8e-01

1.3e-01

cases:3.89%

controls:3.69%

cases:4.90%

controls:2.81%

cases:2.05%

controls:0.83%

cases:0.30%

controls:0.02%

cases:1.44%

controls:0.82%

cases:3.60%

controls:2.74%

cases:4.12%

controls:3.63%

179

1697

4417

44239

225

1292

4371

44644

382

4502

45554

4582

45925

375

4530

45532

164

1242

4393

44028

167

1448

3891

38453

Tachycardia, unspecified
R00.0 [45606790]

8.7e-01

3.0e+00

—

-1.0e+50

8.7e-01

7.4e-01

cases:0.72%

controls:0.30%

cases:1.91%

controls:0.10%

—

cases:0.00%

controls:0.01%

cases:0.26%

controls:0.11%

cases:1.08%

controls:0.52%

139

4563

45797

4508

45890

—

4596

45902

4545

45220

208

4014

39693

INR in Blood by Coagulation assay
34714-6 [3032080]

-2.5e-02

5.0e-01

7.6e-01

2.1e+00

6.0e-01

3.5e-01

2.5e-01

cases:7.07%

controls:7.24%

cases:6.85%

controls:4.26%

cases:2.50%

controls:1.19%

cases:0.57%

controls:0.07%

cases:2.13%

controls:1.18%

cases:5.90%

controls:4.23%

cases:13.63%

controls:10.98%

325

3325

4271

42611

315

1955

4281

43981

115

547

4481

45389

4570

45904

541

4498

45366

269

1915

4288

43355

553

4383

3505

35518

Speech therapy
Z50.5 [45547321]

—

3.1e+00

1.4e+00

—

cases:0.31%

controls:0.01%

cases:0.30%

controls:0.07%

—

4543

45264

4046

39872

Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
2324-2 [3026910]

2.4e-03

5.1e-01

1.3e+00

1.6e+00

8.9e-01

2.1e-01

1.1e-01

cases:14.43%

controls:14.40%

cases:11.42%

controls:7.22%

cases:3.26%

controls:0.89%

cases:0.20%

controls:0.04%

cases:2.02%

controls:0.84%

cases:9.35%

controls:7.72%

cases:25.75%

controls:23.69%

663

6613

3933

39323

525

3315

4071

42621

150

410

4446

45526

4587

45918

387

4503

45520

426

3496

4131

41774

1045

9453

3013

30448

Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
33762-6 [3029187]

1.4e-01

8.6e-01

2.1e+00

—

8.3e-01

5.0e-01

2.6e-01

cases:3.44%

controls:3.00%

cases:4.11%

controls:1.78%

cases:1.70%

controls:0.22%

—

cases:0.48%

controls:0.21%

cases:3.12%

controls:1.92%

cases:7.86%

controls:6.16%

158

1380

4438

44556

189

819

4407

45117

101

4518

45835

—

4574

45811

142

867

4415

44403

319

2459

3739

37442

Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma
1777-2 [3001467]

2.8e-01

1.8e+00

—

2.7e+00

-3.4e-02

cases:0.15%

controls:0.12%

cases:0.26%

controls:0.04%

—

cases:0.72%

controls:0.05%

cases:0.30%

controls:0.31%

4589

45883

4584

45917

—

4524

45247

122

4046

39779

Hypercalcemia
E83.50 [2000501535]

—

2.3e+00

—

2.2e+00

4.5e-01

—

cases:0.17%

controls:0.02%

—

cases:0.18%

controls:0.02%

cases:0.17%

controls:0.11%

—

4588

45928

—

4549

45261

4051

39857

Reticulocytes [#/volume] in Blood
14196-0 [3023520]

2.4e-03

8.7e-01

2.0e+00

—

1.6e+00

3.7e-01

1.4e-01

cases:0.74%

controls:0.74%

cases:0.81%

controls:0.34%

cases:0.35%

controls:0.05%

—

cases:0.26%

controls:0.05%

cases:0.59%

controls:0.41%

cases:1.80%

controls:1.57%

339

4562

45597

155

4559

45781

4580

45914

—

4584

45883

185

4530

45085

626

3985

39275

Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
16182-8 [3021952]

3.3e-01

1.8e+00

—

2.7e+00

-1.5e-01

cases:0.24%

controls:0.17%

cases:0.35%

controls:0.06%

—

cases:1.05%

controls:0.08%

cases:0.39%

controls:0.46%

4585

45857

4580

45909

—

4509

45236

182

4042

39719

Smooth muscle Ab [Titer] in Serum
8095-2 [3007566]

-1.2e-01

9.5e-01

—

2.5e+00

9.7e-01

3.0e-01

cases:0.39%

controls:0.44%

cases:0.39%

controls:0.15%

—

cases:0.13%

controls:0.01%

cases:0.46%

controls:0.17%

cases:0.79%

controls:0.58%

203

4578

45733

4578

45866

—

4590

45902

4536

45191

233

4026

39668

Scheduled procedure
ZXD10 [2001311387]

1.5e-01

3.4e-01

7.5e-01

—

1.3e+00

1.7e+00

1.1e+00

cases:7.42%

controls:6.42%

cases:2.46%

controls:1.76%

cases:0.33%

controls:0.15%

—

cases:0.50%

controls:0.14%

cases:5.71%

controls:1.15%

cases:8.50%

controls:2.97%

341

2951

4255

42985

113

808

4483

45128

4581

45865

—

4573

45841

260

519

4297

44751

345

1185

3713

38716

Mitochondria Ab [Titer] in Serum
20483-4 [3034770]

-1.2e-01

9.0e-01

2.1e+00

—

2.3e+00

1.1e+00

3.1e-01

cases:0.39%

controls:0.44%

cases:0.39%

controls:0.16%

cases:0.11%

controls:0.01%

—

cases:0.13%

controls:0.01%

cases:0.53%

controls:0.17%

cases:0.76%

controls:0.56%

202

4578

45734

4578

45863

4591

45930

—

4590

45901

4533

45194

223

4027

39678

Extensive CT examination of head and neck for dose design of radiotherapy
YA1BD [2001300719]

-1.0e+50

—

2.1e+00

2.2e+00

cases:0.00%

controls:0.02%

cases:0.00%

controls:0.01%

—

cases:0.13%

controls:0.02%

cases:0.30%

controls:0.03%

4596

45926

4596

45930

—

4551

45263

4046

39888

Atherosclerotic heart disease
I25.1 [45596196]

-4.5e-02

3.2e-01

9.9e-01

3.3e+00

7.4e-01

2.7e-01

2.0e-01

cases:1.87%

controls:1.95%

cases:1.41%

controls:1.03%

cases:0.46%

controls:0.17%

cases:0.30%

controls:0.01%

cases:0.46%

controls:0.22%

cases:1.49%

controls:1.14%

cases:3.25%

controls:2.68%

898

4510

45038

474

4531

45462

4575

45858

4582

45931

100

4575

45807

518

4489

44752

132

1069

3926

38832

Hypoparathyroidism
106 [2001600106]

-1.0e+50

—

1.0e+50

4.3e+00

cases:0.00%

controls:0.02%

—

cases:0.22%

controls:0.00%

cases:0.94%

controls:0.01%

4596

45929

—

4547

45270

4020

39896

Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
47598-8 [3048816]

3.3e-01

8.4e-01

1.5e+00

—

1.1e+00

9.0e-01

1.0e+00

cases:1.50%

controls:1.08%

cases:1.31%

controls:0.57%

cases:0.50%

controls:0.11%

—

cases:0.26%

controls:0.08%

cases:1.49%

controls:0.61%

cases:4.68%

controls:1.73%

498

4527

45438

260

4536

45676

4573

45887

—

4584

45868

276

4489

44994

190

690

3868

39211

Bilateral
ZXA10 [2001311348]

2.4e-01

4.8e-01

—

1.6e+00

1.1e+00

cases:2.70%

controls:2.14%

cases:0.87%

controls:0.54%

—

cases:0.22%

controls:0.04%

cases:2.70%

controls:0.57%

cases:4.88%

controls:1.64%

124

983

4472

44953

249

4556

45687

—

4586

45887

123

256

4434

45014

198

655

3860

39246

General anesthesia, balanced
WX408 [2001310808]

1.2e-01

3.6e-01

—

1.5e+00

1.6e+00

1.2e+00

cases:4.68%

controls:4.15%

cases:1.46%

controls:1.02%

cases:0.13%

controls:0.09%

—

cases:0.41%

controls:0.09%

cases:3.45%

controls:0.73%

cases:6.38%

controls:2.03%

215

1908

4381

44028

468

4529

45468

4590

45894

—

4577

45866

157

331

4400

44939

259

811

3799

39090

Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
30248-9 [3015399]

-4.6e-02

7.9e-01

1.7e+00

—

1.2e+00

3.4e-01

2.3e-01

cases:3.61%

controls:3.78%

cases:4.18%

controls:1.94%

cases:1.26%

controls:0.23%

—

cases:0.72%

controls:0.21%

cases:3.01%

controls:2.16%

cases:8.65%

controls:7.02%

166

1735

4430

44201

192

893

4404

45043

104

4538

45832

—

4563

45809

137

976

4420

44294

351

2800

3707

37101

More than one and less than three hours
ZXE10 [2001311401]

8.6e-02

1.9e-02

-3.3e-02

—

1.5e+00

1.6e+00

1.1e+00

cases:6.57%

controls:6.06%

cases:1.72%

controls:1.69%

cases:0.13%

controls:0.13%

—

cases:0.50%

controls:0.11%

cases:5.46%

controls:1.14%

cases:8.87%

controls:3.00%

302

2786

4294

43150

775

4517

45161

4590

45874

—

4573

45857

249

515

4308

44755

360

1196

3698

38705

Intravenous general anesthesia
WX404 [2001310807]

2.7e-02

2.3e-01

—

1.4e+00

1.6e+00

1.3e+00

cases:3.72%

controls:3.62%

cases:1.37%

controls:1.09%

—

cases:0.26%

controls:0.07%

cases:3.20%

controls:0.66%

cases:5.50%

controls:1.58%

171

1665

4425

44271

501

4533

45435

—

4584

45876

146

301

4411

44969

223

630

3835

39271

Reticulocytes/Erythrocytes in Blood
4679-7 [3027945]

-5.3e-04

7.3e-01

2.2e+00

—

1.3e+00

3.6e-01

1.6e-01

cases:1.35%

controls:1.35%

cases:1.31%

controls:0.64%

cases:0.76%

controls:0.08%

—

cases:0.37%

controls:0.10%

cases:0.99%

controls:0.69%

cases:2.64%

controls:2.25%

620

4534

45316

292

4536

45644

4561

45897

—

4579

45861

313

4512

44957

107

898

3951

39003

rivaroxaban; oral
B01AF01 [43534761]

1.1e-01

6.3e-01

1.0e+00

—

1.3e+00

7.6e-01

5.0e-01

cases:1.70%

controls:1.53%

cases:1.70%

controls:0.91%

cases:0.94%

controls:0.34%

—

cases:1.11%

controls:0.30%

cases:2.04%

controls:0.97%

cases:3.57%

controls:2.19%

701

4518

45235

417

4518

45519

158

4553

45778

—

136

4545

45771

438

4464

44832

145

873

3913

39028

Paroxysmal atrial fibrillation
I48.0 [45581776]

-4.1e-02

1.3e+00

2.0e+00

—

1.3e+00

9.1e-01

4.4e-01

cases:0.26%

controls:0.27%

cases:0.89%

controls:0.25%

cases:0.41%

controls:0.05%

—

cases:0.24%

controls:0.07%

cases:0.86%

controls:0.34%

cases:1.53%

controls:0.99%

125

4584

45811

115

4555

45821

4577

45911

—

4585

45876

156

4518

45114

396

3996

39505

Tremor, unspecified
R25.1 [45539327]

2.1e-01

2.1e+00

—

4.8e-01

4.9e-01

cases:0.22%

controls:0.18%

cases:0.74%

controls:0.09%

cases:0.20%

controls:0.02%

—

cases:0.15%

controls:0.09%

cases:0.42%

controls:0.26%

4586

45855

4562

45894

4587

45925

—

4550

45227

103

4041

39798

Cardiology
6 [38004451]

-4.2e-02

6.2e-01

1.3e+00

—

1.3e+00

6.4e-01

3.9e-01

cases:6.94%

controls:7.22%

cases:6.01%

controls:3.32%

cases:1.85%

controls:0.53%

—

cases:1.52%

controls:0.44%

cases:6.01%

controls:3.25%

cases:12.20%

controls:8.62%

319

3316

4277

42620

276

1524

4320

44412

242

4511

45694

—

201

4526

45706

274

1472

4283

43798

495

3439

3563

36462

Irregular heartbeat other
K05 [2002000548]

4.0e-02

1.9e+00

2.3e+00

—

5.0e-01

cases:0.22%

controls:0.21%

cases:0.28%

controls:0.04%

cases:0.13%

controls:0.01%

—

cases:0.54%

controls:0.33%

4586

45840

4583

45916

4590

45930

—

132

4036

39769

Abnormal result investigation NOS
A91 [2002000224]

5.9e-02

1.2e+00

2.3e+00

—

7.2e-01

5.9e-01

cases:0.41%

controls:0.39%

cases:0.57%

controls:0.17%

cases:0.15%

controls:0.02%

—

cases:0.33%

controls:0.16%

cases:1.01%

controls:0.56%

179

4577

45757

4570

45860

4589

45929

—

4542

45197

224

4017

39677

Pain in throat
R07.0 [45592406]

1.5e-01

8.6e-01

1.3e+00

—

2.3e+00

9.5e-01

3.9e-01

cases:0.72%

controls:0.62%

cases:0.59%

controls:0.25%

cases:0.13%

controls:0.03%

—

cases:0.22%

controls:0.02%

cases:0.61%

controls:0.24%

cases:1.75%

controls:1.20%

285

4563

45651

115

4569

45821

4590

45920

—

4586

45897

108

4529

45162

477

3987

39424

Papillary carcinoma of the thyroid gland (thyroid gland)
C73.91 [2000501197]

—

-2.4e-01

1.2e+00

—

1.5e+00

1.9e+00

2.2e+00

—

cases:0.13%

controls:0.17%

cases:0.11%

controls:0.03%

—

cases:0.15%

controls:0.03%

cases:1.03%

controls:0.15%

cases:2.12%

controls:0.25%

—

4590

45860

4591

45921

—

4589

45892

4510

45201

3972

39803

CBC W Ordered Manual Differential panel - Blood
57782-5 [40760892]

2.8e-02

6.8e-01

1.8e+00

—

7.2e-01

5.2e-01

3.2e-01

cases:3.92%

controls:3.81%

cases:4.55%

controls:2.35%

cases:2.28%

controls:0.37%

—

cases:0.85%

controls:0.41%

cases:4.02%

controls:2.42%

cases:9.59%

controls:7.15%

180

1752

4416

44184

209

1078

4387

44858

105

172

4491

45764

—

190

4557

45717

183

1095

4374

44175

389

2853

3669

37048

Postprocedural hypothyroidism, other or several procedures
E89.09 [2000501555]

—

4.1e+00

—

cases:1.01%

controls:0.02%

—

4017

39894

Orbita CT
CA1AD [2001300861]

—

1.0e+50

4.0e+00

—

cases:0.70%

controls:0.00%

cases:0.67%

controls:0.01%

—

4525

45270

4031

39896

Examination of eyes and vision
Z01.0 [45566391]

3.3e-03

2.9e-01

1.1e+00

—

1.1e+00

1.0e+00

7.1e-01

cases:2.35%

controls:2.34%

cases:1.20%

controls:0.89%

cases:0.33%

controls:0.11%

—

cases:0.33%

controls:0.11%

cases:2.76%

controls:0.99%

cases:6.46%

controls:3.30%

108

1076

4488

44860

411

4541

45525

4581

45886

—

4581

45858

126

449

4431

44821

262

1315

3796

38586

Intravenous
ZX120 [2001311495]

1.2e-01

2.0e-01

1.4e-01

1.0e+50

1.4e+00

1.7e+00

8.4e-01

cases:1.35%

controls:1.20%

cases:0.61%

controls:0.50%

cases:0.15%

controls:0.13%

cases:0.13%

controls:0.00%

cases:0.48%

controls:0.12%

cases:2.06%

controls:0.37%

cases:2.05%

controls:0.90%

552

4534

45384

230

4568

45706

4589

45875

4590

45936

4574

45852

168

4463

45102

358

3975

39543

Heart failure, unspecified
I50.9 [45576879]

-2.2e-01

1.1e+00

1.4e+00

—

1.4e+00

3.0e-01

5.2e-02

cases:0.61%

controls:0.76%

cases:1.24%

controls:0.42%

cases:0.35%

controls:0.08%

—

cases:0.30%

controls:0.07%

cases:0.66%

controls:0.49%

cases:1.38%

controls:1.31%

348

4568

45588

195

4539

45741

4580

45897

—

4582

45874

221

4527

45049

523

4002

39378

Celiac disease serology panel - Serum
94494-2 [36660697]

-2.3e-01

1.1e+00

2.0e+00

—

1.4e+00

8.3e-01

2.5e-01

cases:1.11%

controls:1.39%

cases:1.26%

controls:0.40%

cases:0.52%

controls:0.07%

—

cases:0.15%

controls:0.04%

cases:1.16%

controls:0.51%

cases:3.08%

controls:2.41%

639

4545

45297

186

4538

45750

4572

45902

—

4589

45889

231

4504

45039

125

961

3933

38940

Thorax X-ray examination
GD1AA [2001303617]

7.8e-02

7.5e-01

1.2e+00

—

7.3e-01

6.7e-01

5.6e-01

cases:7.46%

controls:6.94%

cases:5.46%

controls:2.66%

cases:1.11%

controls:0.33%

—

cases:0.61%

controls:0.29%

cases:4.21%

controls:2.20%

cases:12.37%

controls:7.48%

343

3190

4253

42746

251

1223

4345

44713

153

4545

45783

—

135

4568

45772

192

998

4365

44272

502

2984

3556

36917

Tissue transglutaminase IgG Ab [Units/volume] in Serum
32998-7 [3046870]

-2.3e-02

1.3e+00

2.6e+00

—

5.3e-01

2.2e-01

cases:0.48%

controls:0.49%

cases:0.67%

controls:0.19%

cases:0.30%

controls:0.02%

—

cases:0.50%

controls:0.30%

cases:2.00%

controls:1.61%

225

4574

45711

4565

45849

4582

45926

—

135

4534

45135

642

3977

39259

Swelling
A08 [2002000149]

4.4e-02

1.2e+00

2.1e+00

—

-1.2e-01

6.0e-01

cases:0.35%

controls:0.33%

cases:0.41%

controls:0.13%

cases:0.13%

controls:0.02%

—

cases:0.13%

controls:0.15%

cases:1.06%

controls:0.59%

153

4580

45783

4577

45876

4590

45929

—

4551

45203

234

4015

39667

Electrophysiological examination of eye
XCD10 [2001300413]

-4.5e-02

3.3e-01

-1.0e+50

—

2.2e+00

1.7e+00

cases:0.24%

controls:0.25%

cases:0.11%

controls:0.08%

cases:0.00%

controls:0.01%

—

cases:0.57%

controls:0.06%

cases:0.94%

controls:0.17%

115

4585

45821

4591

45900

4596

45931

—

4531

45241

4020

39832

Recording of ECG
SPAT1097 [2001700198]

-1.2e-02

1.1e+00

2.3e+00

—

1.2e+00

1.4e-01

5.1e-01

cases:1.68%

controls:1.70%

cases:1.72%

controls:0.58%

cases:0.57%

controls:0.06%

—

cases:0.13%

controls:0.04%

cases:0.64%

controls:0.55%

cases:3.03%

controls:1.84%

779

4519

45157

266

4517

45670

4570

45909

—

4590

45889

251

4528

45019

123

735

3935

39166

Monitoring of emergency patient
SPAT1104 [2001700205]

-1.3e-01

1.1e+00

2.8e+00

—

-2.7e-01

1.0e-01

cases:0.59%

controls:0.67%

cases:0.61%

controls:0.20%

cases:0.24%

controls:0.02%

—

cases:0.15%

controls:0.20%

cases:0.71%

controls:0.65%

307

4569

45629

4568

45844

4585

45929

—

4550

45179

258

4029

39643

Dry eye syndrome
H04.10 [2000502254]

4.7e-02

3.2e-01

7.3e-01

—

1.8e+00

1.2e+00

9.1e-01

cases:1.17%

controls:1.12%

cases:0.65%

controls:0.48%

cases:0.13%

controls:0.06%

—

cases:0.39%

controls:0.07%

cases:1.89%

controls:0.58%

cases:5.35%

controls:2.23%

515

4542

45421

219

4566

45717

4590

45907

—

4578

45876

261

4471

45009

217

889

3841

39012

Recession of extraocular muscle
CEC00 [2001301083]

—

3.8e+00

—

cases:0.57%

controls:0.01%

—

4035

39896

apixaban; oral
B01AF02 [43534762]

-9.7e-02

6.7e-01

1.2e+00

—

1.2e+00

7.9e-01

2.8e-01

cases:0.72%

controls:0.79%

cases:1.72%

controls:0.88%

cases:1.48%

controls:0.46%

—

cases:1.50%

controls:0.47%

cases:2.28%

controls:1.04%

cases:2.46%

controls:1.88%

363

4563

45573

406

4517

45530

213

4528

45723

—

215

4527

45692

104

473

4453

44797

100

750

3958

39151

Hypothyroidism due to medicaments and other exogenous substances
E03.2 [45566718]

—

-1.0e+50

—

3.8e+00

—

cases:0.00%

controls:0.01%

—

cases:2.22%

controls:0.05%

—

4596

45930

—

3968

39881

Extensive CT examination of arteria pulmonalis
FB1BD [2001302407]

-2.4e-01

1.5e+00

2.3e+00

—

2.5e-01

5.4e-01

cases:0.54%

controls:0.69%

cases:0.96%

controls:0.22%

cases:0.28%

controls:0.03%

—

cases:0.20%

controls:0.15%

cases:1.01%

controls:0.59%

316

4571

45620

4552

45837

4583

45923

—

4548

45200

236

4017

39665

Folate [Moles/volume] in Red Blood Cells
14731-4 [3019309]

-1.9e-01

5.8e-01

1.8e+00

—

1.1e+00

2.5e-01

3.4e-01

cases:2.74%

controls:3.28%

cases:1.91%

controls:1.08%

cases:0.59%

controls:0.10%

—

cases:0.28%

controls:0.09%

cases:1.25%

controls:0.98%

cases:3.87%

controls:2.78%

126

1507

4470

44429

496

4508

45440

4569

45889

—

4583

45864

444

4500

44826

157

1110

3901

38791

Exophthalmic conditions
H05.2 [45571878]

—

3.7e+00

—

cases:0.84%

controls:0.02%

—

4024

39893

Calcium [Moles/volume] corrected for albumin in Serum or Plasma
29265-6 [3020059]

6.5e-02

7.4e-01

1.8e+00

—

4.6e-01

5.0e-01

6.3e-01

cases:2.57%

controls:2.41%

cases:2.55%

controls:1.23%

cases:1.07%

controls:0.17%

—

cases:0.30%

controls:0.19%

cases:2.00%

controls:1.22%

cases:7.61%

controls:4.22%

118

1107

4478

44829

117

563

4479

45373

4547

45858

—

4582

45819

551

4466

44719

309

1685

3749

38216

General anaesthesia
WX402 [2001310806]

6.4e-02

1.7e-01

3.8e-01

—

1.7e+00

1.1e+00

8.5e-01

cases:1.74%

controls:1.63%

cases:1.09%

controls:0.92%

cases:0.13%

controls:0.09%

—

cases:0.44%

controls:0.08%

cases:3.01%

controls:0.97%

cases:8.72%

controls:3.91%

751

4516

45185

423

4546

45513

4590

45895

—

4576

45869

137

441

4420

44829

354

1560

3704

38341

Sleep apnoea
G47.3 [45562094]

9.0e-02

1.7e-01

2.0e-01

3.3e+00

2.5e-02

1.6e-01

2.8e-01

cases:3.44%

controls:3.15%

cases:2.46%

controls:2.08%

cases:0.57%

controls:0.46%

cases:0.54%

controls:0.02%

cases:0.50%

controls:0.49%

cases:2.68%

controls:2.28%

cases:6.78%

controls:5.22%

158

1448

4438

44488

113

955

4483

44981

212

4570

45724

4571

45927

224

4573

45683

122

1033

4435

44237

275

2081

3783

37820

Sweating problem
A09 [2002000150]

—

2.3e+00

—

2.1e+00

1.3e+00

—

cases:0.17%

controls:0.02%

—

cases:0.11%

controls:0.01%

cases:0.37%

controls:0.11%

—

4588

45928

—

4552

45264

4043

39859

Type 1 diabetes mellitus, Without complications
E10.9 [45581351]

-3.6e-01

-3.4e-01

9.0e-02

3.9e+00

5.3e-02

-1.7e-01

-3.0e-01

cases:2.15%

controls:3.05%

cases:1.35%

controls:1.88%

cases:0.48%

controls:0.44%

cases:0.85%

controls:0.02%

cases:0.46%

controls:0.43%

cases:1.58%

controls:1.86%

cases:2.24%

controls:3.00%

1403

4497

44533

865

4534

45071

201

4574

45735

4557

45928

199

4575

45708

842

4485

44428

1196

3967

38705

Neurology
13 [38004458]

-1.5e-01

2.2e-01

6.0e-01

2.4e+00

5.7e-01

1.1e-01

8.7e-02

cases:8.42%

controls:9.65%

cases:5.20%

controls:4.22%

cases:1.54%

controls:0.85%

cases:0.44%

controls:0.04%

cases:1.35%

controls:0.77%

cases:4.61%

controls:4.14%

cases:10.42%

controls:9.64%

387

4432

4209

41504

239

1938

4357

43998

392

4525

45544

4576

45917

354

4534

45553

210

1873

4347

43397

423

3847

3635

36054

Asthma, unspecified
J45.9 [45562456]

-4.0e-02

1.1e-01

-2.5e-01

3.2e+00

2.5e-01

3.0e-01

3.1e-01

cases:2.98%

controls:3.10%

cases:1.68%

controls:1.50%

cases:0.24%

controls:0.31%

cases:0.41%

controls:0.02%

cases:0.35%

controls:0.27%

cases:2.02%

controls:1.50%

cases:5.47%

controls:4.07%

137

1423

4459

44513

689

4519

45247

141

4585

45795

4577

45928

124

4580

45783

678

4465

44592

222

1622

3836

38279

Hypocalcemia
E83.51 [2000501538]

-1.0e+50

—

3.5e+00

cases:0.00%

controls:0.02%

—

cases:1.03%

controls:0.03%

4596

45928

—

4016

39888

retinol
S01XA02 [21605128]

-1.7e-01

1.1e+00

—

2.2e+00

1.3e+00

cases:0.22%

controls:0.26%

cases:0.20%

controls:0.07%

—

cases:0.70%

controls:0.08%

cases:1.01%

controls:0.28%

118

4586

45818

4587

45905

—

4525

45234

113

4017

39788

Hyperparathyroidism, unspecified
E21.3 [45581360]

—

1.6e+00

—

1.8e+00

6.4e-01

—

cases:0.20%

controls:0.04%

—

cases:0.15%

controls:0.02%

cases:0.15%

controls:0.08%

—

4587

45918

—

4550

45259

4052

39870

Nontoxic single thyroid nodule
E04.1 [45537947]

—

1.6e+00

1.0e+50

—

1.8e+00

5.9e-01

—

cases:0.24%

controls:0.05%

cases:0.13%

controls:0.00%

—

cases:0.31%

controls:0.05%

cases:0.32%

controls:0.18%

—

4585

45913

4590

45936

—

4543

45248

4045

39830

Cortisol [Moles/volume] in Serum or Plasma
14675-3 [3036481]

2.9e-01

4.5e-01

2.2e+00

—

8.8e-01

5.5e-01

6.5e-01

cases:2.09%

controls:1.58%

cases:1.20%

controls:0.76%

cases:0.81%

controls:0.09%

—

cases:0.28%

controls:0.12%

cases:1.32%

controls:0.77%

cases:4.53%

controls:2.41%

725

4500

45211

351

4541

45585

4559

45894

—

4583

45853

347

4497

44923

184

961

3874

38940

zopiclone; oral
N05CF01 [21604654]

1.3e-01

1.7e-01

3.6e-01

2.1e+00

4.4e-01

3.9e-01

cases:7.96%

controls:7.06%

cases:4.72%

controls:4.03%

cases:1.39%

controls:0.98%

cases:0.39%

controls:0.05%

cases:1.54%

controls:1.00%

cases:6.08%

controls:4.00%

cases:9.88%

controls:6.89%

366

3242

4230

42694

217

1849

4379

44087

449

4532

45487

4578

45914

459

4525

45448

277

1813

4280

43457

401

2750

3657

37151

Iron/Transferrin [Ratio] in Serum or Plasma
60517-0 [40763571]

-2.9e-01

5.7e-01

1.5e+00

—

9.6e-01

4.1e-01

3.2e-01

cases:1.22%

controls:1.62%

cases:1.70%

controls:0.96%

cases:0.59%

controls:0.13%

—

cases:0.37%

controls:0.14%

cases:1.60%

controls:1.07%

cases:4.53%

controls:3.34%

745

4540

45191

442

4518

45494

4569

45876

—

4579

45842

485

4484

44785

184

1334

3874

38567

Subacute thyroiditis
E06.1 [45600632]

5.1e-01

3.4e+00

—

1.0e+50

—

cases:0.11%

controls:0.07%

cases:0.44%

controls:0.02%

—

cases:0.11%

controls:0.00%

—

4591

45906

4576

45929

—

4591

45936

—

Plain photography of ocular fundus
CK2S4 [2001301455]

2.7e-01

6.2e-01

—

1.8e+00

9.2e-01

6.6e-01

cases:0.59%

controls:0.45%

cases:0.39%

controls:0.21%

—

cases:0.15%

controls:0.03%

cases:0.70%

controls:0.28%

cases:1.90%

controls:0.99%

207

4569

45729

4578

45839

—

4589

45895

127

4525

45143

395

3981

39506

Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
48065-7 [3051714]

1.1e-02

1.0e+00

2.1e+00

—

9.1e-02

3.0e-01

2.3e-01

cases:3.70%

controls:3.66%

cases:3.98%

controls:1.47%

cases:1.22%

controls:0.16%

—

cases:0.17%

controls:0.16%

cases:2.06%

controls:1.54%

cases:7.34%

controls:5.95%

170

1682

4426

44254

183

677

4413

45259

4540

45864

—

4588

45834

695

4463

44575

298

2374

3760

37527

Cathetrisation of vein
TPH04 [2001309597]

-5.1e-02

3.9e-01

6.6e-01

—

1.5e+00

1.2e+00

5.3e-01

cases:2.48%

controls:2.61%

cases:1.48%

controls:1.01%

cases:0.24%

controls:0.12%

—

cases:0.57%

controls:0.12%

cases:3.01%

controls:0.90%

cases:5.22%

controls:3.15%

114

1198

4482

44738

464

4528

45472

4585

45879

—

4570

45851

137

409

4420

44861

212

1256

3846

38645

Other specified special examinations
Z01.8 [45581003]

5.2e-02

5.7e-01

8.9e-01

1.0e+50

1.5e+00

8.7e-01

2.9e-01

cases:3.13%

controls:2.98%

cases:1.46%

controls:0.83%

cases:0.24%

controls:0.10%

cases:0.11%

controls:0.00%

cases:0.33%

controls:0.07%

cases:2.08%

controls:0.89%

cases:4.39%

controls:3.33%

144

1368

4452

44568

380

4529

45556

4585

45891

4591

45936

4581

45873

402

4462

44868

178

1329

3880

38572

Inpatient Visit
IP [9201]

1.4e-01

3.0e-01

1.9e-01

—

1.3e+00

1.0e+00

8.1e-01

cases:4.74%

controls:4.17%

cases:2.59%

controls:1.93%

cases:0.30%

controls:0.25%

—

cases:0.78%

controls:0.20%

cases:5.73%

controls:2.09%

cases:16.14%

controls:7.86%

218

1914

4378

44022

119

886

4477

45050

116

4582

45820

—

4560

45813

261

944

4296

44326

655

3137

3403

36764

Perimetry
XCK00 [2001301380]

-4.1e-02

6.2e-01

—

1.5e+00

2.2e+00

1.0e+00

cases:0.74%

controls:0.77%

cases:0.46%

controls:0.25%

—

cases:0.15%

controls:0.03%

cases:1.69%

controls:0.19%

cases:1.70%

controls:0.61%

354

4562

45582

113

4575

45823

—

4589

45892

4480

45182

245

3989

39656

Other disorders affecting eyelid function
H02.5 [45581540]

—

3.2e+00

—

cases:0.37%

controls:0.02%

—

4043

39895

Other specified dysphonia
R49.08 [2000503601]

6.4e-02

1.1e+00

—

1.9e+00

1.3e+00

cases:0.17%

controls:0.16%

cases:0.15%

controls:0.05%

—

cases:0.44%

controls:0.07%

cases:0.81%

controls:0.22%

4588

45861

4589

45912

—

4537

45240

4025

39812

Erythrocytes [#/volume] in Urine
30391-7 [3002582]

-6.7e-02

1.4e-01

7.1e-01

2.5e+00

4.1e-01

2.0e-01

1.3e-01

cases:4.72%

controls:5.03%

cases:3.26%

controls:2.86%

cases:0.85%

controls:0.42%

cases:0.15%

controls:0.01%

cases:0.59%

controls:0.39%

cases:3.31%

controls:2.72%

cases:9.22%

controls:8.19%

217

2312

4379

43624

150

1315

4446

44621

193

4557

45743

4589

45930

180

4569

45727

151

1231

4406

44039

374

3268

3684

36633

Other visual field testing
CS494 [2001301478]

-2.1e-01

—

1.8e+00

1.4e+00

cases:0.13%

controls:0.16%

—

cases:0.48%

controls:0.08%

cases:1.06%

controls:0.27%

4590

45862

—

4535

45233

107

4015

39794

Treatment plan or consultation
WZC00 [2001310885]

7.6e-02

1.0e-01

5.5e-01

2.3e+00

7.1e-01

4.3e-01

cases:5.90%

controls:5.49%

cases:2.26%

controls:2.04%

cases:0.41%

controls:0.24%

cases:0.13%

controls:0.01%

cases:0.46%

controls:0.22%

cases:2.98%

controls:1.97%

cases:9.66%

controls:6.53%

271

2522

4325

43414

104

939

4492

44997

110

4577

45826

4590

45930

103

4575

45804

136

891

4421

44379

392

2605

3666

37296

Creatine kinase.MB [Mass/volume] in Serum or Plasma
13969-1 [3005785]

-2.5e-01

9.5e-01

2.2e+00

—

6.9e-01

4.8e-01

4.9e-02

cases:0.87%

controls:1.12%

cases:1.07%

controls:0.42%

cases:0.37%

controls:0.04%

—

cases:0.11%

controls:0.05%

cases:0.64%

controls:0.40%

cases:1.45%

controls:1.39%

514

4556

45422

191

4547

45745

4579

45917

—

4591

45882

179

4528

45091

553

3999

39348

Albumin [Mass/volume] in Serum or Plasma
1751-7 [3024561]

-4.5e-02

4.2e-01

1.3e+00

1.6e+00

7.2e-01

3.1e-01

3.8e-01

cases:6.81%

controls:7.10%

cases:6.24%

controls:4.19%

cases:2.37%

controls:0.65%

cases:0.13%

controls:0.03%

cases:1.39%

controls:0.68%

cases:5.53%

controls:4.12%

cases:15.80%

controls:11.40%

313

3263

4283

42673

287

1927

4309

44009

109

297

4487

45639

4590

45924

314

4532

45593

252

1867

4305

43403

641

4549

3417

35352

Other radiotherapy
WF099 [2001310707]

—

3.1e+00

—

cases:0.52%

controls:0.02%

—

4037

39892

Obstetrics / Gynecology
16 [38004461]

9.7e-02

2.7e-01

-5.1e-02

2.4e+00

2.1e-01

2.4e-01

cases:24.96%

controls:23.19%

cases:11.86%

controls:9.32%

cases:1.68%

controls:1.76%

cases:1.04%

controls:0.09%

cases:2.11%

controls:1.73%

cases:10.42%

controls:8.65%

cases:26.07%

controls:21.80%

1147

10652

3449

35284

545

4281

4051

41655

809

4519

45127

4548

45893

792

4499

45115

475

3918

4082

41352

1058

8699

3000

31202

Cardiac arrhythmia, unspecified
I49.9 [45581778]

9.4e-02

1.0e+00

1.7e+00

—

3.2e-01

3.8e-01

cases:1.41%

controls:1.29%

cases:1.24%

controls:0.44%

cases:0.33%

controls:0.06%

—

cases:0.61%

controls:0.45%

cases:2.66%

controls:1.83%

592

4531

45344

201

4539

45735

4581

45908

—

202

4529

45068

108

731

3950

39170

Tissue Pathology biopsy report
66121-5 [40768804]

5.5e-02

3.3e-02

5.0e-01

2.1e+00

5.3e-01

5.9e-01

4.2e-01

cases:8.55%

controls:8.13%

cases:3.50%

controls:3.39%

cases:0.54%

controls:0.33%

cases:0.17%

controls:0.02%

cases:0.54%

controls:0.32%

cases:5.33%

controls:3.04%

cases:14.96%

controls:10.33%

393

3736

4203

42200

161

1559

4435

44377

152

4571

45784

4588

45926

147

4571

45760

243

1375

4314

43895

607

4123

3451

35778

Ferritin [Mass/volume] in Serum or Plasma
2276-4 [3001122]

8.3e-02

6.7e-01

1.3e+00

—

6.3e-01

2.1e-01

2.8e-01

cases:8.49%

controls:7.86%

cases:9.57%

controls:5.13%

cases:2.44%

controls:0.68%

—

cases:1.26%

controls:0.67%

cases:7.09%

controls:5.82%

cases:22.18%

controls:17.69%

390

3611

4206

42325

440

2355

4156

43581

112

314

4484

45622

—

309

4538

45598

323

2636

4234

42634

900

7060

3158

32841

Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma
2742-5 [3034780]

1.3e-01

4.4e-01

1.7e+00

—

1.3e+00

7.8e-01

6.5e-01

cases:0.78%

controls:0.69%

cases:0.50%

controls:0.32%

cases:0.24%

controls:0.05%

—

cases:0.15%

controls:0.04%

cases:0.57%

controls:0.26%

cases:1.58%

controls:0.83%

316

4560

45620

149

4573

45787

4585

45915

—

4589

45887

119

4531

45151

332

3994

39569

Dyspnoea
R06.0 [45558449]

2.0e-01

1.2e+00

1.5e+00

—

5.4e-01

4.5e-02

3.9e-01

cases:3.44%

controls:2.82%

cases:3.37%

controls:1.08%

cases:0.67%

controls:0.15%

—

cases:0.24%

controls:0.14%

cases:1.18%

controls:1.13%

cases:5.96%

controls:4.11%

158

1296

4438

44640

155

495

4441

45441

4565

45868

—

4585

45843

513

4503

44757

242

1638

3816

38263

Leukocytes [#/volume] in Urine
30405-5 [3018095]

-2.1e-02

9.8e-02

6.1e-01

2.5e+00

3.3e-01

2.2e-01

1.1e-01

cases:5.68%

controls:5.79%

cases:3.87%

controls:3.52%

cases:0.91%

controls:0.50%

cases:0.15%

controls:0.01%

cases:0.67%

controls:0.49%

cases:4.15%

controls:3.37%

cases:11.56%

controls:10.49%

261

2661

4335

43275

178

1619

4418

44317

228

4554

45708

4589

45930

224

4565

45683

189

1526

4368

43744

469

4187

3589

35714

Malaise and fatigue
R53 [45553741]

6.3e-02

1.2e+00

1.6e+00

—

6.5e-01

3.1e-01

3.2e-01

cases:2.74%

controls:2.58%

cases:3.11%

controls:1.00%

cases:0.67%

controls:0.14%

—

cases:0.28%

controls:0.15%

cases:1.65%

controls:1.22%

cases:7.02%

controls:5.18%

126

1184

4470

44752

143

459

4453

45477

4565

45870

—

4583

45839

551

4482

44719

285

2068

3773

37833

Pediatric Medicine
37 [38004477]

-2.9e-01

4.0e-02

4.3e-01

1.0e+50

1.6e+00

7.9e-01

6.2e-01

cases:0.83%

controls:1.10%

cases:0.44%

controls:0.42%

cases:0.17%

controls:0.11%

cases:0.63%

controls:0.00%

cases:0.41%

controls:0.08%

cases:0.81%

controls:0.37%

cases:0.86%

controls:0.46%

506

4558

45430

192

4576

45744

4588

45884

4567

45936

4577

45869

167

4520

45103

185

4023

39716

Isotope imaging of secondary neoplasms of thyroid origin
JN5PN [2001300743]

-1.0e+50

—

3.0e+00

cases:0.00%

controls:0.05%

—

cases:0.25%

controls:0.01%

4596

45912

—

4048

39896

Feeling ill
A05 [2002000146]

-1.0e-01

8.9e-01

2.1e+00

—

1.7e-01

2.9e-01

cases:0.78%

controls:0.87%

cases:0.50%

controls:0.21%

cases:0.17%

controls:0.02%

—

cases:0.24%

controls:0.20%

cases:0.94%

controls:0.70%

399

4560

45537

4573

45841

4588

45926

—

4546

45178

279

4020

39622

Other primary hyperparathyroidism
E21.09 [2000501463]

-6.6e-01

5.9e-01

—

1.0e+50

—

1.5e+00

1.4e+00

cases:0.11%

controls:0.21%

cases:0.15%

controls:0.08%

—

cases:0.15%

controls:0.00%

—

cases:0.42%

controls:0.09%

cases:0.47%

controls:0.11%

4591

45839

4589

45897

—

4589

45936

—

4538

45228

4039

39857

Urinalysis microscopic panel [#/volume] - Urine by Automated count
50554-5 [3029287]

-7.3e-02

9.3e-02

6.2e-01

2.3e+00

3.0e-01

1.1e-01

1.4e-01

cases:5.68%

controls:6.08%

cases:3.59%

controls:3.28%

cases:0.83%

controls:0.45%

cases:0.15%

controls:0.02%

cases:0.59%

controls:0.44%

cases:3.45%

controls:3.09%

cases:10.30%

controls:9.05%

261

2793

4335

43143

165

1508

4431

44428

205

4558

45731

4589

45929

201

4569

45706

157

1400

4400

43870

418

3612

3640

36289

Pulmonary embolism without mention of acute cor pulmonale
I26.9 [45552785]

-6.1e-03

9.5e-01

2.0e+00

—

1.3e+00

5.7e-01

2.9e-01

cases:0.39%

controls:0.39%

cases:0.48%

controls:0.19%

cases:0.33%

controls:0.05%

—

cases:0.11%

controls:0.03%

cases:0.29%

controls:0.16%

cases:0.71%

controls:0.53%

181

4578

45755

4574

45851

4581

45915

—

4591

45893

4544

45197

213

4029

39688

Neoplasm of uncertain or unknown behaviour: Thyroid gland
D44.0 [45605366]

-2.2e-01

6.2e-01

—

2.9e+00

5.5e-01

cases:0.11%

controls:0.13%

cases:0.11%

controls:0.06%

—

cases:0.53%

controls:0.03%

cases:0.25%

controls:0.14%

4591

45874

4591

45909

—

4533

45257

4048

39844

Stereotactic intracranial radiotherapy
AAG50 [2001300312]

—

-1.0e+50

—

2.9e+00

—

cases:0.00%

controls:0.02%

—

cases:0.27%

controls:0.02%

—

4596

45929

—

4047

39895

Other specified disorders of thyroid
E07.89 [2000501423]

—

2.9e+00

—

cases:0.22%

controls:0.01%

—

4049

39896

Bilirubin.conjugated [Moles/volume] in Serum or Plasma
29760-6 [3005772]

2.0e-01

5.9e-01

1.8e+00

—

6.1e-01

5.1e-01

1.8e-01

cases:2.22%

controls:1.83%

cases:1.48%

controls:0.83%

cases:0.54%

controls:0.09%

—

cases:0.26%

controls:0.14%

cases:1.36%

controls:0.82%

cases:3.30%

controls:2.78%

102

839

4494

45097

379

4528

45557

4571

45893

—

4584

45842

371

4495

44899

134

1109

3924

38792

Haptoglobin [Mass/volume] in Serum or Plasma
4542-7 [3012336]

6.9e-02

8.8e-01

2.0e+00

—

3.0e-01

3.6e-01

cases:0.46%

controls:0.43%

cases:0.50%

controls:0.21%

cases:0.17%

controls:0.02%

—

cases:0.33%

controls:0.24%

cases:1.11%

controls:0.77%

196

4575

45740

4573

45840

4588

45925

—

110

4542

45160

309

4013

39592

Telehealth
OMOP5556618 [722455]

3.0e-02

3.7e-01

9.1e-01

1.3e+00

2.6e-01

1.5e-01

2.5e-01

cases:29.20%

controls:28.58%

cases:17.32%

controls:12.61%

cases:5.05%

controls:2.10%

cases:0.28%

controls:0.08%

cases:2.65%

controls:2.06%

cases:13.01%

controls:11.38%

cases:28.83%

controls:24.06%

1342

13128

3254

32808

796

5791

3800

40145

232

963

4364

44973

4583

45901

122

944

4474

44963

593

5150

3964

40120

1170

9601

2888

30300

Physiotherapy
R4110 [2001310233]

8.8e-02

-3.0e-03

1.1e-01

2.5e+00

-2.6e-01

1.7e-01

3.5e-01

cases:4.79%

controls:4.40%

cases:1.81%

controls:1.81%

cases:0.28%

controls:0.25%

cases:0.13%

controls:0.01%

cases:0.17%

controls:0.23%

cases:1.87%

controls:1.57%

cases:5.84%

controls:4.18%

220

2021

4376

43915

832

4513

45104

116

4583

45820

4590

45931

104

4588

45803

713

4472

44557

237

1667

3821

38234

Microorganisms panel - Urine sediment
58435-9 [40761536]

3.0e-01

6.6e-01

1.1e+00

—

6.2e-01

5.1e-01

6.2e-01

cases:2.42%

controls:1.80%

cases:1.68%

controls:0.88%

cases:0.35%

controls:0.12%

—

cases:0.22%

controls:0.12%

cases:1.43%

controls:0.86%

cases:3.89%

controls:2.14%

111

828

4485

45108

402

4519

45534

4580

45880

—

4586

45853

390

4492

44880

158

852

3900

39049

pantoprazole; oral, parenteral
A02BC02 [21600097]

1.1e-01

1.6e-01

2.3e-01

1.7e+00

4.1e-01

4.3e-01

3.2e-01

cases:18.65%

controls:17.06%

cases:10.73%

controls:9.27%

cases:2.31%

controls:1.84%

cases:0.54%

controls:0.10%

cases:2.70%

controls:1.81%

cases:13.72%

controls:9.39%

cases:26.10%

controls:20.42%

857

7837

3739

38099

493

4260

4103

41676

106

844

4490

45092

4571

45889

124

830

4472

45077

625

4251

3932

41019

1059

8146

2999

31755

Radiotherapy with large shaped fields - isocentric therapy
ZX012 [2001311468]

3.1e-01

-3.1e-01

—

-1.0e+50

1.5e+00

1.3e+00

cases:0.65%

controls:0.48%

cases:0.13%

controls:0.18%

—

cases:0.00%

controls:0.03%

cases:0.39%

controls:0.09%

cases:0.99%

controls:0.26%

221

4566

45715

4590

45854

—

4596

45895

4539

45228

103

4018

39798

esomeprazole; oral, parenteral
A02BC05 [21600100]

2.1e-01

2.5e-01

9.9e-02

1.7e+00

3.4e-01

3.1e-01

2.7e-01

cases:10.44%

controls:8.64%

cases:5.68%

controls:4.46%

cases:1.07%

controls:0.97%

cases:0.17%

controls:0.03%

cases:1.31%

controls:0.93%

cases:5.90%

controls:4.41%

cases:11.56%

controls:9.03%

480

3967

4116

41969

261

2049

4335

43887

444

4547

45492

4588

45922

427

4536

45480

269

1997

4288

43273

469

3604

3589

36297

Hypothyroidism/myxoedema
T86 [2002001128]

-6.4e-01

8.6e-01

—

-1.0e+50

7.0e-01

1.9e+00

cases:0.24%

controls:0.45%

cases:0.44%

controls:0.19%

—

cases:0.00%

controls:0.02%

cases:0.48%

controls:0.24%

cases:4.76%

controls:0.73%

208

4585

45728

4576

45851

—

4596

45897

109

4535

45161

193

291

3865

39610

Corticotropin [Mass/volume] in Plasma
2141-0 [3035637]

4.1e-01

1.8e-01

2.0e+00

—

2.8e+00

8.9e-01

6.9e-01

cases:0.28%

controls:0.19%

cases:0.13%

controls:0.11%

cases:0.11%

controls:0.02%

—

cases:0.17%

controls:0.01%

cases:0.22%

controls:0.09%

cases:0.57%

controls:0.29%

4583

45850

4590

45886

4591

45929

—

4588

45902

4547

45229

114

4035

39787

Nuclear Ab [Titer] in Serum
29953-7 [3037522]

1.8e-02

2.5e-01

1.0e+00

—

1.3e+00

3.6e-01

3.8e-01

cases:2.70%

controls:2.65%

cases:1.35%

controls:1.06%

cases:0.33%

controls:0.12%

—

cases:0.28%

controls:0.08%

cases:1.29%

controls:0.90%

cases:5.13%

controls:3.56%

124

1218

4472

44718

485

4534

45451

4581

45883

—

4583

45872

409

4498

44861

208

1419

3850

38482

Audiology
64 [38004489]

4.1e-02

2.6e-01

4.1e-01

—

9.3e-01

1.1e+00

6.9e-01

cases:2.24%

controls:2.15%

cases:1.09%

controls:0.84%

cases:0.24%

controls:0.16%

—

cases:0.37%

controls:0.15%

cases:2.66%

controls:0.88%

cases:4.98%

controls:2.57%

103

989

4493

44947

388

4546

45548

4585

45863

—

4579

45840

121

400

4436

44870

202

1026

3856

38875

Intramuscular
ZX114 [2001311493]

5.4e-01

—

1.5e+00

1.3e+00

cases:0.26%

controls:0.15%

—

cases:0.26%

controls:0.06%

cases:0.37%

controls:0.10%

4584

45866

—

4545

45242

4043

39860

Convergent concomitant strabismus
H50.0 [45552716]

—

-1.0e+50

—

2.7e+00

—

cases:0.00%

controls:0.01%

—

cases:0.57%

controls:0.04%

—

4596

45930

—

4035

39885

Blood type and Crossmatch panel - Blood
34531-4 [3044640]

-1.4e-02

1.3e-01

4.1e-01

—

1.0e+00

9.3e-01

7.2e-01

cases:5.55%

controls:5.62%

cases:2.94%

controls:2.59%

cases:0.46%

controls:0.30%

—

cases:0.74%

controls:0.27%

cases:5.35%

controls:2.19%

cases:13.80%

controls:7.23%

255

2583

4341

43353

135

1192

4461

44744

139

4575

45797

—

125

4562

45782

244

992

4313

44278

560

2883

3498

37018

Other hypothyroidism
E03 [45581337]

-5.3e-01

-7.3e-02

-1.0e+50

—

1.2e+00

1.4e+00

cases:0.59%

controls:1.00%

cases:0.35%

controls:0.37%

cases:0.00%

controls:0.03%

—

cases:1.29%

controls:0.38%

cases:4.90%

controls:1.26%

458

4569

45478

172

4580

45764

4596

45920

—

170

4498

45100

199

501

3859

39400

General Practice
1 [38004446]

9.8e-02

2.5e-01

4.5e-01

2.4e+00

4.8e-01

-3.9e-02

1.5e-01

cases:12.64%

controls:11.60%

cases:5.44%

controls:4.27%

cases:0.94%

controls:0.60%

cases:0.26%

controls:0.02%

cases:0.96%

controls:0.59%

cases:4.08%

controls:4.24%

cases:14.24%

controls:12.54%

581

5330

4015

40606

250

1963

4346

43973

275

4553

45661

4584

45925

273

4552

45634

186

1919

4371

43351

578

5002

3480

34899

Primary hyperparathyroidism
E21.0 [45571667]

3.3e-01

1.1e+00

2.0e+00

1.0e+50

—

1.6e+00

1.0e+00

cases:0.11%

controls:0.08%

cases:0.20%

controls:0.07%

cases:0.11%

controls:0.02%

cases:0.13%

controls:0.00%

—

cases:0.48%

controls:0.09%

cases:0.59%

controls:0.22%

4591

45900

4587

45906

4591

45929

4590

45936

—

4535

45227

4034

39815

Senile nuclear cataract
H25.1 [45581628]

3.4e-02

3.3e-01

4.0e-01

2.6e+00

6.6e-01

1.2e-01

1.6e-01

cases:1.81%

controls:1.75%

cases:0.94%

controls:0.67%

cases:0.15%

controls:0.10%

cases:0.15%

controls:0.01%

cases:0.24%

controls:0.12%

cases:0.94%

controls:0.84%

cases:3.18%

controls:2.72%

802

4513

45134

310

4553

45626

4589

45889

4589

45931

4585

45850

381

4514

44889

129

1085

3929

38816

Oncology Clinic/Center
261QX0200X [38004268]

7.4e-02

-1.6e-01

8.0e-01

—

1.6e+00

5.7e-01

4.8e-01

cases:4.37%

controls:4.08%

cases:1.07%

controls:1.25%

cases:0.22%

controls:0.10%

—

cases:0.37%

controls:0.08%

cases:1.58%

controls:0.90%

cases:5.32%

controls:3.37%

201

1872

4395

44064

575

4547

45361

4586

45891

—

4579

45872

406

4485

44864

216

1343

3842

38558

Malignant neoplasm of thyroid gland
C73 [45590920]

—

2.6e+00

—

cases:0.15%

controls:0.01%

—

4550

45265

—

Assessment of colour vision
XCW12 [2001301505]

—

2.6e+00

—

cases:0.17%

controls:0.01%

—

4051

39896

Closure of lacrimal canaliculus with plug
TCC40 [2001301048]

—

2.6e+00

—

cases:0.17%

controls:0.01%

—

4051

39896

More than three and less than five hours
ZXE20 [2001311408]

-2.4e-01

-3.0e-01

1.4e+00

—

1.5e+00

1.7e+00

8.9e-01

cases:1.31%

controls:1.66%

cases:0.30%

controls:0.41%

cases:0.15%

controls:0.04%

—

cases:0.15%

controls:0.03%

cases:1.40%

controls:0.25%

cases:1.77%

controls:0.74%

761

4536

45175

189

4582

45747

4589

45919

—

4589

45892

114

4493

45156

295

3986

39606

Esophagoscopy, gastroscopy and duodenoscopy
UJD10 [2001304788]

2.1e-02

4.7e-01

8.1e-01

—

1.3e+00

5.6e-01

3.0e-01

cases:4.20%

controls:4.11%

cases:1.74%

controls:1.10%

cases:0.28%

controls:0.13%

—

cases:0.35%

controls:0.10%

cases:1.84%

controls:1.06%

cases:5.20%

controls:3.92%

193

1890

4403

44046

503

4516

45433

4583

45878

—

4580

45863

482

4473

44788

211

1565

3847

38336

furosemide; oral, parenteral
C03CA01 [21601518]

-1.4e-01

2.1e-01

4.6e-01

1.7e+00

4.1e-01

3.9e-01

2.2e-01

cases:3.37%

controls:3.85%

cases:3.66%

controls:3.00%

cases:1.37%

controls:0.87%

cases:0.17%

controls:0.03%

cases:1.39%

controls:0.93%

cases:4.39%

controls:3.02%

cases:6.14%

controls:4.96%

155

1767

4441

44169

168

1376

4428

44560

399

4533

45537

4588

45922

427

4532

45480

200

1367

4357

43903

249

1981

3809

37920

Urinalysis macro (dipstick) panel - Urine
24357-6 [3037467]

-3.9e-03

1.6e-01

5.5e-01

1.9e+00

1.7e-01

1.1e-01

1.4e-01

cases:16.47%

controls:16.53%

cases:10.18%

controls:8.84%

cases:2.26%

controls:1.32%

cases:0.22%

controls:0.03%

cases:1.52%

controls:1.29%

cases:9.55%

controls:8.66%

cases:25.80%

controls:23.16%

757

7591

3839

38345

468

4063

4128

41873

104

605

4492

45331

4586

45921

591

4526

45316

435

3921

4122

41349

1047

9242

3011

30659

Sequelae of cerebral infarction
I69.3 [45533476]

-3.1e-01

-1.6e-02

9.7e-01

2.6e+00

1.0e+00

5.3e-01

-4.2e-02

cases:0.37%

controls:0.51%

cases:0.28%

controls:0.29%

cases:0.11%

controls:0.04%

cases:0.17%

controls:0.01%

cases:0.13%

controls:0.05%

cases:0.55%

controls:0.32%

cases:0.79%

controls:0.82%

232

4579

45704

132

4583

45804

4591

45917

4588

45930

4590

45885

147

4532

45123

328

4026

39573

Holo-transcobalamin II [Moles/volume] in Serum
72160-5 [43054903]

-5.5e-02

6.2e-01

1.8e+00

—

6.1e-01

1.6e-01

2.0e-01

cases:5.64%

controls:5.93%

cases:5.48%

controls:3.03%

cases:1.83%

controls:0.32%

—

cases:0.65%

controls:0.36%

cases:4.19%

controls:3.60%

cases:14.24%

controls:11.94%

259

2726

4337

43210

252

1390

4344

44546

148

4512

45788

—

164

4566

45743

191

1630

4366

43640

578

4765

3480

35136

Supervision of other high-risk pregnancies
Z35.8 [45552076]

4.0e-01

9.2e-01

—

9.4e-01

7.3e-01

4.9e-01

cases:2.02%

controls:1.36%

cases:0.89%

controls:0.36%

—

cases:0.20%

controls:0.08%

cases:0.81%

controls:0.39%

cases:1.95%

controls:1.21%

626

4503

45310

165

4555

45771

—

4587

45872

177

4520

45093

481

3979

39420

Weakness/tiredness general
A04 [2002000145]

1.7e-01

8.9e-01

1.6e+00

-1.0e+50

2.9e-01

4.3e-01

1.9e-01

cases:2.02%

controls:1.71%

cases:1.61%

controls:0.67%

cases:0.46%

controls:0.09%

cases:0.00%

controls:0.02%

cases:0.13%

controls:0.10%

cases:1.05%

controls:0.69%

cases:3.20%

controls:2.67%

785

4503

45151

306

4522

45630

4575

45895

4596

45928

4590

45862

311

4509

44959

130

1067

3928

38834

Thyroiditis, unspecified
E06.9 [45566722]

—

1.0e+50

—

1.0e+50

—

2.5e+00

—

cases:0.15%

controls:0.00%

—

cases:0.11%

controls:0.00%

—

cases:0.25%

controls:0.02%

—

4589

45936

—

4591

45907

—

4048

39893

Atrial fibrillation/flutter
K78 [2002000605]

-2.5e-01

9.3e-01

1.1e+00

—

6.9e-01

6.3e-01

5.3e-01

cases:0.48%

controls:0.61%

cases:0.78%

controls:0.31%

cases:0.30%

controls:0.11%

—

cases:0.22%

controls:0.11%

cases:0.55%

controls:0.29%

cases:1.18%

controls:0.70%

281

4574

45655

143

4560

45793

4582

45887

—

4586

45857

133

4532

45137

279

4010

39622

ABO and Rh group [Type] in Blood by Confirmatory method
77397-8 [46236098]

1.6e-02

2.7e-01

7.9e-01

—

9.2e-01

8.6e-01

7.3e-01

cases:3.55%

controls:3.49%

cases:2.15%

controls:1.65%

cases:0.39%

controls:0.18%

—

cases:0.52%

controls:0.21%

cases:3.55%

controls:1.54%

cases:10.67%

controls:5.47%

163

1604

4433

44332

758

4497

45178

4578

45854

—

4572

45811

162

697

4395

44573

433

2182

3625

37719

Flexible laryngoscopy
UDQ12 [2001301827]

2.5e-02

4.0e-01

—

1.7e+00

7.8e-01

cases:0.52%

controls:0.51%

cases:0.24%

controls:0.16%

—

cases:0.86%

controls:0.16%

cases:1.38%

controls:0.64%

234

4572

45702

4585

45862

—

4518

45199

254

4002

39647

Teaching
WZC30 [2001310891]

-9.7e-02

2.4e-03

7.6e-01

—

1.1e+00

9.1e-01

4.7e-01

cases:1.37%

controls:1.51%

cases:0.76%

controls:0.76%

cases:0.22%

controls:0.10%

—

cases:0.35%

controls:0.12%

cases:1.89%

controls:0.77%

cases:3.99%

controls:2.54%

693

4533

45243

349

4561

45587

4586

45889

—

4580

45854

349

4471

44921

162

1013

3896

38888

Liver function tests outside reference range
166603001 [438878]

—

1.5e+00

—

2.5e+00

4.0e-01

—

cases:0.13%

controls:0.03%

—

cases:0.13%

controls:0.01%

cases:0.20%

controls:0.13%

—

4590

45922

—

4551

45265

4050

39848

Subtotal parathyroidectomy
BBA40 [2001300786]

-1.0e+50

—

2.5e+00

—

cases:0.00%

controls:0.03%

—

cases:0.13%

controls:0.01%

—

4596

45920

—

4551

45265

—

Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
5013-8 [3008733]

6.4e-01

—

2.5e+00

6.7e-02

cases:0.15%

controls:0.08%

—

cases:0.13%

controls:0.01%

cases:0.12%

controls:0.12%

4589

45899

—

4551

45265

4053

39855

Thoracic and Cardiac Surgery
OMOP4822009 [45756830]

1.5e-01

7.0e-01

1.6e+00

—

8.6e-01

2.0e-01

cases:0.96%

controls:0.83%

cases:0.57%

controls:0.28%

cases:0.17%

controls:0.03%

—

cases:0.53%

controls:0.22%

cases:0.74%

controls:0.61%

380

4552

45556

129

4570

45807

4588

45920

—

101

4533

45169

242

4028

39659

Other obesity
E66.8 [45533036]

1.5e-02

-2.5e-02

—

2.5e+00

4.3e-01

2.0e-01

2.9e-01

cases:0.87%

controls:0.86%

cases:0.44%

controls:0.45%

—

cases:0.15%

controls:0.01%

cases:0.17%

controls:0.11%

cases:0.61%

controls:0.51%

cases:1.60%

controls:1.20%

394

4556

45542

205

4576

45731

—

4589

45930

4588

45855

229

4529

45041

480

3993

39421

Standard cardiac ultrasound examination
FM1AE [2001303278]

-9.4e-02

6.4e-01

1.4e+00

—

7.2e-01

4.5e-01

4.0e-01

cases:1.76%

controls:1.93%

cases:1.54%

controls:0.82%

cases:0.35%

controls:0.08%

—

cases:0.15%

controls:0.07%

cases:1.12%

controls:0.72%

cases:3.10%

controls:2.11%

888

4515

45048

378

4525

45558

4580

45897

—

4589

45873

325

4506

44945

126

843

3932

39058

Eye and orbita extensive MRI examination with 3 Tesla magnet
CA1CM [2001300870]

—

2.4e+00

—

cases:0.17%

controls:0.02%

—

4051

39895

Weight loss
T08 [2002001071]

9.2e-01

2.4e+00

—

7.1e-01

cases:0.20%

controls:0.08%

cases:0.37%

controls:0.03%

—

cases:0.17%

controls:0.09%

4587

45900

4579

45921

—

4051

39867

Unknown and unspecified causes of morbidity
R69 [45558480]

4.9e-01

2.4e+00

—

5.9e-01

cases:0.20%

controls:0.12%

cases:0.20%

controls:0.02%

—

cases:0.17%

controls:0.10%

4587

45881

4587

45928

—

4051

39863

Transferrin [Mass/volume] in Serum or Plasma
3034-6 [3004789]

-2.5e-01

5.9e-01

1.5e+00

—

8.7e-01

3.7e-01

3.0e-01

cases:1.37%

controls:1.75%

cases:1.85%

controls:1.04%

cases:0.65%

controls:0.14%

—

cases:0.37%

controls:0.15%

cases:1.69%

controls:1.17%

cases:4.93%

controls:3.71%

806

4533

45130

477

4511

45459

4566

45871

—

4579

45836

531

4480

44739

200

1480

3858

38421

Other investigative procedure of eye
XCW99 [2001301491]

2.3e-01

3.7e-01

1.0e+00

—

1.0e+00

1.3e+00

1.1e+00

cases:1.72%

controls:1.37%

cases:0.72%

controls:0.50%

cases:0.17%

controls:0.06%

—

cases:0.24%

controls:0.09%

cases:1.82%

controls:0.51%

cases:4.41%

controls:1.53%

630

4517

45306

228

4563

45708

4588

45907

—

4585

45867

232

4474

45038

179

610

3879

39291

Calcium [Moles/time] in 24 hour Urine
14637-3 [3010838]

-8.1e-02

2.8e-01

—

1.1e+00

1.2e+00

cases:0.26%

controls:0.28%

cases:0.24%

controls:0.18%

—

cases:0.42%

controls:0.13%

cases:1.33%

controls:0.40%

130

4584

45806

4585

45853

—

4538

45210

159

4004

39742

calcium carbonate
A02AC01 [21600065]

-5.1e-01

—

9.8e-01

1.4e+00

cases:0.15%

controls:0.25%

—

cases:0.48%

controls:0.18%

cases:1.23%

controls:0.32%

116

4589

45820

—

4535

45188

126

4008

39775

calcium carbonate; oral
A12AA04 [21600863]

-5.1e-01

—

9.8e-01

1.4e+00

cases:0.15%

controls:0.25%

—

cases:0.48%

controls:0.18%

cases:1.23%

controls:0.32%

116

4589

45820

—

4535

45188

126

4008

39775

Correction of lax skin and resection of herniated fat in upper eyelid
CBB21 [2001300930]

—

-1.0e+50

2.4e+00

—

cases:0.00%

controls:0.01%

cases:0.39%

controls:0.04%

—

4557

45265

4042

39886

General and Unspecified, Result test/procedure
A60 [2002000194]

3.7e-01

1.4e+00

1.7e+00

—

2.4e-01

8.8e-01

cases:0.63%

controls:0.44%

cases:0.39%

controls:0.09%

cases:0.11%

controls:0.02%

—

cases:0.13%

controls:0.10%

cases:0.84%

controls:0.35%

200

4567

45736

4578

45893

4591

45927

—

4551

45223

140

4024

39761

Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay
63459-2 [40766189]

-9.0e-02

7.5e-01

2.3e+00

—

5.4e-01

3.3e-01

cases:0.65%

controls:0.71%

cases:0.41%

controls:0.20%

cases:0.20%

controls:0.02%

—

cases:0.31%

controls:0.18%

cases:0.89%

controls:0.64%

328

4566

45608

4577

45846

4587

45927

—

4543

45189

256

4022

39645

Use of surgical navigator
ZXC95 [2001311381]

—

-1.0e+50

—

2.3e+00

1.3e+00

—

cases:0.00%

controls:0.03%

—

cases:0.20%

controls:0.02%

cases:0.22%

controls:0.06%

—

4596

45922

—

4548

45261

4049

39876

Eye movement mapping
CE2W4 [2001301111]

-1.0e+50

—

2.3e+00

cases:0.00%

controls:0.02%

—

cases:0.17%

controls:0.02%

4596

45927

—

4051

39894

Thiamine [Mass/volume] in Blood
2998-3 [3028717]

-1.0e+50

—

2.3e+00

cases:0.00%

controls:0.02%

—

cases:0.15%

controls:0.02%

4596

45929

—

4052

39895

LabWAS

↥

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

1628

3871

5.95

307.65

1.5

1.2

226.75

143.40

u/ml

8.51

894

1454

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

2980

1131

72.61

307.65

3.7

1.6

21.90

8.53

iu/l

0.56

2071

392

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

3121

3046

29.59

307.65

8.9

2.9

4.87

4.46

pmol/l

35.18

2989

2733

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

4523

34332

17.27

284.68

18.6

4.6

15.55

14.54

pmol/l

151.54

4426

32244

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

2991

19309

2.56

196.60

7.5

6.7

1.21

1.22

mmol/l

2.32

2589

16811

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

858

2992

3.29

191.77

2.8

3.6

52.73

81.20

ng/l

22.80

767

2593

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

2663

17133

2.31

163.57

6.3

6.1

1.21

1.22

mmol/l

0.43

2500

15953

(3018418) pH of Serum or Plasma

2004

11718

2.26

151.54

4.9

4.0

7.40

1.40

1506

8333

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

4541

39020

11.49

145.07

20.0

5.6

1.68

1.81

mu/l

5.11

4445

36941

(3013650) Neutrophils [#/volume] in Blood by Automated count

3295

24027

2.30

138.43

10.1

9.7

3.68

3.99

e9/l

16.90

2866

21063

(3015377) Calcium [Moles/volume] in Serum or Plasma

2158

14177

1.98

108.73

3.0

3.4

2.34

2.36

mmol/l

9.93

1995

13069

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

3765

30894

2.19

91.48

9.5

8.0

80.12

76.29

u/l

6.19

3636

29463

(42868691) Thyroxine (T4) free [Moles/volume] in Serum or Plasma by Dialysis

128

170

7.72

90.82

1.6

1.5

15.89

14.39

pmol/l

1.41

114

141

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

2661

20117

1.76

74.17

2.8

2.5

75.01

76.69

nmol/l

2.61

2479

18653

(3013707) Erythrocyte sedimentation rate [Velocity] in Red Blood Cells by Westergren method

3673

30982

1.91

66.51

4.5

4.4

10.78

11.01

mm/h

0.56

3504

29360

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

192

509

3.89

63.38

4.4

4.9

89.78

83.38

u/ml

0.06

162

(3001019) Free T4 and TSH panel - Serum or Plasma

617

3072

2.16

62.03

2.3

1.7

—

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

127

300

4.32

48.98

5.3

7.2

40.10

84.26

ug/l

0.34

192

(3002030) Lymphocytes/Leukocytes in Blood

2559

20351

1.58

48.60

5.6

6.6

29.15

28.94

0.48

2400

19398

(3013115) Eosinophils [#/volume] in Blood

2751

22299

1.58

47.66

5.7

6.7

0.19

e9/l

0.12

2430

19776

(40758558) Short blood count panel - Blood

1735

12680

1.59

47.04

7.2

6.2

—

(3022096) Basophils/Leukocytes in Blood

2482

19726

1.56

46.28

5.7

6.7

0.65

0.70

3.91

2298

18561

(3019550) Sodium [Moles/volume] in Serum or Plasma

4383

40571

2.61

46.08

16.3

15.2

139.80

139.70

mmol/l

2.39

4321

39802

(3023103) Potassium [Moles/volume] in Serum or Plasma

4388

40664

2.62

45.55

16.6

15.4

3.93

mmol/l

0.73

4323

39815

(3019069) Monocytes/Leukocytes in Blood

2482

19768

1.55

45.52

5.7

6.7

8.74

8.49

4.15

2302

18666

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

1597

11513

1.59

45.51

1.4

1.3

2.02

1.59

u/ml

0.56

447

3325

(3006504) Eosinophils/Leukocytes in Blood

2478

19742

1.55

45.28

5.6

6.6

2.83

2.82

0.06

2302

18604

(3018010) Neutrophils/Leukocytes in Blood

2497

20026

1.54

43.53

5.4

6.5

55.98

56.63

2.17

2369

19212

(3019198) Lymphocytes [#/volume] in Blood

2700

22070

1.54

42.78

5.5

6.5

1.90

1.95

e9/l

0.95

2405

19717

(3006315) Basophils [#/volume] in Blood

2648

21610

1.53

41.82

5.5

6.5

0.04

e9/l

6.21

2297

18831

(3001604) Monocytes [#/volume] in Blood

2641

21568

1.53

41.36

5.5

6.5

0.55

e9/l

0.13

2298

18808

(40764999) Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)/1.73 sq M

4217

38948

1.96

36.05

14.5

13.0

87.40

85.97

ml/min/173m2

4.94

3937

35803

(3021589) Normoblasts [#/volume] in Blood

2291

18653

1.45

33.10

12.7

10.6

0.00

e9/l

0.30

1886

15226

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

4496

42848

2.94

31.56

15.1

11.4

24.61

25.02

u/l

1.00

4439

41872

(3007164) IgA [Mass/volume] in Serum or Plasma

1330

9817

1.50

31.36

1.5

2.17

2.24

g/l

0.84

807

6277

(3013826) Glucose [Moles/volume] in Serum or Plasma

2714

22947

1.44

31.19

4.5

4.7

6.51

6.47

mmol/l

0.47

2550

21448

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

4329

40728

2.02

29.27

14.5

14.1

19.58

21.14

mg/l

2.61

3583

33191

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

238

1095

2.24

28.54

1.3

1.2

—

(3019225) pH of Specimen

562

3527

1.68

26.30

4.6

3.9

7.38

7.35

8.35

451

2520

(3036481) Cortisol [Moles/volume] in Serum or Plasma

667

4386

1.61

25.91

2.1

2.3

371.73

374.17

nmol/l

0.12

619

4078

(3020564) Creatinine [Moles/volume] in Serum or Plasma

4480

42938

2.50

25.21

18.9

17.2

69.25

70.62

umol/l

3.68

4439

42490

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

488

3009

1.70

24.33

3.9

3.6

1.22

1.23

mmol/l

2.61

426

2612

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

4034

37545

1.59

23.61

6.2

5.6

38.76

38.17

mmol/mol

3.51

3802

35653

(3001122) Ferritin [Mass/volume] in Serum or Plasma

2623

22714

1.36

22.19

3.5

3.2

95.07

91.73

ug/l

0.37

2465

21553

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

4118

38645

1.61

21.75

4.9

4.6

5.81

5.76

mmol/l

1.62

3857

36208

(3024561) Albumin [Mass/volume] in Serum or Plasma

2076

17527

1.34

19.87

4.3

4.8

36.59

36.41

g/l

0.88

1936

16532

(3044640) Blood type and Crossmatch panel - Blood

1658

13590

1.34

19.20

2.2

2.3

—

(3003458) Phosphate [Moles/volume] in Serum or Plasma

684

4846

1.48

18.48

4.0

5.6

1.07

1.04

mmol/l

2.26

644

4494

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

2421

21057

1.32

18.10

5.7

6.4

10.45

10.37

umol/l

0.15

2290

20065

(3012095) Magnesium [Moles/volume] in Serum or Plasma

856

6352

1.43

18.08

2.9

3.4

0.80

0.82

mmol/l

5.19

809

5997

(3013512) EKG study

1531

12492

1.34

17.98

3.4

3.2

1.00

0.74

—

(3002385) Erythrocyte [DistWidth] in Red Blood Cells

3773

35061

1.42

17.95

22.3

17.1

13.45

13.48

0.94

3731

34614

(36660697) Celiac disease serology panel - Serum

572

3955

1.51

17.35

1.2

—

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

1012

7789

1.38

17.18

2.7

2.8

2.43

2.44

mmol/l

1.72

888

7018

(3024731) MCV [Entitic mean volume] in Red Blood Cells

4556

44471

2.98

16.40

28.4

21.5

90.30

90.72

9.31

4537

44131

(3035941) MCH [Entitic mass]

4556

44471

2.98

16.40

28.4

21.4

30.02

30.18

7.96

4537

44132

(3009542) Hematocrit [Volume Fraction] of Blood by calculation

4556

44474

2.98

16.34

28.8

21.9

40.60

40.70

0.17

4534

44109

(3026361) Erythrocytes [#/volume] in Blood

4556

44477

2.97

16.28

28.5

21.5

4.54

4.47

e12/l

21.18

4497

43682

(3007461) Platelets [#/volume] in Blood

4555

44463

2.94

16.27

28.5

21.6

263.76

262.78

e9/l

0.53

4509

43761

(3010813) Leukocytes [#/volume] in Blood

4556

44480

2.97

16.22

28.6

21.6

6.48

6.65

e9/l

5.00

4497

43670

(3010838) Calcium [Moles/time] in 24 hour Urine

166

831

2.03

16.09

2.0

5.03

5.26

mmol/24h

0.42

147

747

(3000963) Hemoglobin [Mass/volume] in Blood

4556

44487

2.95

16.09

28.7

21.7

135.45

134.09

g/l

12.01

4538

44148

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

1190

9520

1.34

15.51

3.1

3.0

927.19

952.58

ng/l

0.10

986

8032

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

1268

10240

1.33

15.48

2.1

2.2

—

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

2269

19805

1.29

15.45

2.6

2.7

—

estimate

—

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

1320

10733

1.32

15.33

2.3

2.57

2.71

mg/l

1.59

1153

9365

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

1653

13870

1.30

15.21

3.4

3.3

47.03

83.99

ng/l

0.42

938

8092

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

1989

17139

1.28

14.74

2.1

2.0

96.92

98.67

pmol/l

0.91

1089

8939

(40768804) Tissue Pathology biopsy report

2043

17922

1.25

12.19

2.1

—

(3032080) INR in Blood by Coagulation assay

1877

16314

1.25

12.14

11.5

11.0

1.17

1.16

inr

0.62

1584

13420

(40760892) CBC W Ordered Manual Differential panel - Blood

1247

10345

1.28

11.86

3.9

4.6

—

(3037522) Nuclear Ab [Titer] in Serum

861

6915

1.30

10.34

1.4

501.11

553.08

titre

0.44

216

1485

(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma

255

2.49

10.31

1.9

1.6

101.38

91.08

ng/l

0.13

255

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

3187

29709

1.24

9.63

3.4

3.2

40.88

40.36

u/l

0.13

3042

28295

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

1168

9816

1.25

9.62

2.0

1.8

0.80

1.03

mg/l

4.11

900

7542

(3017732) Neutrophils [#/volume] in Blood

707

5586

1.31

9.52

3.0

3.1

4.27

4.39

e9/l

0.13

620

4967

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

433

2.05

9.11

1.2

90.70

56.73

u/l

2.85

389

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

4172

40284

1.37

8.96

5.0

4.7

4.73

4.80

mmol/l

5.51

3937

38321

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

1488

12924

1.22

8.90

2.6

2.7

71.56

65.29

u/l

0.15

1365

12048

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

4154

40118

1.36

8.60

4.9

4.6

1.50

1.53

mmol/l

3.33

3907

37974

(40761536) Microorganisms panel - Urine sediment

452

3399

1.37

8.47

3.8

3.7

—

(3004789) Transferrin [Mass/volume] in Serum or Plasma

759

6141

1.28

8.47

2.3

2.5

2.43

2.40

g/l

0.70

695

5701

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

4204

40700

1.37

8.36

5.6

5.3

2.81

2.83

mmol/l

0.98

3953

38562

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

1953

17498

1.20

8.31

2.0

1.9

1.32

1.36

mmol/l

1.55

1629

15109

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

254

2.30

8.06

1.5

1.6

6.49

5.99

u/l

0.11

211

(3022948) Iron [Moles/volume] in Serum or Plasma

808

6690

1.25

7.36

2.3

2.5

13.87

13.74

umol/l

0.20

745

6263

(3020961) Endomysium IgA Ab [Titer] in Serum

333

2449

1.39

7.17

1.1

91.82

163.93

titre

0.81

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

1026

8750

1.22

7.07

1.3

6.04

9.61

u/ml

1.54

388

3614

(3023323) Follitropin [Units/volume] in Serum or Plasma

481

3757

1.31

6.97

1.5

1.4

27.34

28.18

iu/l

0.23

414

3260

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

837

7001

1.24

6.93

3.8

3.5

122.08

387.07

ng/l

4.68

565

4671

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

227

1570

1.47

6.88

1.3

54.00

32.51

u/ml

—

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

3949

38087

1.26

6.71

4.1

4.0

1.22

1.25

mmol/l

1.91

3683

35792

(3041449) Collagen crosslinked C-telopeptide [Mass/volume] in Serum or Plasma

105

2.87

6.62

1.2

1.6

0.58

0.34

ug/l

1.42

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

1098

9491

1.21

6.53

1.4

1.3

26.68

28.84

iu/ml

0.19

315

2939

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

113

674

1.69

6.51

1.2

1.3

388.89

417.31

titre

—

(3008832) Norclozapine [Moles/volume] in Serum or Plasma

288

0.17

6.47

18.8

15.2

734.00

5358.07

nmol/l

—

277

(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum

205

1409

1.48

6.43

1.3

—

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

675

5572

1.25

6.26

2.4

2.5

22.48

23.02

0.54

621

5180

(3003694) ABO and Rh group [Type] in Blood

1459

12979

1.18

6.23

1.6

—

(3000081) cloZAPine [Moles/volume] in Serum or Plasma

298

0.20

6.22

19.3

20.6

1171.50

4669.02

nmol/l

—

288

(3019309) Folate [Moles/volume] in Red Blood Cells

699

5798

1.24

6.21

1.7

1074.92

1182.41

nmol/l

2.79

549

4470

(3027945) Reticulocytes/Erythrocytes in Blood

478

3818

1.28

5.85

2.4

2.7

1.69

1.77

1.07

432

3417

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

205

1445

1.44

5.68

1.3

29.00

7.56

u/ml

0.69

227

(3026782) Osmolality of Urine

848

7241

1.21

5.65

2.8

511.48

516.60

mosm/kgh2o

0.28

735

6330

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

1326

11798

1.17

5.52

2.1

207.52

179.52

u/l

0.20

1253

11227

(3033670) Parathyrin related protein [Moles/volume] in Serum or Plasma

2.74

5.52

1.2

6.71

11.03

pmol/l

—

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

199

1404

1.44

5.50

1.9

2.0

—

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

204

1446

1.43

5.50

1.3

2.44

5.14

u/ml

0.61

145

(40768797) Stomach Pathology biopsy report

705

5933

1.22

5.43

1.3

1.2

—

(3033658) Prothrombin time (PT) actual/Normal

1166

10278

1.18

5.42

3.9

3.8

93.01

95.12

2.36

1139

10033

(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum

294

1.95

5.34

1.1

5.30

5.47

nmol/l

—

(3041096) Erythrocytes [Presence] in Urine by Automated

1404

12578

1.17

5.33

3.4

3.1

0.16

0.11

estimate

0.12

435

3753

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

590

4898

1.23

5.18

2.7

2.6

5.77

6.77

umol/l

1.37

505

4238

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

188

1329

1.43

5.16

1.1

5.25

6.44

eliau/ml

0.21

194

(3009445) Proteinase 3 Ab [Units/volume] in Serum

221

1611

1.39

5.10

1.4

1.5

11.66

11.23

iu/ml

—

(3031040) Bacteria [#/volume] in Urine by Automated count

2890

27337

1.15

5.08

4.7

4.5

2323.76

2010.39

e6/l

0.08

319

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

449

3625

1.26

5.05

3.0

—

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

306

2352

1.32

5.02

3.3

2.9

141.72

155.37

ng/l

0.42

269

2126

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

174

1220

1.44

5.00

1.2

1.3

47.99

36.54

u/ml

0.40

124

(3021960) Folate [Moles/volume] in Serum or Plasma

1205

10730

1.17

4.87

1.6

1.7

20.12

20.64

nmol/l

0.65

1035

9273

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

166

1165

1.44

4.77

1.2

1.3

0.94

2.85

u/ml

—

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

180

1283

1.42

4.75

1.8

1.9

—

(3025159) Blasts/Leukocytes in Blood

439

3574

1.25

4.60

3.5

4.9

0.05

0.30

1.06

822

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

107

694

1.55

4.52

1.1

205.14

16373.25

iu/ml

0.60

159

(3007566) Smooth muscle Ab [Titer] in Serum

180

1308

1.39

4.29

1.3

1.2

127.27

152.96

titre

0.22

125

(3004616) Nuclear Ab [Presence] in Serum

602

1.57

4.22

1.3

—

(3021440) Promyelocytes/Leukocytes in Blood

427

3501

1.24

4.22

3.6

4.7

0.09

0.12

0.33

857

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

918

8097

1.17

4.12

1.6

1.7

62225524.03

35296250.89

pmol/l

0.56

773

6930

(3011985) Renin [Units/volume] in Plasma

585

1.57

4.04

2.2

1.5

62.18

57.73

mu/l

0.13

533

(3023520) Reticulocytes [#/volume] in Blood

351

2832

1.26

4.01

2.2

2.7

73.89

71.06

e9/l

0.60

256

2041

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

1591

14619

1.13

3.96

3.2

29.28

30.93

u/l

0.83

1522

13894

(3017181) Myelocytes/Leukocytes in Blood

439

3644

1.23

3.88

3.6

4.7

1.01

0.92

0.16

1002

(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma

153

2.10

3.77

1.0

1.1

—

5.43

—

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

165

1211

1.38

3.75

2.3

0.14

0.73

g/l

5.92

144

1064

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

684

5936

1.18

3.74

1.8

1.9

—

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

542

1.56

3.70

1.2

1.3

0.17

0.21

nmol/l

0.66

414

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

277

2199

1.28

3.64

3.0

3.4

5.22

5.16

kpa

0.46

267

2124

(3002582) Erythrocytes [#/volume] in Urine

1371

12535

1.13

3.63

3.4

3.2

25.34

73.62

e6/l

3.31

1035

9418

(3026179) Normetanephrine [Moles/volume] in Serum or Plasma

626

1.51

3.60

1.3

0.59

3.40

nmol/l

0.50

606

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

178

1332

1.35

3.59

2.2

2.3

2.82

2.88

g/l

0.47

164

1232

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

195

1481

1.33

3.57

1.5

2.0

0.24

0.23

g/l

0.54

185

1405

(3009343) pH of Capillary blood

268

2125

1.28

3.56

2.9

3.5

7.41

7.42

0.99

216

1777

(3048689) Calprotectin [Mass/mass] in Stool

747

6568

1.16

3.47

2.0

2.4

105.71

113.29

ug/g

0.23

583

5224

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

2.66

3.39

1.5

—

(3030467) Casts [#/volume] in Urine by Automated count

1193

10865

1.13

3.32

3.3

3.0

0.30

0.37

e6/l

0.79

861

7838

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

137

997

1.39

3.32

2.4

2.2

0.01

0.00

g/l

0.50

126

888

(3022145) Colonoscopy Study observation

559

4830

1.18

3.23

1.3

1.4

—

(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma

650

1.47

3.23

1.3

0.36

0.41

nmol/l

—

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

529

4550

1.18

3.23

4.9

4.5

32.79

32.51

0.25

372

3176

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

237

1884

1.27

3.12

2.1

40.79

39.84

u/l

0.27

217

1732

(3018095) Leukocytes [#/volume] in Urine

1614

15008

1.12

3.12

4.0

3.8

60.50

86.26

e6/l

1.40

1115

10173

(3002179) Metamyelocytes/Leukocytes in Blood

413

3487

1.20

3.11

3.4

4.5

0.84

0.69

0.43

961

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

141

1045

1.36

3.08

2.4

2.2

0.00

0.01

g/l

0.65

131

955

(3023420) DNA double strand Ab [Units/volume] in Serum

260

2095

1.26

3.07

1.7

2.0

4.24

6.99

iu/ml

1.98

509

(3005719) IgG [Mass/volume] in Serum or Plasma

403

3400

1.20

3.06

2.2

2.9

10.28

10.50

g/l

0.55

369

3161

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

182

1405

1.31

3.02

2.4

2.2

3.66

3.69

g/l

0.10

167

1307

(3021601) Nitrite [Presence] in Urine by Test strip

2359

22410

1.11

3.01

3.8

0.00

estimate

1.84

519

4618

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

182

1407

1.31

2.99

2.5

2.2

4.27

4.30

g/l

0.13

168

1306

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

182

1408

1.30

2.98

2.5

2.2

7.38

7.37

g/l

0.04

167

1307

(1761868) Lipid panel - Serum or Plasma

1911

17973

1.11

2.94

2.9

2.8

—

(3018658) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum

242

1.74

2.93

1.1

—

21.00

u/ml

—

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

195

1529

1.29

2.89

1.5

1.9

1.23

1.18

g/l

1.31

184

1455

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

230

1845

1.26

2.84

2.4

3.4

1.71

1.76

mmol/l

0.07

156

1380

(3035350) Ketones [Presence] in Urine by Test strip

2376

22624

1.10

2.82

3.8

2.85

4.55

estimate

0.23

528

4718

(3034274) Bile acid [Moles/volume] in Serum --fasting

119

873

1.37

2.80

2.0

2.2

5.27

4.74

umol/l

0.25

640

(3009214) Lutropin [Units/volume] in Serum or Plasma

184

1441

1.29

2.77

1.5

1.3

11.20

12.24

u/l

0.46

151

1200

(3020682) Albumin/Creatinine [Ratio] in Urine

1257

11605

1.11

2.71

4.5

4.1

6.05

8.55

mg/mmol

1.49

751

6943

(3000850) Epithelial cells [#/volume] in Urine

952

8663

1.12

2.64

2.8

2.6

6.99

7.22

e6/l

0.16

859

7854

(3022313) Gas panel - Capillary blood

187

1480

1.27

2.61

2.8

3.5

—

(3002256) Pathology report gross observation

641

5693

1.15

2.60

1.2

1.3

—

(3009261) Glucose [Presence] in Urine by Test strip

2387

22795

1.10

2.57

3.8

0.11

0.09

estimate

0.07

514

4523

(3009508) Creatinine [Moles/volume] in Urine

1383

12864

1.11

2.57

3.5

3.4

7.37

7.33

mmol/l

0.13

1185

11072

(3042934) Triiodothyronine (T3) Ab [Presence] in Serum

7.15

2.55

1.0

—

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

101

736

1.38

2.51

1.1

2.98

3.84

eliau/ml

0.35

364

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

340

1.57

2.50

1.2

1.4

—

(3012516) Albumin [Mass/volume] in Urine

1237

11463

1.11

2.46

3.7

3.4

33.46

44.66

mg/l

1.38

757

6923

(3052851) Hemolysis interference index of Serum or Plasma

137

1050

1.31

2.46

2.9

1.66

2.13

index

0.56

546

(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)

248

1.66

2.46

1.9

1.7

5.61

3.99

nmol/l

0.17

185

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

547

1.43

2.42

1.4

271.97

379.20

pmol/l

1.33

479

(3020630) Protein [Mass/volume] in Serum or Plasma

333

2828

1.19

2.41

2.4

2.7

65.93

67.02

g/l

1.89

306

2619

(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count

1471

13767

1.10

2.39

3.4

3.2

—

1.98

—

(4034850) Laboratory test

1273

0.73

2.35

9.7

8.8

—

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

150

1173

1.29

2.34

2.1

2.2

10.93

11.43

mg/l

0.34

141

1104

(1616796) Gas panel - Central venous blood

101

747

1.36

2.32

3.5

3.4

—

(3012565) Volume of 24 hour Urine

214

1.69

2.31

1.7

2.2

2075.03

1936.08

0.36

198

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

677

6085

1.13

2.30

3.0

2.8

3.85

3.76

e6/l

0.07

341

2816

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

149

1168

1.28

2.28

2.4

3.6

24.83

24.95

mmol/l

0.18

137

1083

(3000570) Elastase.pancreatic [Mass/mass] in Stool

157

1239

1.28

2.28

1.5

1.4

292.51

298.35

ug/g

0.13

100

662

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

151

1186

1.28

2.28

2.6

2.2

9.55

10.20

g/l

1.54

136

1076

(3039162) Centromere protein B Ab [Units/volume] in Serum

639

1.38

2.27

1.2

1.3

49.98

60.52

u/ml

—

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

451

3947

1.16

2.27

4.5

4.4

225.25

239.32

u/l

1.75

418

3753

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

321

2735

1.19

2.25

1.1

—

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

3082

29904

1.09

2.13

3.5

3.4

—

(3017446) Testosterone [Moles/volume] in Serum or Plasma

214

1766

1.22

2.12

2.3

2.2

11.23

11.28

nmol/l

0.03

195

1599

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

462

4072

1.15

2.12

2.8

2.4

40.07

49.87

u/l

0.34

389

3412

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

445

1.44

2.12

1.2

1.3

—

titre

—

(3021447) Carbon dioxide [Partial pressure] in Venous blood

387

3367

1.16

2.12

2.8

3.6

5.87

5.82

kpa

0.54

369

3273

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

1116

10362

1.10

2.11

1.7

—

(3026493) Urate [Moles/volume] in Serum or Plasma

1099

10198

1.10

2.10

2.4

313.39

317.44

umol/l

0.77

971

9186

(3024980) IgG subclass 4 [Mass/volume] in Serum

102

770

1.33

2.08

1.6

0.79

0.68

g/l

0.48

605

(3027456) Digoxin [Moles/volume] in Serum or Plasma

497

1.41

2.08

4.0

3.5

0.76

0.79

nmol/l

0.39

409

(3022621) pH of Urine by Test strip

400

3496

1.16

2.07

2.7

2.5

6.11

6.13

0.20

271

2232

(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing

0.00

2.06

0.0

1.2

—

(3028433) Virus identified in Specimen by Culture

124

1.86

2.06

1.0

1.2

—

(36304617) Golimumab [Mass/volume] in Serum or Plasma by Immunoassay

0.00

2.06

0.0

2.1

—

1.31

—

(3014051) Protein [Presence] in Urine by Test strip

1360

12769

1.09

2.01

2.8

2.9

0.06

0.05

0.07

237

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

246

2076

1.20

1.96

1.6

1.7

—

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

403

1.44

1.95

1.3

1.2

0.98

1.35

u/ml

0.19

206

(3002032) Base excess in Venous blood by calculation

374

3271

1.16

1.93

2.8

3.6

1.78

1.85

mmol/l

0.13

312

2866

(3032352) Blasts [#/volume] in Cerebral spinal fluid

2.73

1.93

2.7

2.0

—

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

400

3517

1.15

1.92

1.5

1.6

952.39

1008.73

mu/l

0.58

319

2933

(3009466) Valproate [Moles/volume] in Serum or Plasma

545

0.64

1.91

6.3

6.0

368.67

371.31

umol/l

0.04

475

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

333

0.54

1.90

1.0

1.5

—

(4035726) Immunohistochemistry procedure

399

3513

1.15

1.88

1.4

—

(36306063) Golimumab Ab [Mass/volume] in Serum or Plasma by Immunoassay

0.00

1.88

0.0

1.8

—

(3013139) Helicobacter pylori Ag [Presence] in Stool

370

3243

1.15

1.86

1.2

1.3

—

(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma

252

1.55

1.86

1.2

78.00

86.26

u/l

0.21

219

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

685

6243

1.11

1.86

1.5

—

(3002079) Sodium [Moles/time] in 24 hour Urine

205

1.61

1.85

1.2

1.4

156.42

152.38

mmol/24h

0.13

205

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

189

2267

0.83

1.82

1.5

—

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

622

1.34

1.82

1.2

—

(3035933) Granulocytes/Leukocytes in Blood

122

965

1.27

1.81

2.5

3.3

57.96

57.43

0.19

122

965

(3003181) Sodium [Moles/volume] in Urine

658

1.33

1.80

1.4

69.69

63.05

mmol/l

0.62

532

(3023511) Choriogonadotropin [Units/volume] in Urine

171

1407

1.22

1.79

1.3

—

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

131

1047

1.26

1.79

1.3

30.16

27.60

u/l

0.36

106

860

(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma

247

1.54

1.78

1.2

14.03

25.79

u/l

1.14

210

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

163

1340

1.22

1.73

1.2

4.13

4.33

0.08

207

(3014326) Insulin-like growth factor-I [Moles/volume] in Serum or Plasma

355

1.44

1.73

2.1

18.64

19.38

nmol/l

0.24

339

(40759850) Jo-1 extractable nuclear Ab [Presence] in Serum by Immunoblot

431

1.40

1.72

1.2

—

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

234

1.54

1.70

1.0

1.1

—

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

477

4288

1.13

1.66

5.2

4.8

2.03

2.21

ug/l

0.25

413

3890

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

317

1.46

1.66

1.1

1.07

1.05

ratio

0.77

257

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

415

3700

1.13

1.65

2.2

2.3

0.21

0.22

g/l

0.46

387

3491

(3027135) IgG subclass 1 [Mass/volume] in Serum

480

1.36

1.60

1.4

6.18

6.67

g/l

0.72

350

(3024139) IgG subclass 3 [Mass/volume] in Serum

480

1.36

1.60

1.4

0.34

0.39

g/l

0.75

347

(3028192) IgG subclass 2 [Mass/volume] in Serum

480

1.36

1.60

1.4

2.82

2.95

g/l

0.30

350

(21494755) Public health laboratory ask at order entry panel

451

5010

0.89

1.60

1.3

—

(3012544) pH of Venous blood

382

3396

1.14

1.60

2.9

3.6

7.38

0.02

216

1896

(3050129) First trimester maternal screen panel - Serum or Plasma

269

2333

1.16

1.60

1.4

—

(3005322) IgE [Units/volume] in Serum or Plasma

388

3453

1.14

1.60

1.4

1.3

142.86

206.47

u/ml

1.26

368

3231

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

405

1.39

1.57

1.2

116.61

112.49

pmol/l

0.27

405

(40759836) Histone Ab [Presence] in Serum by Immunoblot

422

1.38

1.57

1.2

—

(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal

465

1.36

1.56

1.4

1.5

—

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

176

1477

1.20

1.55

1.8

1.45

1.50

g/l

0.34

147

1285

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

701

1.29

1.55

1.4

1.6

436.46

367.98

mu/l

0.45

559

(3021387) Prolactin [Units/volume] in Serum or Plasma

253

2191

1.16

1.54

1.5

1.7

272.74

294.60

mu/l

0.71

215

1964

(3000475) Leukocytes [#/volume] in Synovial fluid

115

924

1.25

1.54

1.8

1.7

7490.96

8711.83

e6/l

0.19

646

(3025130) Human papilloma virus identified in Specimen

133

1088

1.23

1.52

1.8

1.9

—

(3028026) IgM [Mass/volume] in Serum or Plasma

304

2672

1.15

1.52

1.6

1.9

1.11

1.33

g/l

3.62

283

2484

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

378

3371

1.13

1.52

2.4

15.81

20.45

au/ml

1.08

430

(3027035) Albumin [Mass/time] in 24 hour Urine

0.00

1.52

0.0

1.3

—

108.60

—

(3029937) Albumin [Presence] in Urine by Test strip

1275

12068

1.08

1.51

3.9

0.00

estimate

2.60

501

4402

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

417

1.37

1.50

2.2

2.1

29.70

24.18

mg/l

0.30

162

(4062490) Immunoglobulin typing, IgG

469

1.35

1.49

1.4

—

(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma

126

0.40

1.49

3.0

2.1

8.66

16.21

umol/l

—

126

(3028679) Herpes simplex virus Ab [Presence] in Serum

308

1.43

1.49

1.3

1.2

—

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

487

1.34

1.48

1.3

1.2

—

(3006462) Nitrate [Presence] in Urine

178

1.58

1.48

3.0

3.1

—

(3004451) EKG impression Narrative

186

1.56

1.48

1.3

—

(46236952) Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)/1.73 sq M

285

3241

0.87

1.48

2.4

2.6

71.96

71.28

ml/min/173m2

0.09

114

1361

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

947

8883

1.08

1.41

1.7

—

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

316

2802

1.14

1.41

2.2

5755.93

5654.39

u/l

0.02

131

1134

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

147

1227

1.20

1.40

1.9

2.3

206.34

577.22

ug/l

1.36

135

1148

(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay

2.18

1.39

1.1

—

(3016650) Hepatitis A virus Ab [Presence] in Serum

777

1.25

1.37

1.1

—

(40767663) Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum

0.00

1.34

0.0

1.0

—

0.09

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

401

1.35

1.33

1.2

—

(3015171) Extractable nuclear Ab [Units/volume] in Serum

236

2062

1.15

1.32

1.3

0.47

1.35

u/ml

1.69

161

(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method

0.00

1.31

0.0

1.1

—

(3035320) C reactive protein [Mass/volume] in Body fluid

334

1.38

1.30

2.9

2.6

23.31

26.65

mg/l

0.31

231

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

1785

17170

1.06

1.30

3.7

3.6

1.19

0.21

estimate

0.40

433

3812

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

1.84

1.29

1.0

1.1

—

(3018333) Ribosomal P Ab [Presence] in Serum

386

1.35

1.29

1.2

—

(3031067) HIV 1 p24 Ag [Mass/volume] in Serum or Plasma by Immunoassay

2.78

1.28

1.0

1.1

—

(3033099) Centromere Ab [Titer] in Serum

114

1.67

1.28

1.1

—

(3036669) Protein S actual/normal in Platelet poor plasma by Coagulation assay

218

1.47

1.28

1.1

87.67

92.23

0.48

171

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

413

1.34

1.27

1.2

—

(3043409) Potassium [Moles/volume] in Arterial blood

882

0.78

1.27

2.3

3.9

3.78

3.82

mmol/l

0.36

875

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

422

1.33

1.27

1.4

1.6

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

414

1.33

1.26

1.2

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

397

1.34

1.25

1.2

—

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

244

1.44

1.25

1.8

—

(3041678) Intrinsic coagulation system thromboelastography panel - Blood

2.40

1.24

1.2

1.3

—

(3012501) Base excess in Blood by calculation

691

1.25

1.21

3.3

3.6

2.43

2.52

mmol/l

0.12

456

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

238

1.43

1.20

1.2

1.1

—

(3008898) HLA-B27 [Presence]

229

2015

1.14

1.18

1.1

—

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

341

1.35

1.17

1.2

230.00

210.75

titre

—

(4211845) Urine protein measurement

198

1.47

1.16

3.0

—

(3026008) Bacteria identified in Urine by Culture

1318

12602

1.06

1.14

3.0

—

(3017569) Oxygen content in Arterial blood

183

1.48

1.13

2.6

2.4

16.19

16.33

0.09

183

(3018405) Lactate [Moles/volume] in Arterial blood

1064

0.81

1.12

2.3

3.7

1.24

1.37

mmol/l

0.78

1049

(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma

582

1.26

1.12

1.1

1.50

1.49

g/l

0.06

525

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

225

1.43

1.11

1.2

1.1

—

(3006184) Hemoglobin [Mass/volume] in Capillary blood

102

844

1.21

1.11

2.0

2.3

132.73

129.71

g/l

0.72

674

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

717

1.23

1.11

2.6

52.60

83.49

ug/min

0.63

434

(3000330) Specific gravity of Urine by Test strip

214

1886

1.14

1.10

2.9

3.2

1.02

ratio

0.79

191

1686

(3034860) Kappa light chains.free [Mass/volume] in Serum

124

1048

1.19

1.09

3.4

3.5

38.25

51.41

mg/l

0.87

104

904

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

345

3131

1.11

1.09

1.3

49.59

47.11

au/ml

0.07

204

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

382

1.31

1.07

1.4

1.6

—

(3011288) Drugs identified in Urine by Screen method Nominal

135

1576

0.85

1.06

1.8

2.8

—

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

421

3865

1.10

1.06

6.4

7.9

5.11

5.08

kpa

0.18

406

3721

(3027801) Oxygen [Partial pressure] in Arterial blood

421

3865

1.10

1.06

6.4

7.9

13.02

12.95

kpa

0.08

404

3720

(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma

2.12

1.05

5.0

3.1

—

(3021879) Hepatitis B virus core Ab [Presence] in Serum

431

3965

1.10

1.04

1.4

1.5

—

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

261

2340

1.12

1.04

1.4

1.5

—

(3020876) Protein [Mass/time] in 24 hour Urine

417

0.72

1.03

2.3

2.5

1.19

1.14

g/24h

0.07

246

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

130

1.54

1.02

3.5

4.6

—

(40767503) Oxygen content in Capillary blood by calculation

699

1.22

1.01

2.5

17.00

16.52

0.84

687

(3042936) Bacteria identified in Isolate by Culture

585

5463

1.08

1.01

2.1

2.0

—

(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma

117

993

1.18

1.00

1.4

2.23

3.79

ug/l

2.82

107

893

(4146454) Self-monitoring of blood glucose

334

1.32

1.00

3.1

2.8

—

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

123

1049

1.18

1.00

3.4

3.5

33.30

52.68

mg/l

0.97

103

905

(3035880) pH of Pleural fluid

131

1.53

0.99

1.2

1.3

7.44

7.40

0.38

(3029396) Erythrocyte agglutination [Presence] in Blood

189

1.43

0.98

2.4

3.0

—

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

213

1895

1.13

0.97

7.8

10.5

16.38

15.97

1.38

205

1821

(3052592) Norovirus Ag [Presence] in Stool

1.85

0.96

1.7

1.3

—

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

468

4342

1.09

0.95

1.7

1.8

—

(3023183) Ammonium ion [Moles/volume] in Plasma

746

0.80

0.94

2.2

2.9

35.77

33.80

umol/l

0.18

690

(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum

1.65

0.94

1.1

10.36

6.75

u/ml

0.39

(40757373) Influenza virus identified in Isolate

1.78

0.94

2.0

1.9

—

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

364

1.29

0.94

1.6

1.7

—

(3015183) Erythrocyte sedimentation rate [Velocity] in Red Blood Cells

268

1.35

0.94

1.2

9.61

9.76

mm/h

0.03

268

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

370

3404

1.09

0.92

3.8

4.0

23.70

21.23

1.85

152

1468

(3008757) Leukocyte morphology finding [Identifier] in Blood

330

1.31

0.92

3.4

—

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

327

0.70

0.92

2.3

2.7

—

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

169

1913

0.88

0.91

1.1

0.59

0.63

ratio

0.40

223

(4024509) Urine culture

218

1953

1.12

0.91

1.9

—

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

117

1005

1.17

0.89

1.7

1.3

15.57

28.63

e6/l

0.73

730

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

456

1.25

0.89

1.8

1.6

—

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

109

931

1.17

0.89

3.5

3.2

1.24

2.92

ratio

2.33

527

(3016273) Islet cell 512 Ab [Units/volume] in Serum

2.07

0.89

1.0

1.1

—

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

803

1.19

0.88

1.7

1.8

—

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

211

1.38

0.88

1.7

2.6

157.57

175.32

umol/l

0.09

112

(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection

128

0.55

0.88

1.0

1.2

—

(3016502) Oxygen saturation in Arterial blood

368

3395

1.09

0.87

6.7

8.4

95.79

95.95

0.21

352

3288

(3020491) Glucose [Moles/volume] in Blood

298

1.31

0.87

1.5

1.6

6.34

6.17

mmol/l

0.18

223

(3023410) Appearance of Cerebral spinal fluid

485

1.24

0.87

2.2

1.5

—

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

146

1279

1.15

0.87

3.2

3.6

110.14

1358.42

u/ml

0.95

122

1097

(3000991) Gas panel - Venous blood

326

2992

1.10

0.87

7.4

8.7

—

(3009876) Amylase isoenzyme 3 panel - Serum or Plasma

2.00

0.87

1.5

1.1

—

(3003396) Base excess in Arterial blood by calculation

413

3834

1.08

0.85

6.5

8.0

0.80

0.92

mmol/l

0.24

338

3139

(3022475) Manganese [Moles/volume] in Blood

1.94

0.84

1.2

1.4

0.16

umol/l

—

(3025941) Bacteria identified in Stool by Culture

282

2576

1.10

0.83

1.2

—

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

248

1.33

0.83

1.3

1.2

—

(3020874) Milk IgE Ab [Units/volume] in Serum

363

1.27

0.82

1.0

0.86

1.80

u/ml

0.39

113

(3000093) Morphology [Interpretation] in Blood Narrative

310

1.29

0.82

1.2

1.1

—

(3040151) Glucose [Moles/volume] in Capillary blood

356

1.27

0.79

9.7

5.5

7.26

7.10

mmol/l

0.09

308

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

224

1.34

0.79

1.2

1.1

—

(3041008) Bicarbonate [Moles/volume] standard in Arterial cord blood

0.00

0.79

0.0

1.2

—

21.83

—

(3038864) risperiDONE [Moles/volume] in Serum or Plasma

0.00

0.79

0.0

1.4

—

39.76

—

(3045683) HLA typing for celiac disease panel - Blood or Tissue

322

1.28

0.77

1.0

—

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

283

2599

1.09

0.77

2.9

3.0

0.68

0.72

ug/l

0.56

165

1525

(3006922) Hepatitis E virus Ab [Presence] in Serum

367

1.26

0.77

1.0

1.1

—

(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma

191

1.36

0.76

1.1

1.2

0.31

0.29

g/l

0.49

153

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

117

1021

1.15

0.76

1.8

1.4

755.25

1355.35

e6/l

0.66

791

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

208

1882

1.11

0.76

1.5

1.6

11.95

12.52

u/ml

0.06

511

(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine

0.00

0.76

0.0

2.0

—

(3019977) pH of Arterial blood

414

3866

1.08

0.76

6.5

8.0

7.42

0.68

214

2097

(3048929) Epstein Barr virus Ab [Presence] in Serum

180

1616

1.12

0.76

1.2

—

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

724

1.18

0.75

1.1

1.04

2.85

1.77

137

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

108

938

1.16

0.75

1.6

—

(3034092) Cytoplasmic Ig cells/cells in Blood

1.70

0.75

4.7

7.0

0.13

0.18

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

192

1.36

0.75

1.5

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

192

1.36

0.75

1.5

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

192

1.36

0.75

1.5

—

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

651

1.19

0.74

1.6

1.7

—

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

201

1.35

0.74

2.1

1.6

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

193

1.35

0.73

1.5

—

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

543

1.20

0.72

1.2

1.4

—

(3033888) Pepsinogen I [Mass/volume] in Serum or Plasma

1.52

0.72

1.0

72.73

76.83

ug/l

—

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

168

1.37

0.71

1.0

1.1

—

(36305075) Vedolizumab [Mass/volume] in Serum or Plasma by Immunoassay

1.75

0.71

5.3

2.9

30.29

21.78

mg/l

—

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

535

1.20

0.71

1.2

1.4

—

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

1.58

0.71

3.0

2.1

—

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

109

1.47

0.70

1.1

—

(3006571) Granulocytes/Leukocytes in Synovial fluid

435

1.22

0.70

1.4

1.6

48.65

53.95

0.44

263

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

165

1482

1.12

0.70

1.8

—

(3008799) Glucose [Moles/volume] in Serum or Plasma --30 minutes post dose glucose

1.92

0.70

1.4

1.0

9.28

8.16

mmol/l

—

(3019768) Coxiella burnetii Ab [Presence] in Serum

1.92

0.70

1.0

1.1

—

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

160

1.38

0.70

1.1

1.2

—

(3019150) Specific gravity of Urine by Refractometry

959

9969

0.95

0.69

3.7

3.9

1.02

1.32

kg/l

0.80

678

6578

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

185

1674

1.11

0.69

1.6

—

(3030981) Hyaline casts [#/volume] in Urine by Automated count

324

3011

1.08

0.69

2.4

0.28

0.42

e6/l

1.13

305

2838

(3024522) Salmonella sp identified in Specimen by Organism specific culture

537

1.19

0.69

1.2

1.4

—

(3023368) Bacteria identified in Blood by Culture

989

9520

1.05

0.68

3.9

4.1

—

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

112

985

1.14

0.68

1.5

1.4

—

(3002619) Bacteria identified in Specimen by Culture

117

0.60

0.67

1.1

1.2

—

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

182

2006

0.90

0.67

1.4

1.3

231.88

229.98

miu/ml

0.02

989

(3007853) Bacteria identified in Skin by Aerobe culture

509

4813

1.06

0.67

1.9

1.7

—

(3014111) Lactate [Moles/volume] in Serum or Plasma

338

3152

1.08

0.66

6.5

7.5

1.29

1.27

mmol/l

0.10

327

3096

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

276

2554

1.09

0.66

2.0

2.2

5.50

6.55

ug/l

0.68

233

2269

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

706

6746

1.05

0.66

2.9

2.7

1.12

1.24

e6/l

0.24

372

3482

(4094501) Cardiovascular stress test using bicycle ergometer

120

1063

1.13

0.66

1.1

—

(3047007) Chlamydophila sp Ab [Presence] in Serum

763

1.16

0.65

1.2

—

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

202

0.69

0.65

1.2

1.1

—

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

215

1.30

0.65

1.2

1.6

—

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

422

1.21

0.64

1.9

1.5

—

(3014271) Vancomycin [Susceptibility]

120

1.42

0.64

2.5

2.7

—

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

127

1132

1.13

0.63

1.7

1.4

0.50

0.43

nmol/l

0.55

887

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

139

1247

1.12

0.63

1.5

69.49

60.65

ug/l

1.14

139

1247

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

208

1907

1.10

0.62

2.4

2.3

—

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

110

974

1.13

0.62

1.5

1.6

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

147

1.36

0.61

1.3

—

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

147

1.36

0.61

1.3

—

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

508

1.18

0.60

1.1

1.4

—

(44806420) Estimation of glomerular filtration rate

610

1.17

0.60

2.5

2.3

—

(40760543) Extractable nuclear Ab [Presence] in Serum by Immunoblot

280

1.25

0.60

1.1

1.2

—

(3017414) Tyrophagus putrescentiae IgE Ab [Units/volume] in Serum

0.00

0.60

0.0

1.0

—

0.27

—

(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.57

0.60

1.1

1.0

—

(37208534) Antinuclear antibody arbitrary concentration in serum

148

1.35

0.59

1.1

—

(3040668) CNBP gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

0.00

0.59

0.0

1.0

—

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

733

1.15

0.59

1.5

—

(3004716) Salmonella sp identified in Stool by Organism specific culture

268

2492

1.08

0.59

1.3

1.4

—

(3042631) Mycobacterium sp identified in Specimen

427

1.20

0.58

2.1

2.7

—

(3005988) Vibrio sp identified in Specimen by Organism specific culture

510

1.18

0.58

1.1

1.4

—

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

363

1.21

0.58

1.0

1.1

—

(3015736) pH of Urine

1851

18114

1.04

0.58

3.2

3.4

6.16

6.23

1.83

1089

10400

(3017958) Strawberry IgE Ab [Units/volume] in Serum

0.00

0.58

0.0

1.0

—

0.03

—

(40763476) Honey bee phospholipase A2 recombinant (rApi m) 1 IgE Ab [Units/volume] in Serum

0.00

0.58

0.0

1.1

—

0.04

—

(3040370) OLANZapine [Moles/volume] in Serum or Plasma

162

0.68

0.58

2.6

2.5

111.36

154.67

nmol/l

1.01

145

(3002173) Hemoglobin [Mass/volume] in Arterial blood

342

3211

1.07

0.58

7.2

8.8

121.96

120.94

g/l

0.40

332

3139

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

1.46

0.58

1.2

1.1

—

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

393

3709

1.07

0.57

3.4

4.2

11.95

30.15

ug/l

0.99

300

2874

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

329

3087

1.07

0.57

3.4

48.54

51.27

u/ml

0.07

317

2991

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

346

1.22

0.57

1.2

—

(3029536) Hepatitis C virus RNA [Units/volume] (viral load) in Specimen by NAA with probe detection

230

0.74

0.57

1.6

1.5

—

1397375.67

—

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

1.46

0.56

1.1

1.2

—

(3008295) Osmolality of Serum or Plasma

448

1.19

0.56

1.4

1.5

274.83

278.69

mosm/kgh2o

0.58

353

(3003329) Lymphocytes/Leukocytes in Synovial fluid

329

1.22

0.55

1.4

1.6

35.08

37.13

0.11

188

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

150

1.33

0.55

1.6

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

150

1.33

0.55

1.6

—

(4010399) Spirometry for bronchospasm with prolonged evaluation after bronchodilator

326

3064

1.07

0.55

1.5

1.4

—

(3042733) HLA Ab [Presence] in Serum

123

0.65

0.54

5.9

5.0

—

(3045462) Protein/Creatinine [Ratio] in Urine

1.58

0.54

1.3

2.7

22.17

16.74

mg/mmol

—

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

151

1.33

0.53

1.7

1.6

—

(3017143) Hepatitis C virus Ab [Presence] in Serum

609

5835

1.05

0.53

1.5

1.6

—

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

1.48

0.53

1.1

1.2

—

(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection

1.49

0.53

1.0

1.7

—

7566.67

—

(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay

108

1.39

0.53

1.1

—

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

204

1887

1.08

0.53

1.4

1.5

—

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

350

1.20

0.52

1.2

—

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

196

1.28

0.52

1.1

1.2

—

(42870325) Hepcidin 25 amino acid peptide [Moles/volume] in Serum or Plasma

1.43

0.52

1.3

2.0

5.04

654006.16

nmol/l

—

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

0.62

0.52

1.2

1.1

—

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

294

2762

1.07

0.51

1.5

1.7

—

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

206

1911

1.08

0.50

1.4

1.5

0.93

0.95

ratio

0.36

120

1152

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

206

1911

1.08

0.50

1.4

1.5

1.16

1.21

ratio

0.37

122

1157

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

144

1.32

0.50

1.6

1.7

40.02

40.87

g/l

0.27

144

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

313

0.80

0.49

2.9

4.0

—

(3023430) Cat dander IgE Ab [Units/volume] in Serum

860

0.88

0.49

1.0

1.1

1.38

3.95

u/ml

2.03

367

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

435

4144

1.05

0.49

1.8

—

(21494434) Karyotype in Bone marrow

279

0.79

0.48

1.2

—

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

205

1907

1.08

0.48

1.4

1.5

1.06

1.16

ratio

1.02

119

1148

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

1.49

0.47

1.0

—

(3017315) Amylase [Enzymatic activity/volume] in Urine

211

0.76

0.47

1.3

219.63

286.40

u/l

0.45

194

(4195642) Thrombophilia screening test

720

1.13

0.47

1.2

—

(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay

720

1.13

0.47

1.1

114.09

118.25

0.55

651

(3024891) Influenza virus A+B Ag [Presence] in Specimen

137

1254

1.10

0.47

1.1

—

(3047189) Immunofixation for 24 hour Urine

154

0.71

0.47

2.0

1.6

—

(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

1.46

0.46

1.1

—

(3004446) Plasmodium sp identified in Blood by Light microscopy

1.46

0.46

3.3

2.6

—

(3005082) Progesterone [Moles/volume] in Serum or Plasma

411

1.17

0.46

1.4

26.28

33.73

nmol/l

1.15

372

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

200

1.25

0.46

1.2

1.3

—

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

291

1.20

0.46

1.4

1.3

—

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

202

1882

1.08

0.46

1.6

1.5

—

(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid

1.43

0.46

1.1

—

(1761482) Bacteria [#/volume] in Urine by Culture

731

1.12

0.46

3.7

4.1

—

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

218

2038

1.07

0.45

1.4

1.5

59.86

59.87

ug/l

0.00

174

1692

(3027273) Bicarbonate [Moles/volume] in Venous blood

156

1439

1.09

0.45

2.7

3.0

25.51

25.36

mmol/l

0.22

146

1379

(3000034) Microalbumin [Mass/volume] in Urine

301

1.20

0.45

2.6

3.0

18.35

46.66

mg/l

0.69

218

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

1069

10409

1.04

0.45

1.6

1.5

—

(3025468) Yersinia sp identified in Specimen by Organism specific culture

506

1.15

0.44

1.1

1.4

—

(21494814) CD8 cells/Lymphocytes in Specimen

175

0.74

0.44

1.6

2.1

26.00

30.26

0.54

175

(3032868) Hemoglobin electrophoresis panel in Blood

1.37

0.44

1.7

1.5

—

(3013201) Beta-2-Microglobulin [Mass/volume] in Serum or Plasma

307

0.81

0.43

1.8

1.7

2.75

3.60

mg/l

0.92

299

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

274

0.80

0.43

3.0

2.0

2.73

1.83

u/field

0.48

147

(3037121) Protein [Mass/volume] in Urine

135

1242

1.09

0.42

2.9

3.3

1503.81

404.89

mg/l

0.43

518

(3047181) Lactate [Moles/volume] in Blood

113

1031

1.10

0.42

4.3

6.6

1.21

1.23

mmol/l

0.11

906

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

151

0.73

0.42

1.3

1.1

—

(3004119) Hemoglobin [Mass/volume] in Venous blood

224

2103

1.07

0.42

2.7

3.0

132.75

129.26

g/l

1.63

215

2039

(3036489) Thrombin time

174

1620

1.08

0.42

2.1

2.0

21.11

20.65

0.27

148

1396

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

765

1.11

0.42

3.0

2.4

0.91

0.88

nmol/l

0.12

664

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

294

0.82

0.41

1.0

1.1

1476.50

1521.71

miu/ml

0.07

294

(42868555) Amyloid beta 40 peptide [Mass/volume] in Cerebral spinal fluid

0.00

0.41

0.0

1.0

—

10694.40

—

(3035401) Herpes virus 6 DNA [Presence] in Specimen by NAA with probe detection

0.00

0.41

0.0

1.1

—

(3007302) Hemoglobin [Mass/volume] in Mixed venous blood

0.00

0.41

0.0

8.1

—

108.31

—

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

482

1.14

0.41

1.1

—

(3036525) Urea [Moles/time] in 24 hour Urine

0.00

0.40

0.0

2.8

—

(46234826) Other cells/Leukocytes in Peritoneal fluid by Manual count

0.00

0.40

0.0

1.5

—

18.63

—

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

204

1.23

0.40

1.2

1.3

—

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

215

2022

1.07

0.40

2.8

3.9

24.36

24.33

mmol/l

0.05

215

2003

(3014037) CD3+CD4+ (T4 helper) cells/cells in Blood

223

1.21

0.39

2.1

2.8

41.91

45.72

0.58

126

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

1.31

0.39

1.0

1.4

—

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

205

1.22

0.39

1.2

1.6

—

(3007625) Streptococcus pneumoniae Ag [Presence] in Specimen

0.00

0.39

0.0

1.1

—

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

476

1.14

0.38

1.7

—

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

742

1.11

0.38

1.9

1.6

—

(3022806) Fractional oxyhemoglobin in Capillary blood

401

1.15

0.38

1.9

1.7

89.49

90.19

0.23

396

(40765096) Chromosome analysis panel by Banding

113

0.71

0.37

1.1

—

(4268621) Lupus anticoagulant assay

535

0.88

0.36

2.4

2.3

—

(3020911) Cortisol [Moles/time] in 24 hour Urine

180

1.22

0.35

1.7

1.4

128.32

238.62

nmol/24h

0.31

180

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

148

1381

1.07

0.35

2.3

2.1

95.34

95.39

0.01

140

1324

(3002523) Influenza virus A Ag [Presence] in Specimen

110

1015

1.09

0.35

1.0

1.1

—

(3045781) Inhibin B [Mass/volume] in Serum or Plasma

117

1.28

0.35

4.5

3.3

53.33

115.65

ng/l

—

(3011397) Hemoglobin [Presence] in Urine by Test strip

1006

10290

0.97

0.35

3.4

3.7

0.00

0.20

—

(3026389) Candida sp identified in Specimen by Organism specific culture

718

1.10

0.34

1.3

—

(3019832) Treponema pallidum Ab [Presence] in Serum

652

6331

1.03

0.34

1.7

1.8

—

(3023419) Bacteria identified in Sputum by Culture

458

0.87

0.34

2.5

2.9

—

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

1.37

0.34

1.2

1.1

—

(40758355) Pancreatic polypeptide [Moles/volume] in Serum or Plasma

1.36

0.34

2.2

2.1

40.28

56.58

pmol/l

—

(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)

1.36

0.34

1.3

1.2

—

(3014133) Dog dander IgE Ab [Units/volume] in Serum

919

0.91

0.34

1.0

1.1

3.34

3.58

u/ml

0.06

437

(3028707) Methadone [Presence] in Urine by Screen method

949

0.92

0.33

1.8

2.8

—

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

144

0.76

0.33

1.1

—

(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum

1.30

0.33

1.3

1.1

144.00

78.61

titre

—

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

136

1271

1.07

0.32

1.3

—

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

731

1.10

0.32

1.4

1.5

—

(3051611) Lipemic interference index of Serum or Plasma

360

1.14

0.32

3.4

3.1

16.07

13.76

index

0.38

224

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

780

0.91

0.32

1.0

1.1

0.25

0.35

u/ml

0.19

238

(3022493) Free Hemoglobin [Mass/volume] in Plasma

146

1.23

0.32

13.7

5.1

93.69

63.58

mg/l

0.91

106

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

857

1.09

0.31

1.2

1.4

161.48

154.11

au/ml

0.23

244

(3041806) Other cells [#/volume] in Blood by Manual count

183

1.20

0.31

1.5

1.6

0.53

0.49

e9/l

0.27

183

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

183

1.20

0.31

1.0

1.1

—

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

761

1.09

0.31

1.2

1.4

—

(3001556) Androgen free Index in Serum or Plasma

1.30

0.30

2.4

1.1

—

(3003740) Influenza virus B Ag [Presence] in Specimen

109

1014

1.08

0.30

1.0

1.1

—

(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal

362

1.13

0.30

1.2

1.4

1.40

1.44

nmol/l

0.09

326

(42529528) Centromere protein B Ab [Units/volume] in Serum by Line blot

111

1.26

0.30

1.1

—

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

1.27

0.30

1.6

—

(3044290) Cell count panel - Cerebral spinal fluid

103

958

1.08

0.29

1.7

1.3

—

(4133840) Spirometry

106

0.75

0.29

1.0

1.2

—

(3044007) Cell count panel - Peritoneal fluid

111

0.72

0.28

1.6

2.0

—

(21494890) Protein electrophoresis panel - 24 hour Urine

302

0.86

0.28

2.2

2.0

—

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

154

1455

1.06

0.28

4.3

5.4

1.74

1.60

0.68

145

1372

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

565

1.10

0.28

1.2

1.5

—

(1617658) Protocol used for examination of sentinel lymph nodes

428

0.89

0.27

1.1

—

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

371

3837

0.96

0.27

1.8

1.9

—

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

252

1.15

0.27

1.8

1.62

1.75

u/ml

—

(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma

499

1.10

0.27

2.5

2.4

13.51

546.97

u/ml

0.53

494

(42529527) Centromere protein A Ab [Units/volume] in Serum by Line blot

1.21

0.26

1.1

1.0

—

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

586

1.09

0.26

1.2

1.3

35.29

25.77

u/l

0.18

507

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

1.30

0.26

1.1

1.5

1.17

1.18

mmol/l

—

(3009871) Measles virus Ab [Titer] in Serum

203

0.84

0.25

1.8

1.7

5696.00

3437.33

titre

—

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

149

0.80

0.25

1.0

1.1

—

(3015302) Jo-1 extractable nuclear Ab [Units/volume] in Serum

1.25

0.25

2.4

1.7

—

(3024889) Methemoglobin/Hemoglobin.total in Venous blood

168

1765

0.95

0.25

2.5

2.9

0.63

0.62

0.33

168

1755

(3051387) C reactive protein [Mass/volume] in Capillary blood

781

1.08

0.25

3.6

3.4

20.31

23.29

mg/l

0.40

537

(3045142) Bone marrow Pathology biopsy report

403

0.89

0.24

1.2

1.4

—

(42868678) Cholesterol non HDL [Moles/volume] in Serum or Plasma

429

4414

0.97

0.24

1.6

3.52

3.51

mmol/l

0.09

290

2978

(21494815) CD4 cells/Lymphocytes in Specimen

371

0.89

0.24

1.7

2.2

41.65

40.72

0.14

365

(3001686) Cold agglutinin [Titer] in Serum or Plasma

1.17

0.24

1.8

1.3

—

143.80

—

(3028531) Enolase.neuron specific [Mass/volume] in Serum or Plasma

331

1.12

0.24

2.6

2.0

20.95

23.44

ug/l

0.14

325

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

124

1.21

0.24

1.1

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

124

1.21

0.24

1.1

—

(3013637) Mi-2 Ab [Presence] in Serum

124

1.21

0.24

1.1

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

124

1.21

0.24

1.1

—

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

227

1.15

0.23

1.2

1.5

—

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

113

1066

1.06

0.23

2.6

2.8

—

(3023199) Leukocytes [#/volume] in Pleural fluid

322

1.12

0.23

1.3

1.4

1835.43

2546.73

e6/l

0.59

215

(3029080) Hemoglobin [Entitic mass] in Reticulocytes

408

1.10

0.23

1.8

2.3

32.02

32.00

0.01

408

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

127

1203

1.06

0.23

1.2

1.1

—

(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma

294

1.12

0.23

1.6

1.5

4.83

5.51

u/l

1.03

259

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

458

4700

0.97

0.23

2.0

—

(3045716) Anion gap in Serum or Plasma by calculation

361

1.11

0.23

2.3

2.7

11.38

10.43

mmol/l

0.95

356

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

304

1.12

0.22

1.2

1.0

1.51

1.08

u/l

0.73

116

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

763

0.93

0.22

1.3

1.2

3.41

3.93

u/ml

0.25

319

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

153

1.18

0.22

1.0

1.1

—

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

1.27

0.22

1.1

1.2

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

314

1.12

0.22

1.5

1.4

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

314

1.12

0.22

1.5

1.4

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

314

1.12

0.22

1.5

1.4

—

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

933

1.06

0.22

1.2

1.4

—

(4027681) Cerebrospinal fluid IgG ratio and IgG index

305

1.12

0.21

1.4

1.2

0.78

0.63

ratio

0.35

193

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

778

1.07

0.21

1.1

—

(3020356) Listeria sp identified in Specimen by Organism specific culture

1.19

0.21

1.0

1.2

—

(3025886) Oxalate [Mass/time] in 24 hour Urine

0.00

0.21

0.0

1.3

—

33.37

—

(3027505) Alpha-1-Fetoprotein [Units/volume] in Amniotic fluid

0.00

0.21

0.0

1.0

—

9943.73

—

(3036955) Alkaline phosphatase.liver/Alkaline phosphatase.total in Serum or Plasma

0.00

0.21

0.0

2.2

—

25.34

—

(3022670) pH of Venous cord blood

0.00

0.21

0.0

1.2

—

(3041184) Isoniazid [Presence] in Urine

0.00

0.21

0.0

1.7

—

(40757578) FLT3 gene targeted mutation analysis in Bone marrow by Molecular genetics method

0.00

0.21

0.0

1.0

—

(3020093) Fractional oxyhemoglobin in Venous cord blood

0.00

0.21

0.0

1.2

—

71.51

—

(3032390) JC virus DNA [#/volume] (viral load) in Urine by NAA with probe detection

0.00

0.21

0.0

1.7

—

(3024354) Oxygen [Partial pressure] in Venous blood

289

2799

1.03

0.21

2.6

3.1

4.55

4.56

kpa

0.02

275

2719

(3003932) Carbon dioxide [Partial pressure] in Arterial cord blood

0.00

0.21

0.0

1.2

—

6.95

—

(1175310) Leucine-rich glioma-inactivated protein 1 Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay

0.00

0.21

0.0

1.0

—

(3027874) Urate [Moles/volume] in Urine

0.00

0.21

0.0

1.0

—

2.23

—

(3006598) pH of Arterial cord blood

0.00

0.21

0.0

1.2

—

(3021706) Oxygen [Partial pressure] in Arterial cord blood

0.00

0.21

0.0

1.2

—

4.38

—

(3014765) Yersinia sp identified in Stool by Organism specific culture

127

1208

1.05

0.21

1.1

—

(3043649) Fibrin monomer [Presence] in Platelet poor plasma by Hemagglutination

0.00

0.21

0.0

1.2

—

(3009883) Potato IgE Ab [Units/volume] in Serum

0.00

0.21

0.0

1.0

—

0.18

—

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

268

1.12

0.20

1.3

1.6

—

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

134

0.82

0.20

1.5

10.08

8.63

ug/l

0.32

134

(21494227) Amikacin free [Mass/volume] in Serum or Plasma

0.00

0.20

0.0

4.7

—

3.09

—

(40763091) Bacteria identified in Peritoneal dialysis fluid by Culture

0.00

0.20

0.0

2.4

—

(3027318) Ethylene glycol [Moles/volume] in Serum or Plasma

0.00

0.20

0.0

1.3

—

(3016284) Epstein Barr virus nuclear Ab [Units/volume] in Serum

0.00

0.20

0.0

1.0

—

264.64

—

(3024932) HLA-DR beta [Type]

111

0.81

0.20

1.1

1.2

—

(3024471) HLA-A [Type]

113

0.80

0.20

1.0

—

(3003434) Protein [Mass/volume] in Pleural fluid

355

1.10

0.20

1.3

1.4

32.74

34.25

g/l

0.32

326

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

649

6371

1.02

0.19

2.0

2.1

—

(3019539) Treponema pallidum Ab [Titer] in Serum by Hemagglutination

530

0.92

0.19

1.7

—

1766.67

—

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

1.13

0.18

1.0

1.1

—

(3025577) Chromium [Mass/volume] in Blood

156

1.15

0.18

2.1

2.2

1.71

2.73

ug/l

1.01

136

(3019473) Protein [Mass/volume] in Cerebral spinal fluid

122

1165

1.05

0.18

1.4

1.3

467.07

486.67

mg/l

0.22

115

1122

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

105

999

1.05

0.18

1.1

1.2

53.74

49.55

u/ml

—

(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum

931

1.05

0.18

1.1

10.93

15.58

au/ml

0.37

248

(1001926) Buprenorphine [Presence] in Urine by Screen method

166

1723

0.96

0.17

1.6

2.1

—

(42529406) Shigella sp [Presence] in Stool by Culture

127

1216

1.05

0.17

1.2

1.1

—

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

108

1030

1.05

0.17

1.6

—

(3025018) Bordetella pertussis Ab [Titer] in Serum

393

0.92

0.17

1.1

1.2

—

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

320

0.91

0.17

1.7

2.9

—

(3028717) Thiamine [Mass/volume] in Blood

1.22

0.17

1.1

1.3

56.00

63.89

ug/l

—

(40761539) Cells [Type] in Urine sediment by Light microscopy

1.22

0.17

1.4

1.1

—

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

957

0.95

0.17

4.4

3.5

0.38

0.36

iu/ml

0.28

526

(3038071) Oxygen [Partial pressure] in Mixed venous blood

0.75

0.17

7.0

7.1

6.96

5.36

kpa

—

(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence

236

0.89

0.16

1.0

1.3

—

873.53

—

(3000494) Fungus identified in Specimen by Culture

524

5145

1.02

0.16

1.5

—

(3018677) aPTT in Platelet poor plasma by Coagulation assay

543

5527

0.98

0.16

2.3

2.1

30.00

29.17

2.24

521

5373

(3017704) Immunofixation for Urine

162

0.86

0.16

3.4

1.5

—

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

133

1279

1.04

0.16

1.2

1.3

—

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

130

1.15

0.15

1.1

25.81

38.70

iu/ml

0.59

130

(3037692) Legionella sp identified in Specimen by Organism specific culture

130

1.15

0.15

2.2

1.5

—

(3012494) Peanut IgE Ab [Units/volume] in Serum

149

1.14

0.15

1.0

1.1

0.07

1.80

u/ml

—

(44806071) Cardiolipin IgM antibody measurement

0.77

0.15

1.2

1.1

—

(3004809) Band form neutrophils/Leukocytes in Blood

565

1.06

0.15

3.1

3.2

1.08

1.50

0.92

516

(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma

1.14

0.15

1.4

—

0.95

—

(40768441) Liver Pathology biopsy report

338

0.92

0.15

1.5

1.4

—

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

400

1.08

0.15

1.1

16.32

15.85

u/ml

0.05

186

(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid

527

1.06

0.14

1.1

—

4.75

—

(3024263) Appearance of Synovial fluid

169

1.12

0.14

2.7

1.9

—

(44816559) Phosphatidylethanol [Mass/volume] in Blood

181

1865

0.97

0.14

1.3

1.6

0.23

0.30

mg/l

1.38

820

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

529

5375

0.98

0.14

1.6

1.8

1.35

1.39

0.89

465

4801

(40768446) Kidney Pathology biopsy report

149

0.87

0.13

1.2

1.6

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

715

7059

1.02

0.13

2.1

2.2

—

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

121

1254

0.96

0.13

2.0

1.9

1.55

2.00

ug/l

0.24

102

1120

(3000012) Reticulocyte production index

422

1.07

0.13

1.9

2.2

0.79

0.89

0.58

270

(3006217) Methemoglobin/Hemoglobin.total in Arterial blood

209

2145

0.97

0.13

9.0

9.8

0.63

0.65

0.33

209

2134

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

257

1.09

0.13

1.2

1.1

—

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

132

1.14

0.13

3.5

2.6

0.61

0.62

mmol/l

0.21

132

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

173

1681

1.03

0.13

1.3

1.4

—

(40765089) Chromosome analysis panel - Blood by G-banded

159

0.88

0.13

1.0

—

(3005791) Eosinophil cationic protein (ECP) [Mass/volume] in Serum

211

0.90

0.13

4.5

2.7

13.10

148.49

ug/l

0.78

197

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

132

1277

1.03

0.13

2.8

2.5

3.52

3.60

g/l

0.25

126

1218

(46235355) HIV 1 and 2 tests - Meaningful Use set

1050

10403

1.01

0.12

1.9

2.0

—

(3007368) IgG [Mass/volume] in Cerebral spinal fluid

414

1.06

0.12

1.3

1.1

40.33

36.03

mg/l

0.24

358

(3045788) Cell count panel - Pleural fluid

272

0.92

0.12

1.4

—

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

412

4186

0.98

0.12

5.2

5.9

—

(3036670) Protein [Mass/volume] in Synovial fluid

1.16

0.11

1.3

1.2

47.82

38.57

g/l

—

(3015076) Soybean IgE Ab [Units/volume] in Serum

333

0.93

0.11

1.0

0.11

0.23

u/ml

—

(40768795) Lymph node Pathology biopsy report

415

1.06

0.11

1.1

1.2

—

(3019420) Tryptase [Mass/volume] in Serum or Plasma

302

0.93

0.11

1.0

1.5

15.54

7.81

ug/l

0.35

268

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

376

1.06

0.11

1.2

1.1

—

(3038177) Helicobacter pylori Ab [Presence] in Serum

857

1.04

0.11

1.2

—

(40768443) Skin Pathology biopsy report

183

1875

0.98

0.11

1.2

—

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

281

0.92

0.11

1.3

1.2

—

(3010726) Horse dander IgE Ab [Units/volume] in Serum

106

1025

1.03

0.11

1.0

1.1

1.74

1.43

u/ml

0.17

499

(3020779) Urea [Moles/volume] in Serum or Plasma

304

2986

1.02

0.11

6.5

7.5

8.58

mmol/l

0.00

293

2878

(3003327) Ova and parasites identified in Stool by Light microscopy

187

1827

1.02

0.10

1.7

—

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

938

1.03

0.10

1.2

261.40

263.03

u/ml

0.02

582

(3009595) Pneumocystis jirovecii DNA [Presence] in Specimen by NAA with probe detection

290

0.93

0.10

2.0

1.7

—

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

382

0.94

0.10

1.1

—

(3019174) dRVVT (LA screen)

1.14

0.10

1.0

1.1

—

(3022689) Creatine [Moles/volume] in Urine

135

0.89

0.09

1.3

1.5

9.31

8.25

mmol/l

0.24

135

(3014599) Egg white IgE Ab [Units/volume] in Serum

359

1.06

0.09

1.1

1.0

0.53

1.38

u/ml

—

(3017354) Segmented neutrophils/Leukocytes in Blood

359

1.06

0.09

3.2

3.0

54.90

56.49

0.17

322

(40768793) Breast Pathology biopsy report

144

1405

1.03

0.09

1.3

—

(3024474) Albumin [Mass/volume] in Cerebral spinal fluid

399

1.05

0.09

1.2

1.1

238.92

224.32

mg/l

0.20

357

(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma

1.13

0.09

1.3

1.1

—

(3014007) Fractional oxyhemoglobin in Arterial blood

219

2230

0.98

0.09

8.7

9.6

94.66

94.16

1.00

219

2221

(3028308) Erythrocytes [#/volume] in Pleural fluid

282

1.06

0.08

1.3

1.4

20436.95

71569.94

e6/l

0.97

146

(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

1.03

0.08

1.0

—

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

947

0.97

0.08

1.3

—

(3052318) Alpha-1-Microglobulin [Mass/volume] in Urine

0.81

0.08

2.0

3.4

—

26.64

—

(3045414) Leukocytes [Presence] in Urine

405

4002

1.01

0.08

2.0

2.1

0.00

0.02

estimate

1.95

869

(3032057) Clostridioides difficile [Presence] in Stool

1.09

0.08

1.4

2.0

—

(3008536) Aspergillus sp Ab [Presence] in Serum

1.08

0.08

1.1

1.8

—

(4015189) Microbial culture of sputum

1.04

0.08

3.0

2.6

—

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

0.84

0.07

1.3

2.5

12.67

5.32

ug/l

—

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

708

1.03

0.07

3.0

3.6

45.78

751.18

u/ml

1.21

648

(40768806) Pleura Pathology biopsy report

284

1.06

0.07

1.6

—

(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma

108

1.11

0.07

1.0

1.2

44.33

67.39

ug/l

2.01

108

(3016244) Insulin [Units/volume] in Serum or Plasma

343

1.05

0.07

2.9

3.5

30.26

27.68

mu/l

0.17

330

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

115

1176

0.98

0.07

2.7

3.4

1.45

1.42

mg/l

0.16

109

1099

(3001964) Herpes simplex virus Ag [Presence] in Specimen

118

1.10

0.07

2.7

1.5

—

(3003338) MCHC [Entitic Mass/volume] in Red Blood Cells

3552

35461

1.01

0.07

22.5

17.7

331.98

331.83

g/l

0.49

3539

35274

(3036071) Salmonella sp Ab [Titer] in Serum

167

1.08

0.06

1.1

—

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

832

0.97

0.06

5.5

5.7

172.63

399.97

iu/ml

—

106

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

0.88

0.06

1.0

1.3

—

(3003888) Timothy IgE Ab [Units/volume] in Serum

106

1084

0.98

0.06

1.0

1.1

3.44

5.05

u/ml

0.77

576

(44790049) Parainfluenza type 3 nucleic acid detection

512

1.04

0.06

1.7

1.5

—

(44790047) Parainfluenza type 1 nucleic acid detection

512

1.04

0.06

1.7

1.5

—

(44790048) Parainfluenza type 2 nucleic acid detection

512

1.04

0.06

1.7

1.5

—

(44806118) Parainfluenza type 4 nucleic acid detection

512

1.04

0.06

1.7

1.5

—

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

192

1891

1.02

0.06

2.0

1.8

3.38

4.33

mg/l

1.15

159

1396

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

101

0.89

0.06

1.0

1.1

—

(3036048) Francisella tularensis Ab [Titer] in Serum

100

0.90

0.06

1.1

—

222.86

—

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

104

0.87

0.06

1.1

—

(3020191) Ethanol [Moles/volume] in Serum or Plasma

315

0.95

0.06

1.3

1.7

1.05

1.19

promille

0.23

250

(3034426) Prothrombin time (PT)

148

1.08

0.06

1.2

27.94

28.28

0.10

148

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

111

0.90

0.06

1.1

—

(4198724) Urine methamphetamine measurement

207

1.06

0.06

1.5

3.2

—

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

582

1.03

0.06

1.1

1.2

—

(3037756) Immunofixation for Serum or Plasma

648

0.97

0.05

2.2

1.6

—

(3045424) Erythrocytes [Presence] in Urine

198

2007

0.99

0.05

2.1

0.04

0.37

estimate

0.45

700

(3039443) Prostate specific Ag panel - Serum or Plasma

306

1.05

0.05

1.4

1.6

—

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

131

0.92

0.05

3.0

3.1

2.04

1.32

0.30

131

(3006442) Creatine [Moles/volume] in Serum or Plasma

257

1.05

0.05

1.1

1.5

68.70

72.67

umol/l

0.68

257

(43055514) Macroprolactin [Presence] in Serum or Plasma

151

0.93

0.05

1.1

1.4

—

(3001186) Copper [Moles/volume] in Serum or Plasma

149

1.07

0.05

1.8

1.4

16.65

17.16

umol/l

0.23

124

(3006653) Thiamine [Moles/volume] in Blood

228

1.05

0.05

1.0

1.4

135.58

131.30

nmol/l

0.25

228

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

404

0.97

0.05

1.2

1.1

—

(3043238) Trisomy 21 risk [Likelihood] in Fetus

166

1638

1.01

0.05

1.5

1.6

—

(3028300) Cannabinoids [Presence] in Urine

219

2214

0.99

0.04

1.5

2.1

—

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

123

1249

0.98

0.04

1.1

2.22

1.88

u/ml

0.12

647

(3049717) Cytology report of Urine Cyto stain

973

1.02

0.04

2.9

2.3

—

(3020650) Glucose [Presence] in Urine

150

0.93

0.04

1.3

1.7

0.00

0.02

estimate

0.50

150

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

1.10

0.04

1.0

—

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

1.10

0.04

1.0

—

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

1.10

0.04

1.0

—

(3010144) Erythrocytes [#/volume] in Synovial fluid

318

1.04

0.04

1.4

26928.74

114965.70

e6/l

1.33

214

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

251

0.96

0.04

1.6

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

170

1.06

0.04

1.7

1.6

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

170

1.06

0.04

1.7

1.6

—

(44813793) Dust mix specific IgE antibody measurement

372

0.97

0.04

1.1

—

(4281824) Cell count and differential, peritoneal fluid

533

0.98

0.04

1.1

—

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

141

1.06

0.03

1.3

1.4

197.28

146.12

pmol/l

0.67

141

(3047352) Trisomy 18 risk [Likelihood] in Fetus

161

1593

1.01

0.03

1.4

1.5

—

(3007930) Methemoglobin/Hemoglobin.total in Blood

135

1334

1.01

0.03

4.5

5.8

0.81

0.90

1.61

127

1255

(3008152) Bicarbonate [Moles/volume] in Arterial blood

203

2012

1.01

0.03

4.3

7.1

24.62

24.45

mmol/l

0.32

192

1922

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

151

1.06

0.03

2.0

2.3

—

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

290

1.03

0.03

1.1

1.3

—

(3034891) Synovial lining cells/cells in Synovial fluid

189

0.95

0.03

1.1

1.5

6.60

4.63

—

(3018572) Chloride [Moles/volume] in Blood

672

0.98

0.03

5.8

8.4

105.38

105.23

mmol/l

0.10

603

(3027944) Amphetamines [Presence] in Urine

217

2187

0.99

0.03

1.5

2.1

—

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

898

1.01

0.02

1.4

1.5

—

(3039000) Anion gap in Blood by calculation

671

0.98

0.02

5.8

8.4

11.22

11.12

mmol/l

0.10

602

(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose

689

1.02

0.02

1.5

1.4

6.45

7.06

mmol/l

1.80

626

(3027008) Opiates [Presence] in Urine

219

2204

0.99

0.02

1.5

2.0

—

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

780

1.01

0.02

1.3

1.2

5.19

3.32

u/ml

0.25

277

(3042111) Morphology [Interpretation] in Bone marrow Narrative

539

0.98

0.02

1.7

—

(3003191) Choriogonadotropin [Presence] in Serum or Plasma

198

1968

1.01

0.02

1.9

—

(3044927) Protein electrophoresis panel - Urine

312

1.03

0.02

1.6

1.2

—

(3005033) Fetal Nuchal fold Thickness US

158

1569

1.01

0.02

1.4

1.5

1.21

1.26

0.77

106

1130

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

681

1.01

0.01

1.6

—

(3014148) Varicella zoster virus Ab [Titer] in Serum

769

0.99

0.01

1.3

1.2

—

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

101

1019

0.99

0.01

1.9

1.6

—

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

582

5807

1.00

0.01

1.8

1.9

3.48

3.39

ratio

0.61

440

4338

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

698

0.99

0.01

1.2

1.3

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

698

0.99

0.01

1.2

1.3

—

(3016879) Cocaine [Presence] in Urine

202

2029

1.00

0.01

1.5

2.1

—

(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum

413

1.02

0.01

1.0

1.1

7.38

9.23

iu/ml

0.41

120

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

474

1.01

0.00

1.0

1.1

—

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

106

1066

0.99

0.00

1.2

1.3

—

(3000764) Benzodiazepines [Presence] in Urine

219

2196

1.00

0.00

1.5

2.1

—

(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay

108

1.02

0.00

1.8

2.3

—

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

118

1.02

0.00

1.2

1.0

—

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

118

1.02

0.00

1.2

1.1

—

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

138

1.01

0.00

1.1

1.2

—

(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay

155

0.97

0.00

1.1

1.3

104.20

95.56

—

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

275

1.02

0.00

1.2

1.1

—

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

153

1528

1.00

0.00

1.6

0.08

0.32

iu/ml

0.91

263

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

755

1.01

0.00

1.1

—

(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain

1.04

0.00

1.5

1.1

—

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

104

0.96

0.00

2.2

5.3

5.03

4.93

kpa

—

104

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

104

0.96

0.00

2.2

5.3

10.39

10.55

kpa

—

104

(3000060) B lymphocytes [#/volume] in Blood

154

0.97

0.00

1.7

2.1

0.21

0.17

e9/l

—

(3011412) CD3 cells [#/volume] in Blood

426

1.01

0.00

1.7

2.3

1248.45

1312.59

e6/l

0.23

371

(40768800) Prostate Pathology biopsy report

247

1.01

0.00

1.1

1.2

—

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

337

1.01

0.00

1.8

2.2

—

(3008401) Mugwort IgE Ab [Units/volume] in Serum

104

1044

1.00

0.00

1.0

1.1

0.40

1.00

u/ml

2.20

441

(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay

161

0.99

0.00

1.1

104.60

92.41

—

(3044242) Glucose [Moles/volume] in Arterial blood

191

0.99

0.00

2.4

2.5

8.47

8.61

mmol/l

0.09

191

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

241

1.00

0.00

1.2

1483.33

1042.55

titre

—

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

299

1.00

0.00

1.7

2.2

534.40

538.80

e6/l

0.02

237

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

369

1.00

0.00

1.2

—

(3034037) Hematocrit [Volume Fraction] of Mixed venous blood by calculation

1.02

0.00

6.8

7.0

13.02

10.77

—

(40762365) Oxygen content in Arterial blood by calculation

1.02

0.00

2.0

2.6

15.60

15.15

ml/dl

—

(3024869) Neuronal Ab [Presence] in Serum

0.94

0.00

1.7

1.1

—

(42868452) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Bone marrow by Molecular genetics method

0.00

-0.00

0.0

1.0

—

(3038714) Yersinia pseudotuberculosis Ab [Titer] in Serum by Agglutination

0.00

-0.00

0.0

1.0

—

(3040944) Yersinia pseudotuberculosis 3 Ab [Titer] in Serum

0.00

-0.00

0.0

1.0

—

(3007919) Fasciola sp Ab [Titer] in Serum

0.00

-0.00

0.0

1.0

—

(3035457) Cefaclor IgE Ab [Units/volume] in Serum

0.85

-0.00

1.0

1.1

0.02

0.03

u/ml

—

(3000219) Insulin receptor Ab [Presence] in Serum

0.00

-0.00

0.0

1.0

—

(3016816) Cytomegalovirus IgG Ab [Presence] in Serum or Plasma

0.00

-0.00

0.0

1.0

—

(3040794) Aluminum [Moles/volume] in Urine

0.00

-0.00

0.0

1.0

—

0.27

—

(3047185) IgG [Mass/volume] in Urine

0.00

-0.00

0.0

1.0

—

(3025830) Chlamydophila pneumoniae IgM Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.0

—

19.20

—

(3013336) Amino acids [Identifier] in Serum or Plasma

0.00

-0.00

0.0

6.7

—

(3042341) Yersinia pseudotuberculosis Ab [Presence] in Serum

0.00

-0.00

0.0

2.0

—

(3043722) Hyaline casts [#/area] in Urine sediment by Automated count

0.00

-0.00

0.0

1.0

—

1.20

—

(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma

0.91

-0.00

1.2

1.1

—

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

120

1.00

-0.00

1.1

—

(3000690) Aldosterone [Moles/time] in 24 hour Urine

0.00

-0.00

0.0

1.0

—

37.17

—

(3044291) Thermoactinomyces vulgaris IgG Ab [Mass/volume] in Serum

0.00

-0.00

0.0

1.0

—

(3033093) Yersinia sp IgM Ab [Titer] in Serum

0.00

-0.00

0.0

2.0

—

(3005011) Chlamydia sp Ab [Titer] in Serum

0.87

-0.00

2.0

1.5

—

(3023693) von Willebrand factor (vWf) multimers in Platelet poor plasma by Immunoblot

0.00

-0.00

0.0

1.3

—

(3028714) Urate [Moles/time] in 24 hour Urine

0.00

-0.00

0.0

1.0

—

(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose

0.97

-0.00

1.3

5.30

5.66

mmol/l

—

(46236344) Yersinia enterocolitica O:9 IgG Ab [Presence] in Serum by Agglutination

0.00

-0.00

0.0

1.0

—

(3027305) Fractional oxyhemoglobin in Arterial cord blood

0.00

-0.00

0.0

1.3

—

34.57

—

(40763641) Cell count and Differential panel - Peritoneal dialysis fluid

0.00

-0.00

0.0

4.9

—

(3039183) Clostridium tetani toxoid IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

0.00

-0.00

0.0

1.0

—

(3012441) Differential panel - Pleural fluid

280

1.00

-0.00

1.2

1.4

—

(3011897) Casein IgE Ab [Units/volume] in Serum

0.92

-0.00

1.1

1.2

0.01

5.67

u/ml

—

(3018910) Alkaline phosphatase.bone [Mass/volume] in Serum or Plasma

0.00

-0.00

0.0

1.2

—

44.98

—

(3002814) Trichinella spiralis Ab [Titer] in Serum

0.00

-0.00

0.0

1.0

—

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

0.97

-0.00

1.2

1.6

—

(3043410) Blood group antigens tested for on Red Blood Cells

110

1.00

-0.00

1.4

1.3

—

(3039817) Yersinia enterocolitica IgA Ab [Presence] in Serum

0.00

-0.00

0.0

2.0

—

Mortality – FinRegistry

↥

Association

Association between endpoint E4_GRAVES_STRICT and mortality.

Females

Parameter	HR [95% CI]	p-value
E4_GRAVES_STRICT	1.07 [0.94, 1.22]	0.294
Birth year	0.992 [0.98, 1.0]	0.082

During the follow-up period (1.1.1998 — 31.12.2019), 1142 out of 16342 females with E4_GRAVES_STRICT died.

Males

Parameter	HR [95% CI]	p-value
E4_GRAVES_STRICT	1.036 [0.89, 1.21]	0.654
Birth year	0.991 [0.98, 1.0]	0.053

During the follow-up period (1.1.1998 — 31.12.2019), 345 out of 3489 males with E4_GRAVES_STRICT died.

Mortality risk

Mortality risk for people of age

years, who have E4_GRAVES_STRICT.

N-year risk	Females	Males
1	0.062%	0.176%
5	0.599%	1.156%
10	1.414%	3.262%
15	2.705%	6.508%
20	4.747%	11.059%

Relationships between endpoints

↥

Index endpoint: E4_GRAVES_STRICT – Graves disease, strict definition

GWS hits: 24

Endpoint

Case Overlap

Survival Analysis

Genetic Correlations

Genetic Signals

N (Jaccard index)

HR [CI]

rg [CI]

Hits

Coloc Hits

FinRegistry

FinnGen

FinRegistry

FinnGen

Loading data

Graves disease, strict definition

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS

Matched cohort

TimeCodeWAS

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints